Crown (CCK) 10-K 28 Feb 22 2021 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2021	Feb. 23, 2022	Jun. 30, 2021
Document Information [Line Items]
Document Type	10-K
Document Annual Report	true
Current Fiscal Year End Date	--12-31
Document Period End Date	Dec. 31, 2021
Document Transition Report	false
Entity File Number	000-50189
Entity Registrant Name	CROWN HOLDINGS, INC.
Entity Incorporation, State or Country Code	PA
Entity Tax Identification Number	75-3099507
Entity Address, Address Line One	770 Township Line Road
Entity Address, City or Town	Yardley
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19067-4232
City Area Code	215
Local Phone Number	698-5100
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Entity Shell Company	false
Entity Public Float			$ 13,507,815,724
Entity Common Stock, Shares Outstanding		124,572,262
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Central Index Key	0001219601
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Document Parts Into Which Incorporated Proxy Statement for the Annual Meeting of Shareholders to be held April 28, 2022 Part III to the extent described therein
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock $5.00 Par Value
Trading Symbol	CCK
Security Exchange Name	NYSE
7 3/8% Debentures Due 2026
Document Information [Line Items]
Title of 12(b) Security	7 3/8% Debentures Due 2026
Trading Symbol	CCK26
Security Exchange Name	NYSE
7 1/2% Debentures Due 2096
Document Information [Line Items]
Title of 12(b) Security	7 1/2% Debentures Due 2096
Trading Symbol	CCK96
Security Exchange Name	NYSE

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2021
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Firm ID	238
Auditor Location	Philadelphia, Pa

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement [Abstract]
Net sales	$ 11,394	$ 9,392	$ 9,559
Cost of products sold, excluding depreciation and amortization	9,029	7,359	7,575
Depreciation and amortization	447	422	431
Selling and administrative expense	583	533	556
Restructuring and other	(28)	30	(30)
Income from operations	1,363	1,048	1,027
Loss from early extinguishments of debt	68	0	27
Other pension and postretirement	1,515	43	10
Interest expense	253	290	367
Interest income	(9)	(8)	(15)
Foreign exchange	(45)	(2)	7
(Loss) / income from continuing operations before income taxes and equity in net earnings of affiliates	(419)	725	631
(Benefit from) / provision for income taxes	(57)	199	136
Equity in net earnings of affiliates	3	6	5
Net (loss) / income from continuing operations	(359)	532	500
Net (loss) / income from discontinued operations	(52)	156	125
Net (loss) / income	(411)	688	625
Net income from continuing operations attributable to noncontrolling interests	148	108	113
Net income from discontinued operations attributable to noncontrolling interests	1	1	2
Net (loss) / income attributable to Crown Holdings	(560)	579	510
Net (loss) / income from continuing operations attributable to Crown Holdings	(507)	424	387
Net (loss) / income from discontinued operations attributable to Crown Holdings	$ (53)	$ 155	$ 123
Earnings per common share attributable to Crown Holdings:
Basic (loss) / earnings per common share from continuing operations (in dollars per share)	$ (3.89)	$ 3.18	$ 2.89
Basic (loss) / earnings per common share from discontinued operations (in dollars per share)	(0.41)	1.16	0.92
Basic (in dollars per share)	(4.30)	4.34	3.81
Diluted (loss) / earnings per common share from continuing operations (in dollars per share)	(3.89)	3.15	2.87
Diluted (loss) / earnings per common share from discontinued operations (in dollars per share)	(0.41)	1.15	0.91
Diluted (in dollars per share)	$ (4.30)	$ 4.30	$ 3.78

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Statement of Comprehensive Income [Abstract]
Net (loss) / income	$ (411)	$ 688	$ 625
Other comprehensive income / (loss), net of tax
Foreign currency translation adjustments	601	(88)	150
Pension and other postretirement benefits	696	(15)	84
Derivatives qualifying as hedges	(2)	46	11
Total other comprehensive income / (loss)	1,295	(57)	245
Total comprehensive income	884	631	870
Net income attributable to noncontrolling interests	149	109	115
Translation adjustments attributable to noncontrolling interests	(1)	3	1
Derivatives qualifying as hedges attributable to noncontrolling interests	1	2	1
Comprehensive income attributable to Crown Holdings	$ 735	$ 517	$ 753

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 531	$ 1,173
Receivables, net	1,889	1,522
Inventories	1,735	1,263
Prepaid expenses and other current assets	243	202
Current assets held for sale	97	743
Total current assets	4,495	4,903
Goodwill	3,007	3,146
Intangible assets, net	1,525	1,755
Property, plant and equipment, net	4,036	3,652
Operating lease right-of-use assets	191	171
Other non-current assets	604	885
Non-current assets held for sale	0	2,179
Total assets	13,858	16,691
Current liabilities
Short-term debt	75	104
Current maturities of long-term debt	135	67
Current portion of operating lease liabilities	42	43
Accounts payable	2,901	2,141
Accrued liabilities	966	946
Current liabilities held for sale	14	981
Total current liabilities	4,133	4,282
Long-term debt, excluding current maturities	6,052	8,023
Postretirement and pension liabilities	497	685
Non-current portion of operating lease liabilities	150	132
Other non-current liabilities	696	766
Non-current liabilities held for sale	0	199
Commitments and contingent liabilities (Note P)
Equity
Noncontrolling interests	418	406
Preferred stock, authorized: 30,000,000; none issued (Note T)	0	0
Common stock, par value: $5.00; authorized: 500,000,000 shares; issued: 185,744,072 shares (Note T)	929	929
Additional paid-in capital	0	179
Accumulated earnings	3,180	4,538
Accumulated other comprehensive loss	(1,898)	(3,193)
Treasury stock at par value (2021 - 59,612,273 shares; 2020 - 50,943,042 shares)	(299)	(255)
Crown Holdings shareholders’ equity	1,912	2,198
Total equity	2,330	2,604
Total liabilities and equity	$ 13,858	$ 16,691

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Preferred stock, shares authorized (in shares)	30,000,000	30,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 5	$ 5
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	185,744,072	185,744,072
Treasury stock (in shares)	59,612,273	50,943,042

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities
Net (loss) / income	$ (411)	$ 688	$ 625
Adjustments to reconcile net (loss) / income to net cash provided by operating activities:
Depreciation and amortization	463	481	490
Restructuring and other	(26)	34	(26)
Loss from disposal of discontinued operations	101	0	0
Goodwill impairment	0	0	25
Pension expense	1,567	92	66
Pension contributions	(236)	(27)	(23)
Stock-based compensation	33	32	29
Loss from early extinguishments of debt	68	0	27
Deferred income taxes	(248)	33	(35)
Changes in assets and liabilities:
Receivables	(590)	(186)	60
Inventories	(609)	(2)	61
Accounts payable and accrued liabilities	873	121	(87)
Other, net	(80)	49	(49)
Net cash provided by operating activities	905	1,315	1,163
Cash flows from investing activities
Capital expenditures	(816)	(587)	(432)
Proceeds from sale of discontinued operations, net of cash disposed	2,255	0	0
Proceeds from sale of property, plant and equipment	44	16	39
Net investment hedges	25	28	23
Other	(1)	8	(4)
Net cash provided by / (used for) investing activities	1,507	(535)	(374)
Cash flows from financing activities
Net change in revolving credit facility and short-term debt	12	29	(10)
Proceeds from long-term debt	144	110	2,216
Payments of long-term debt	(1,834)	(269)	(2,845)
Premiums paid to retire debt	(64)	0	0
Debt issuance costs	0	0	(18)
Foreign exchange derivatives related to debt	(25)	43	(16)
Finance lease payments	(2)	(3)	(15)
Dividends paid to noncontrolling interests	(122)	(87)	(101)
Contribution from noncontrolling interests	0	2	6
Dividends paid to shareholders	(105)	0	0
Common stock issued	2	2	4
Common stock repurchased	(950)	(66)	(7)
Net cash used for financing activities	(2,944)	(239)	(786)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(113)	34	1
Net change in cash, cash equivalents and restricted cash	(645)	575	4
Cash, cash equivalents and restricted cash at January 1	1,238	663	659
Cash, cash equivalents and restricted cash at December 31	$ 593	$ 1,238	$ 663

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Millions		Total	Total Crown Equity	Common Stock	Paid-in Capital	Accumulated Earnings	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2018		$ 1,286	$ 937	$ 929	$ 186	$ 3,449	$ (3,374)	$ (253)	$ 349
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) / income		625	510			510			115
Other comprehensive income (loss)		245	243				243		2
Dividends paid to noncontrolling interests		(101)							(101)
Contribution from noncontrolling interests		10							10
Sale of noncontrolling interests		1	(3)		(3)				4
Restricted stock awarded					(2)			2
Stock-based compensation		29	29		29
Common stock issued		4	4		4
Common stock repurchased		(7)	(7)		(7)
Balance at end of period at Dec. 31, 2019		2,092	1,713	929	207	3,959	(3,131)	(251)	379
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) / income		688	579			579			109
Other comprehensive income (loss)		(57)	(62)				(62)		5
Dividends paid to noncontrolling interests		(87)							(87)
Restricted stock awarded					(2)			2
Stock-based compensation		32	32		32
Common stock issued		2	2		2
Common stock repurchased		(66)	(66)		(60)			(6)
Balance at end of period at Dec. 31, 2020		2,604	2,198	929	179	4,538	(3,193)	(255)	406
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net (loss) / income		(411)	(560)			(560)			149
Other comprehensive income (loss)		1,295	1,295				1,295
Dividends paid to shareholders		(105)	(105)			(105)
Dividends paid to noncontrolling interests		(122)							(122)
Restricted stock awarded		(1)	(1)		(3)			2
Stock-based compensation		33	33		17	16
Common stock issued		2	2		2
Common stock repurchased		(950)	(950)		(195)	(709)		(46)
Disposition of subsidiary with noncontrolling interests	[1]	(15)							(15)
Balance at end of period at Dec. 31, 2021		$ 2,330	$ 1,912	$ 929	$ 0	$ 3,180	$ (1,898)	$ (299)	$ 418
[1]	Relates to the sale of the European Tinplate business. See Note B for further details.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Business and Principles of Consolidation . The consolidated financial statements include the accounts of Crown Holdings, Inc. (the “Company”) and its consolidated subsidiary companies (where the context requires, the “Company” shall include reference to the Company and its consolidated subsidiary companies). The Company is a worldwide leader in the design, manufacture and sale of packaging products for consumer goods and industrial products. The Company's consumer packaging solutions primarily support the beverage and food industries through the sale of aluminum and steel cans. The Company's packaging for industrial products includes steel and plastic consumables and equipment, paper-based protective packaging, and plastic film consumables and equipment, which are sold into the metals, food and beverage, construction, agricultural, corrugated and general industries. The financial statements were prepared in conformity with accounting principles generally accepted in the United States of America and reflect management’s estimates and assumptions. Actual results could differ from those estimates, impacting reported results of operations and financial position. All intercompany accounts and transactions are eliminated in consolidation. In deciding which entities should be reported on a consolidated basis, the Company first determines whether the entity is a variable interest entity (“VIE”). If an entity is a VIE, the Company determines whether it is the primary beneficiary and therefore, should consolidate the VIE. If an entity is not a VIE, the Company consolidates those entities in which it has control, including certain subsidiaries that are not majority-owned. Certain of the Company’s agreements with noncontrolling interests contain provisions in which the Company would surrender certain decision-making rights upon a change in control of the Company. Accordingly, consolidation of these operations may no longer be appropriate subsequent to a change in control of the Company, as defined in the agreements. Investments in companies in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for by the equity method. The proportionate share of the net income / (loss) resulting from these investments is reported in Equity in net earnings of affiliates in the Consolidated Statement of Operations. The carrying value of the Company's equity method investments are reported in Other non-current assets in the Consolidated Balance Sheets. Equity method investments are reported at cost and adjusted each period for the Company's share of the investee's income or loss and dividends paid, if any. The Company assess investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. Other investments are carried at cost. Foreign Currency Translation . For non-U.S. subsidiaries which operate in a local currency environment, assets and liabilities are translated into U.S. dollars at year-end exchange rates. Income, expense and cash flow items are translated at average exchange rates prevailing during the year. Translation adjustments for these subsidiaries are accumulated as a separate component of accumulated other comprehensive income in equity. For non-U.S. subsidiaries that use a U.S. dollar functional currency, local currency inventories and property, plant and equipment are translated into U.S. dollars at rates prevailing when acquired; all other assets and liabilities are translated at year-end exchange rates. Inventories charged to cost of sales and depreciation are remeasured at historical rates; all other income and expense items are translated at average exchange rates prevailing during the year. Gains and losses which result from remeasurement are included in earnings. Revenue Recognition . The majority of the Company’s revenues from metal packaging products are derived from multi-year requirement contracts with leading manufacturers and marketers of packaged consumer products for can sets, comprising a can and an end. As requirement contracts do not typically include fixed volumes, customers often purchase products pursuant to purchase orders or other communications which are short-term in nature. The can and the end are considered separate performance obligations because they are distinct and separately identifiable. Revenues from Transit Packaging are generally derived from individual purchase orders which may include multiple goods and services which are separate performance obligations because they are distinct and separately identifiable. The Company manufactures certain products that have no alternative use to the Company once they are printed or manufactured to customer specifications. If the Company has an enforceable right to payment for custom products at all times in the manufacturing process, revenue is recognized over time. In each of the Company’s geographic markets, revenue from beverage cans is primarily recognized over time using the units produced output method as beverage cans are generally printed for a specific customer in a continuous production process. The timing of revenue recognition for the Company’s other products, including beverage ends and three-piece products, which includes food cans and ends and aerosol cans and ends, may vary as these products may be printed or customized depending upon customer preferences which can vary by geographic market. Revenue that is recognized over time for the Company’s three-piece products and equipment business is generally recognized using the cost-to-cost input method as these products involve an intermediary step that results in customized work-in-process inventory. For products that follow a point in time model, revenue is generally recognized when title and risk of loss transfer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Standalone selling prices for each performance obligation are generally stated in the contract. When the Company offers variable consideration in the form of volume rebates to customers, it estimates the most likely amount of revenue to which it is expected to be entitled and includes the estimate in the transaction price, limited to the amount which is probable will not result in reversal of cumulative revenue recognized when the variable consideration is resolved. When the Company offers customers options to purchase additional product at discounted prices, judgment is required to determine if the discounted prices represent material rights. If so, the transaction price allocated to the discount is based on its relative standalone price and is recognized upon purchase of the additional product. Customer payment terms are typically less than one year and as such, the Company has applied the practical expedient to exclude consideration of significant financing components from the determination of transaction price. Taxes collected from customers and remitted to governmental authorities are excluded from net sales. Shipping and handling fees and costs from product sales are reported as cost of products sold and are accrued when the Company recognizes revenue over time before the shipping and handling activities occur. Costs to obtain a contract are generally immaterial but the Company has elected the practical expedient to expense these costs as incurred if the duration of the contract is one year or less. Unbilled receivables are recorded for revenue recognized over time when the Company has determined that control has passed to the customer but the customer has not yet been invoiced because the Company does not have present right to payment. The Company generally has a present right to payment when title of product transfers. Unbilled receivables are included in receivables in the Consolidated Balance Sheet with a corresponding decrease to inventory. Contract assets are recorded for revenue recognized over time when the Company has determined that control for a performance obligation has passed to the customer, but the right to invoice the customer is contingent upon the completion of the performance obligations included in the contract. Contract assets are classified as current as they are expected to be invoiced within one year and may not exceed their net realizable value. Contract liabilities are established if the Company must defer the recognition of a portion of consideration received because it has to satisfy a future obligation. Contract liabilities are classified as current or noncurrent based on when the Company expects to recognize revenue. Stock-Based Compensation . For awards with a service or market condition, compensation expense is recognized over the vesting period on a straight-line basis using the grant date fair value of the award and the estimated number of awards that are expected to vest. For awards with a performance condition, the Company assesses the probability of vesting at each reporting period and adjusts compensation cost based on its probability assessment. The Company’s plans provide for stock awards which may include accelerated vesting upon retirement, disability, or death of eligible employees. The Company considers a stock-based award to be vested when the service period is no longer contingent on the employee providing future service. Accordingly, the related compensation cost is recognized immediately for awards granted to retirement-eligible individuals, or over the period from the grant date to the date that retirement eligibility is achieved if less than the stated vesting period. Cash, Cash Equivalents and Restricted Cash . Cash equivalents represent investments with maturities of three months or less from the time of purchase and are carried at cost, which approximates fair value because of the short maturity of those instruments. Outstanding checks in excess of funds on deposit are included in accounts payable. The Company generally classifies any cash that is legally restricted as to withdrawal or usage as restricted cash. Accounts Receivable and Allowance for Credit Losses. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The measurement of expected credit losses is based on past events, historical experience, current conditions and forecasts that affect the collectability of accounts receivable. Inventory Valuation . Inventories are stated at the lower of cost or net realizable value, with cost principally determined under the first-in, first-out (“FIFO”) or average cost method. Property, Plant and Equipment . Property, plant and equipment (“PP&E”) is carried at cost less accumulated depreciation and includes expenditures for new facilities and equipment and those costs which substantially increase the useful lives or capacity of existing PP&E. Cost of constructed assets includes capitalized interest incurred during the construction and development period. Maintenance and repairs, including labor and material costs for planned major maintenance such as annual production line overhauls, are expensed as incurred. When PP&E is retired or otherwise disposed, the net carrying amount is eliminated with any gain or loss on disposition recognized in earnings at that time. Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). The Company periodically reviews the estimated useful lives of its PP&E and, where appropriate, changes are made prospectively. Land improvements 25 Buildings and building improvements 25 – 40 Machinery and equipment 3– 18 Goodwill and Intangible Assets . Assets and liabilities of acquired businesses are recorded under the acquisition method of accounting at their estimated fair values at the dates of acquisition. Goodwill represents costs in excess of fair values assigned to the underlying identifiable net assets of acquired businesses. Goodwill is carried at cost and reviewed for impairment annually in the fourth quarter of each year or when facts and circumstances indicate goodwill may be impaired. Goodwill is allocated to the reporting units at the time of each acquisition based on the relative fair values of the reporting units. In assessing goodwill for impairment, the Company may first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Further quantitative assessment may then be required. The quantitative assessment involves a number of assumptions and judgments, including the calculation of fair value for the Company’s identified reporting units. The Company determines the estimated fair value of each reporting unit based on an average of the estimated fair values using an income and a market approach. The income approach utilizes significant assumptions, including revenue and Adjusted EBITDA (a non-GAAP item defined by the Company as net customer sales, less cost of products sold excluding depreciation and amortization, less selling and administrative expenses) margin growth rates, discount rates and terminal year exit multiples. If the carrying value of a reporting unit exceeds its fair value, any impairment loss is measured by comparing the carrying value of the reporting unit to its fair value, not to exceed the carrying amount of goodwill. Definite-lived intangible assets are carried at cost less accumulated amortization. Definite-lived intangibles are amortized on a straight-line basis over their estimated useful lives described below (in years). Definite-lived intangible assets are tested for impairment when facts and circumstances indicate the carrying value may not be recoverable from their undiscounted cash flows. If impaired, the assets are written down to fair value based on either discounted cash flows or appraised values. Customer relationships 11 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8 Impairment or Disposal of Long-Lived Assets . In the event that facts and circumstances indicate that the carrying value of long-lived assets, primarily PP&E, may be impaired, the Company performs a recoverability evaluation. If the evaluation indicates that the carrying value of an asset is not recoverable from its undiscounted cash flows, an impairment loss is measured by comparing the carrying value of the asset to its fair value, based on discounted cash flows. Long-lived assets classified as held for sale are presented in the balance sheet at the lower of their carrying value or fair value less cost to sell. Leases. The Company has operating and finance leases for land and buildings related to certain manufacturing facilities, warehouses and corporate offices, vehicle fleets and certain office and manufacturing equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company's lease terms include options to extend the lease when it is reasonably certain that the Company will exercise the option. Variable lease payment amounts that cannot be determined at commencement of the lease, such as increases in index rates, are not included in the measurement of the lease liabilities and corresponding right-of-use assets and are recognized in the period those payments are incurred. The Company separates lease and non-lease components of lease arrangements and allocates contract consideration based on standalone selling prices. Variable consideration is allocated to the lease and non-lease components to which the variable payments specifically relate. The discount rate implicit within the Company's leases is often not determinable and therefore the Company generally uses its incremental borrowing rate based on the information available at the commencement date of the lease in determining the present value of the lease payments. The incremental borrowing rate is determined based on lease term and the currency in which lease payments are made. The Company's leases do not contain any material residual value guarantees or material restrictive covenants. Taxes on Income . The provision for income taxes is determined using the asset and liability approach. Deferred taxes represent the future expected tax consequences of differences between the financial reporting and tax bases of assets and liabilities based upon enacted tax rates and laws. The Company has made an accounting policy election to treat taxes due on future U.S. inclusions of certain intangible income of foreign subsidiaries as a current period expense when incurred. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Investment tax credits are accounted for using the deferral method. Income tax-related interest and penalties are reported as income tax expense. Derivatives and Hedging . All outstanding derivative financial instruments are recognized in the balance sheet at their fair values. The impact on earnings from recognizing the fair values of these instruments depends on their intended use, their hedge designation and their effectiveness in offsetting changes in the fair values of the exposures they are hedging. Changes in the fair values of instruments designated to reduce or eliminate adverse fluctuations in the fair values of recognized assets and liabilities are reported currently in earnings along with changes in the fair values of the hedged items. Changes in the effective portions of the fair values of instruments used to reduce or eliminate adverse fluctuations in cash flows of anticipated or forecasted transactions are reported in equity as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified to earnings when the related hedged items impact earnings or the forecasted transactions become probable of not occurring. Changes in the fair values of derivative instruments that are not designated as hedges or do not qualify for hedge accounting treatment are reported currently in earnings. Amounts reported in earnings are classified consistent with the item being hedged. The effectiveness of derivative instruments in reducing risks associated with the hedged exposures is assessed at inception and on an ongoing basis. Time value, a component of an instrument’s fair value, is excluded in assessing effectiveness for fair value hedges, except hedges of firm commitments, and included for cash flow hedges. Hedge accounting is discontinued prospectively when (i) the instrument is no longer effective in offsetting changes in fair value or cash flows of the underlying hedged item, (ii) the instrument expires, is sold, terminated or exercised, or (iii) designating the instrument as a hedge is no longer appropriate. The Company formally documents all relationships between its hedging instruments and hedged items at inception, including its risk management objective and strategy for establishing various hedge relationships. Cash flows from hedging instruments are classified in the Consolidated Statements of Cash Flows consistent with the items being hedged. Treasury Stock . Treasury stock is reported at par value. The excess of fair value over par value is first charged to paid-in capital, if any, and then to retained earnings. Research and Development . Research, development and engineering costs of $47 in 2021, $48 in 2020, and $50 in 2019 were expensed as incurred and reported in selling and administrative expense in the Consolidated Statements of Operations. Substantially all engineering and development costs are related to developing new products or designing significant improvements to existing products or processes. Costs primarily include employee salaries and benefits and facility costs. Reclassifications. Certain reclassifications of prior years’ data have been made to conform to the current year presentation. Recent Accounting and Reporting Pronouncements. Recently Adopted Accounting Standards On January 1, 2021, the Company adopted new guidance to simplify the accounting for income taxes by, among other things, reducing complexity in the interim-period accounting for year-to-date loss limitations and changes in tax laws. The guidance did not have a material impact on the Company's consolidated financial statements.

Divestitures

Divestitures	12 Months Ended
	Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]
Divestitures	Divestitures On August 31, 2021, the Company completed the sale (the “Transaction”) of its European Tinplate business (the “Business”) to Kouti B.V., an affiliate of KPS Capital Partners LP. The Business comprised the Company’s European Food segment and its European Aerosol and Promotional Packaging reporting unit which was previously reported in Other. The Company received pre-tax proceeds of approximately €1.9 billion ($2.3 billion) from the Transaction and received a 20% minority interest in the Business. Proceeds from the Transaction, along with cash provided by operating activities, were used to fund capital projects, repurchase Company stock and to redeem certain of the Company's senior notes as further described in Note M . The Company recorded a pre-tax loss of $101, including $553 of currency translation adjustments which were reclassified from accumulated other comprehensive income upon completion of the sale. The Company also recorded income tax charges of $81 related to taxable gains on the sale of the Business. Major components of net (loss) / income from discontinued operations were as follows: For the Years Ended December 31 2021 2020 2019 Net sales $ 1,585 $ 2,183 $ 2,106 Cost of products sold, excluding depreciation and amortization 1,301 1,823 1,774 Depreciation and amortization 16 59 59 Selling and administrative expense 60 81 75 Restructuring and other 2 4 4 Goodwill impairment — — 25 Other pension and postretirement 1 2 3 Interest expense 6 10 11 Interest income — — (2) Foreign exchange — 3 2 Loss on sale of discontinued businesses 101 — — Transaction costs 34 — — Income from discontinued operations before tax 64 201 155 Provision for income taxes 116 45 30 Net (loss) / income from discontinued operations (52) 156 125 Net income from discontinued operations attributable to noncontrolling interests 1 1 2 Net (loss) / income from discontinued operations attributable to Crown Holdings $ (53) $ 155 $ 123 Major classes of assets and liabilities of the Business classified as held for sale at December 31, 2020 were as follows: Receivables, net $ 281 Inventories 410 Prepaid expenses and other current assets 30 Total current assets held for sale $ 721 Goodwill $ 1,447 Intangible assets, net 125 Property, plant and equipment, net 546 Operating lease right-of-use assets, net 43 Other non-current assets 17 Total non-current assets held for sale $ 2,178 Short-term debt $ 17 Current portion of operating lease liabilities 12 Accounts payable 725 Accrued liabilities 227 Total current liabilities held for sale $ 981 Postretirement and pension liabilities $ 77 Non-current portion of operating lease liabilities 32 Other non-current liabilities 90 Total non-current liabilities held for sale $ 199 The table above excludes assets held for sale unrelated to the Business that are not material for disclosure. The capital expenditures of the Business were as follows: For the Years Ended December 31 2021 2020 2019 Capital expenditures $ 29 $ 33 $ 41 The Company accounted for the minority interest received in the Business under the equity method. The Company's share of income of the Business was a loss of $8 for the year ended December 31, 2021.

Cash, Cash Equivalents, and Res

Cash, Cash Equivalents, and Restricted Cash	12 Months Ended
	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash Cash, cash equivalents, and restricted cash included in the Company's Consolidated Balance Sheets and Statements of Cash Flows were as follows: 2021 2020 Cash and cash equivalents $ 531 $ 1,173 Restricted cash included in prepaid expenses and other current assets 61 64 Restricted cash included in other non-current assets 1 1 Total restricted cash 62 65 Total cash, cash equivalents and restricted cash $ 593 $ 1,238 Amounts included in restricted cash primarily represent amounts required to be segregated by certain of the Company's receivables securitization agreements.

Receivables

Receivables	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Receivables	Receivables 2021 2020 Accounts receivable $ 1,289 $ 1,084 Less: allowance for credit losses (20) (20) Net trade receivables 1,269 1,064 Unbilled receivables 325 248 Miscellaneous receivables 295 210 $ 1,889 $ 1,522 The Company uses receivables securitization and factoring facilities in the normal course of business as part of managing its cash flows. The Company primarily accounts for transfers under these facilities as sales because it has met the criteria for control of the receivables to be considered transferred. The Company’s continuing involvement in the transfers is limited to servicing the receivables. The Company receives adequate compensation for servicing the receivables and no servicing asset or liability is recorded. As of December 31, 2021 and 2020, the Company derecognized receivables of $1,011 and $852 related to the facilities. The Company recorded expenses related to the facilities for the years ended December 31, 2021, 2020 and 2019 of $13 as interest expense.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Inventories	Inventories 2021 2020 Raw materials and supplies $ 1,094 $ 800 Work in process 120 89 Finished goods 521 374 $ 1,735 $ 1,263

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill Changes in the carrying amount of goodwill by reportable segment for the years ended December 31, 2021 and 2020 were as follows: Americas Beverage European Beverage Transit Packaging Other Total Balance at January 1, 2020 $ 865 $ 534 $ 1,509 $ 184 $ 3,092 Foreign currency translation (26) 26 52 2 54 Balance at December 31, 2020 839 560 1,561 186 3,146 Held for sale reclassification — — (58) — (58) Foreign currency translation (14) (25) (42) — (81) Balance at December 31, 2021 $ 825 $ 535 $ 1,461 $ 186 $ 3,007 Goodwill reclassified to current assets held for sale during 2021 related to the expected sale of a Transit Packaging business. See Note B for more information. The carrying amount of goodwill at December 31, 2021 and 2020 was net of the following accumulated impairments: Americas Beverage European Beverage Other Total Accumulated impairments $ 29 $ 73 $ 11 $ 113

Intangible Assets Intangible As

Intangible Assets Intangible Assets	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Gross carrying amounts and accumulated amortization of finite-lived intangible assets by major class were as follows: December 31, 2021 December 31, 2020 Gross Accumulated amortization Net Gross Accumulated amortization Net Customer relationships $ 1,363 $ (443) $ 920 $ 1,413 $ (346) $ 1,067 Trade names 544 (86) 458 565 (65) 500 Technology 158 (88) 70 165 (67) 98 Long term supply contracts 137 (63) 74 142 (55) 87 Patents 15 (12) 3 13 (10) 3 $ 2,217 $ (692) $ 1,525 $ 2,298 $ (543) $ 1,755 Amortization expense for the years ended December 31, 2021, 2020, and 2019 was $165, $162 and $169. During the year-ended December 31, 2021, $13 of intangible assets related to the expected sale of a Transit Packaging business were reclassified to current assets held for sale. See Note B for more information.

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant and Equipment 2021 2020 Buildings and improvements $ 1,226 $ 1,137 Machinery and equipment 5,372 4,965 Land and improvements 208 223 Construction in progress 612 483 7,418 6,808 Less: accumulated depreciation and amortization (3,382) (3,156) $ 4,036 $ 3,652

Leases

Leases	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Leases	Leases The components of lease expense for the years ended December 31, 2021, 2020 and 2019 were as follows: 2021 2020 2019 Operating lease costs: Operating lease cost $ 48 $ 39 $ 36 Short-term lease cost 3 5 4 Total operating lease costs $ 51 $ 44 $ 40 Finance lease cost: Amortization of right-of-use assets $ 1 $ 1 $ 1 Total finance lease costs $ 1 $ 1 $ 1 Variable operating lease costs were $3 for each of the years ended December 31, 2021, 2020, and 2019. Interest on finance lease liabilities was less than $1 for each of the years ended December 31, 2021, 2020, and 2019. Supplemental cash flow information related to leases was as follows: 2021 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 51 $ 44 $ 38 Financing cash flows from finance leases 2 3 15 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 73 $ 42 $ 22 Supplemental balance sheet information related to finance leases was as follows: 2021 2020 Finance leases: Property, plant and equipment $ 26 $ 28 Accumulated depreciation (2) (2) Property, plant and equipment, net $ 24 $ 26 Accrued liabilities $ 2 $ 2 Other non-current liabilities 8 10 Total finance lease liabilities $ 10 $ 12 The weighted average remaining lease term and weighted average discount rates for each year were as follows: 2021 2020 Weighted average remaining lease term (years): Operating leases 10.8 10.4 Finance leases 5.7 6.6 Weighted average discount rate: Operating leases 4.3 % 4.4 % Finance leases 3.2 % 3.4 % Maturities of lease liabilities as of December 31, 2021 were as follows: Operating Leases Finance Leases 2022 $ 42 $ 2 2023 33 2 2024 26 2 2025 22 2 2026 18 2 Thereafter 112 1 Total lease payments 253 11 Less imputed interest (61) (1) $ 192 $ 10
Leases	Leases The components of lease expense for the years ended December 31, 2021, 2020 and 2019 were as follows: 2021 2020 2019 Operating lease costs: Operating lease cost $ 48 $ 39 $ 36 Short-term lease cost 3 5 4 Total operating lease costs $ 51 $ 44 $ 40 Finance lease cost: Amortization of right-of-use assets $ 1 $ 1 $ 1 Total finance lease costs $ 1 $ 1 $ 1 Variable operating lease costs were $3 for each of the years ended December 31, 2021, 2020, and 2019. Interest on finance lease liabilities was less than $1 for each of the years ended December 31, 2021, 2020, and 2019. Supplemental cash flow information related to leases was as follows: 2021 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 51 $ 44 $ 38 Financing cash flows from finance leases 2 3 15 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 73 $ 42 $ 22 Supplemental balance sheet information related to finance leases was as follows: 2021 2020 Finance leases: Property, plant and equipment $ 26 $ 28 Accumulated depreciation (2) (2) Property, plant and equipment, net $ 24 $ 26 Accrued liabilities $ 2 $ 2 Other non-current liabilities 8 10 Total finance lease liabilities $ 10 $ 12 The weighted average remaining lease term and weighted average discount rates for each year were as follows: 2021 2020 Weighted average remaining lease term (years): Operating leases 10.8 10.4 Finance leases 5.7 6.6 Weighted average discount rate: Operating leases 4.3 % 4.4 % Finance leases 3.2 % 3.4 % Maturities of lease liabilities as of December 31, 2021 were as follows: Operating Leases Finance Leases 2022 $ 42 $ 2 2023 33 2 2024 26 2 2025 22 2 2026 18 2 Thereafter 112 1 Total lease payments 253 11 Less imputed interest (61) (1) $ 192 $ 10

Other Non-Current Assets

Other Non-Current Assets	12 Months Ended
	Dec. 31, 2021
Investments, All Other Investments [Abstract]
Other Non-Current Assets	Other Non-Current Assets 2021 2020 Pension assets $ 158 $ 532 Deferred taxes 150 235 Investments 161 24 Fair value of derivatives 51 11 Other 84 83 $ 604 $ 885

Accrued Liabilities

Accrued Liabilities	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Accrued Liabilities	Accrued Liabilities 2021 2020 Salaries and employee benefits $ 169 $ 182 Accrued taxes, other than on income 104 117 Income taxes 101 81 Accrued interest 47 85 Fair value of derivatives 32 26 Asbestos liabilities 25 25 Pension and postretirement liabilities 25 21 Restructuring 4 12 Other 459 397 $ 966 $ 946

Restructuring and Other

Restructuring and Other	12 Months Ended
	Dec. 31, 2021
Restructuring and Related Activities [Abstract]
Restructuring and Other	Restructuring and Other The Company recorded restructuring and other items as follows: 2021 2020 2019 Other (income) / costs $ (42) $ 9 $ (41) Asset sales and impairments (20) 2 (7) Restructuring 29 19 18 Asbestos 5 — — $ (28) $ 30 $ (30) 2021 Activity Other (income) / costs included gains of $30 arising from a favorable court ruling in a lawsuit brought by certain of the Company's Brazilian subsidiaries asserting they were overcharged by local tax authorities for indirect taxes paid in prior years. Asset sales and impairments included gains on various asset sales. Restructuring primarily includes charges related to relocation of the Transit Packaging headquarters and headcount reductions across segments. The Company continues to identify cost reduction initiatives in its businesses and it is possible that the Company may record additional restructuring charges in the future. See Note O for more information on the Company's provision for asbestos. 2020 Activity Restructuring costs included charges of $19 related to an internal reorganization and headcount reductions within the Transit Packaging segment. 2019 Activity Other costs / (income) of $41 included gains of $50 arising from favorable court rulings related to the recovery of indirect taxes paid in prior years by certain of the Company's Brazilian subsidiaries and a charge of $7 related to the settlement of a litigation matter related to Transit Packaging that arose prior to its acquisition by the Company in 2018. Restructuring costs included charges of $14 for termination benefits related to headcount reductions across the Company, including $10 related to headcount reductions in the Company's European Beverage and Transit Packaging segments. Asset sales and impairments included gains of $13 related to asset sales partially offset by a charge of $6 related to a fire at a production facility in Asia. Restructuring charges by segment were as follows: 2021 2020 2019 Americas Beverage $ — $ — $ 1 European Beverage 3 — — Asia Pacific 1 1 3 Transit Packaging 19 19 6 Other 3 (1) 5 Corporate 3 — 3 $ 29 $ 19 $ 18 Restructuring charges by type were as follows: 2021 2020 2019 Termination benefits $ 10 $ 8 $ 14 Other exit costs 19 11 4 $ 29 $ 19 $ 18

Debt

Debt	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Debt	Debt 2021 2020 Principal Carrying Principal Carrying outstanding amount outstanding amount Short-term debt $ 75 $ 75 $ 104 $ 104 Long-term debt Senior secured borrowings: Revolving credit facilities 50 50 — — Term loan facilities U.S. dollar due 2024 1,002 997 1,029 1,023 Euro due 2024 1 344 344 387 387 Senior notes and debentures: €650 at 4.0% due 2022 — — 794 791 U. S. dollar at 4.50% due 2023 — — 1,000 997 €335 at 2.25% due 2023 381 380 409 407 €550 at 0.75% due 2023 626 624 671 666 €600 at 2.625% due 2024 683 680 733 729 €600 at 3.375% due 2025 683 679 733 728 U.S. dollar at 4.25% due 2026 400 396 400 396 U.S. dollar at 4.75% due 2026 875 867 875 865 U.S. dollar at 7.375% due 2026 350 348 350 348 €500 at 2.875% due 2026 570 565 610 603 U.S. dollar at 7.50% due 2096 40 40 40 40 Other indebtedness in various currencies: Fixed rate with rates in 2021 from 2.7% to 7.8% due through 2026 189 189 97 97 Variable rate with average rates in 2021 from 1.9% to 3.6% due through 2026 28 28 13 13 Total long-term debt 6,221 6,187 8,141 8,090 Less: current maturities (136) (135) (67) (67) Total long-term debt, less current maturities $ 6,085 $ 6,052 $ 8,074 $ 8,023 (1) €303 and €317 at December 31, 2021 and 2020 The estimated fair value of the Company’s long-term borrowings, using a market approach incorporating level 2 inputs such as quoted market prices for the same or similar issues, was $6,548 at December 31, 2021 and $8,617 at December 31, 2020. In October 2021, the Company redeemed all of its €650, equivalent to $754, 4.0% senior notes due 2022 and its $1,000 4.5% senior notes due 2023. In connection with the redemption, the Company recorded losses from early extinguishments of debt of $68 for premium payments and the write-off of deferred financing fees. The revolving credit facilities include provisions for letters of credit up to $310 that reduce the amount of borrowing capacity otherwise available. At December 31, 2021, the Company’s available borrowing capacity under the credit facilities was $1,535, equal to the facilities’ aggregate capacity of $1,650 less $65 of outstanding letters of credit and $50 of credit facility borrowings. The interest rates on the facilities can vary from LIBOR or EURIBOR, with a floor of zero, plus a margin of up to 1.55%, depending on the facility, based on the Company's leverage ratio. The revolving credit facilities and term loan facilities required the Company to maintain a leverage ratio of no greater than 5.00 times at December 31, 2021. The Company was in compliance with all covenants as of December 31, 2021. The weighted average interest rates were as follows: 2021 2020 2019 Short-term debt 0.6 % 2.1 % 2.8 % Revolving credit facilities 1.2 % 1.8 % 3.0 % Aggregate maturities of long-term debt, excluding unamortized discounts and debt issuance costs, for the five years subsequent to 2021 are $136, $1,144, $1,969, $715 and $2,217. Cash payments for interest during 2021, 2020 and 2019 were $294, $302, and $362.

Derivative and Other Financial

Derivative and Other Financial Instruments	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative and Other Financial Instruments	Derivative and Other Financial Instruments Fair Value Measurements Under U.S. GAAP a framework exists for measuring fair value, providing a three-tier hierarchy of pricing inputs used to report assets and liabilities that are adjusted to fair value. Level 1 includes inputs such as quoted prices which are available in active markets for identical assets or liabilities as of the report date. Level 2 includes inputs other than those available in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 includes unobservable pricing inputs that are not corroborated by market data or other objective sources. The Company has no recurring items valued using Level 3 inputs other than certain pension plan assets. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of assets and liabilities measured at fair value and their placement within the fair value hierarchy. The Company applies a market approach to value its commodity price hedge contracts. Prices from observable markets are used to develop the fair value of these financial instruments and they are reported under Level 2. The Company uses an income approach to value its foreign exchange forward contracts. These contracts are valued using a discounted cash flow model that calculates the present value of future cash flows under the terms of the contracts using market information as of the reporting date, such as foreign exchange spot and forward rates, and are reported under Level 2 of the fair value hierarchy. Fair value disclosures for financial assets and liabilities that were accounted for at fair value on a recurring basis are provided below. In addition, see Note M for fair value disclosures related to debt. Derivative Financial Instruments In the normal course of business the Company is subject to risk from adverse fluctuations in currency exchange rates, interest rates and commodity prices. The Company manages these risks through a program that includes the use of derivative financial instruments, primarily swaps and forwards. Counterparties to these contracts are major financial institutions. The Company is exposed to credit loss in the event of nonperformance by these counterparties. The Company does not use derivative instruments for trading or speculative purposes. The Company’s objective in managing exposure to market and interest rate risk is to limit the impact on earnings and cash flow. The extent to which the Company uses such instruments is dependent upon its access to these contracts in the financial markets and its success using other methods, such as netting exposures in the same currencies to mitigate foreign exchange risk, using sales agreements that permit the pass-through of commodity price and foreign exchange rate risk to customers and borrowing both fixed and floating debt instruments to manage interest rate risk. For derivative financial instruments accounted for in hedging relationships, the Company formally designates and documents, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective and the manner in which effectiveness will be assessed. The Company formally assesses, both at inception and at least quarterly thereafter, whether the hedging relationships are effective in offsetting changes in fair value or cash flows of the related underlying exposures. When a forecasted transaction is reasonably possible, but not probable of occurring, the hedge no longer qualifies for hedge accounting and the change in fair value from the date of the last effectiveness test is recognized in earnings. Any gain or loss which has accumulated in other comprehensive income at the date of the last effectiveness test is reclassified into earnings at the same time of the underlying exposure or when the forecasted transaction becomes probable of not occurring. Cash Flow Hedges The Company designates certain derivative financial instruments as cash flow hedges. No components of the hedging instruments are excluded from the assessment of hedge effectiveness. Changes in fair value of outstanding derivatives accounted for as cash flow hedges are recorded in accumulated other comprehensive income until earnings are impacted by the hedged transaction. Classification of the gain or loss in the Consolidated Statements of Operations upon reclassification from accumulated other comprehensive income is the same as that of the underlying exposure. Contracts outstanding at December 31, 2021 mature between one The Company uses commodity forward contracts to hedge anticipated purchases of various commodities, including aluminum and fuel oil, and these exposures are hedged by a central treasury unit. The Company also designates certain foreign exchange contracts as cash flow hedges of anticipated foreign currency denominated sales or purchases. The Company manages these risks at the operating unit level. Often, foreign currency risk is hedged together with the related commodity price risk. The Company may also uses interest rate swaps to convert interest on floating rate debt to a fixed-rate. The following tables set forth financial information about the impact on other comprehensive income ("OCI"), accumulated other comprehensive income ("AOCI") and earnings from changes in the fair value related to derivative instruments designated as cash flow hedges. Amount of gain / (loss) recognized in AOCI Derivatives in cash flow hedges 2021 2020 Foreign exchange $ (5) $ — Interest rate 2 (1) Commodities 74 10 $ 71 $ 9 Amount of gain / (loss) reclassified from AOCI into income Derivatives in cash flow hedges 2021 2020 Affected line item in the Foreign exchange $ (4) $ (3) Net sales Commodities (54) 18 Net sales Foreign exchange 2 (2) Cost of products sold Commodities 147 (59) Cost of products sold 91 (46) (Loss) / income from continuing operations before taxes and equity in net earnings of affiliates (23) 13 (Benefit from) / provision for income taxes 68 (33) Net (loss) / income from continuing operations Foreign exchange — (1) Net (loss) / income from discontinued operations Commodities 5 (1) Net (loss) / income from discontinued operations Total reclassified $ 73 $ (35) Net (loss) / income For the year ended December 31, 2021, a net gain of $34 ($28, net of tax) is expected to be reclassified to earnings for commodity and foreign exchange contracts. No material amounts were reclassified during the years ended December 31, 2021 and 2020 in connection with anticipated transactions that were no longer considered probable. Fair Value Hedges and Contracts Not Designated as Hedges The Company designates certain derivative financial instruments as fair value hedges of recognized foreign-denominated assets and liabilities, generally trade accounts receivable and payable and unrecognized firm commitments. The notional values and maturity dates of the derivative instruments coincide with those of the hedged items. Changes in fair value of the derivative financial instruments, excluding time value, are offset by changes in fair value of the related hedged items. For the years ended December 31, 2021, and December 31, 2020, the Company recorded gains of $3 and $27 from foreign exchange contracts designated as fair value hedges. These adjustments were reported within foreign exchange in the Consolidated Statements of Operations. Certain derivative financial instruments, including foreign exchange contracts related to intercompany debt, were not designated or did not qualify for hedge accounting; however, they are effective economic hedges as the changes in their fair value, except for time value, are offset by changes from re-measurement of the related hedged items. The Company’s primary use of these derivative instruments is to offset the earnings impact that fluctuations in foreign exchange rates have on certain monetary assets and liabilities denominated in nonfunctional currencies. Changes in fair value of these derivative instruments are immediately recognized in earnings as foreign exchange adjustments. The following table sets forth the impact on earnings from derivatives not designated as hedges. Pre-tax amount of gain / (loss) recognized in earnings Derivatives not designated as hedges 2021 2020 Affected line item in the Foreign exchange $ (3) $ — Net sales Foreign exchange (1) (1) Cost of products sold Foreign exchange (29) 30 Foreign exchange Foreign exchange — 1 Net (loss) / income from discontinued operations $ (33) $ 30 Net Investment Hedges The Company designates certain debt and derivative instruments as net investment hedges to manage foreign currency risk relating to net investments in subsidiaries denominated in foreign currencies. For the years ended December 31, 2021 and 2020, the Company recorded a gain of $103 ($103, net of tax) and a loss of $1 ($1, net of tax) in other comprehensive income for certain debt instruments that are designated as hedges of its net investment in a euro-based subsidiary. As of December 31, 2021 and December 31, 2020, cumulative gains of $69 ($92, net of tax) and losses of $33 ($10, net of tax) were recognized in accumulated other comprehensive income related to these net investment hedges and the carrying amount of the hedged net investment was approximately €1,312 ($1,493) at December 31, 2021. The following tables set forth financial information about the impact on accumulated other comprehensive income from changes in the fair value of derivative instruments designated as net investment hedges. Amount of (loss) / gain recognized in AOCI Derivatives designated as net investment hedges 2021 2020 Foreign exchange $ 47 $ (48) Gains and losses representing components excluded from the assessment of effectiveness on derivatives designated as net investment hedges are recognized in accumulated other comprehensive income. Gains or losses on net investment hedges remain in accumulated other comprehensive income until disposal of the underlying assets. Fair Values of Derivative Financial Instruments and Valuation Hierarchy The following table sets forth the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2021 and December 31, 2020, respectively. The fair value of these financial instruments were reported under Level 2 of the fair value hierarchy. Balance Sheet classification December 31, December 31, Balance Sheet classification December 31, December 31, Derivatives designated as hedging instruments Foreign exchange contracts cash flow Prepaid expenses and other current assets $ 3 $ 5 Accrued liabilities $ 10 $ 5 Current assets held for sale — 4 Current liabilities held for sale — 3 Other non-current assets — — Other non-current liabilities — 1 Foreign exchange contracts fair value Prepaid expenses and other current assets 1 2 Accrued liabilities 2 6 Commodities contracts cash flow Prepaid expenses and other current assets 53 43 Accrued liabilities 17 11 Current assets held for sale — 2 Current liabilities held for sale — — Other non-current assets 2 4 Other non-current liabilities 1 — Interest rate contracts cash flow Other non-current assets — — Other non-current liabilities — 2 Net investment hedge Other non-current assets 49 7 Other non-current liabilities — 20 $ 108 $ 67 $ 30 $ 48 Derivatives not designated as hedging instruments Foreign exchange contracts Prepaid expenses and other current assets $ 3 $ 9 Accrued liabilities $ 3 $ 4 $ 3 $ 9 $ 3 $ 4 Total derivatives $ 111 $ 76 $ 33 $ 52 Fair Value Hedge Carrying Amounts Carrying amount of the hedged assets and liabilities Line item in the Balance Sheet in which the hedged item is included December 31, 2021 December 31, 2020 Cash and cash equivalents 38 22 Receivables, net 21 11 Accrued liabilities 116 100 As of December 31, 2021 and 2020, the cumulative amounts of fair value hedging adjustments included in the carrying amount of the hedged assets and liabilities were net gains of $1 and $4. Offsetting of Derivative Assets and Liabilities Certain derivative financial instruments are subject to agreements with counterparties similar to master netting arrangements and are eligible for offset. The Company has made an accounting policy election not to offset the fair values of these instruments. In the table below, the aggregate fair values of the Company's derivative assets and liabilities are presented on both a gross and net basis, where appropriate. Gross amounts recognized in the Balance Sheet Gross amounts not offset in the Balance Sheet Net amount Balance at December 31, 2021 Derivative assets $ 111 $ 19 $ 92 Derivative liabilities 33 19 14 Balance at December 31, 2020 Derivative assets $ 76 $ 11 $ 65 Derivative liabilities 52 11 41 Notional Values of Outstanding Derivative Instruments The aggregate U.S. dollar-equivalent notional values of outstanding derivative instruments in the Consolidated Balance Sheets at December 31, 2021 and December 31, 2020 were: December 31, 2021 December 31, 2020 Derivatives designated as cash flow hedges: Foreign exchange $ 241 $ 639 Commodities 261 231 Interest rate — 200 Derivatives designated as fair value hedges: Foreign exchange 229 183 Derivatives designated as net investment hedges: Foreign exchange 875 1,075 Derivatives not designated as hedges: Foreign exchange 617 722

Asbestos-Related Liabilities

Asbestos-Related Liabilities	12 Months Ended
	Dec. 31, 2021
Liability for Asbestos and Environmental Claims [Abstract]
Asbestos-Related Liabilities	Asbestos-Related Liabilities Crown Cork & Seal Company, Inc. (“Crown Cork”) is one of many defendants in a substantial number of lawsuits filed throughout the United States by persons alleging bodily injury as a result of exposure to asbestos. These claims arose from the insulation operations of a U.S. company, the majority of whose stock Crown Cork purchased in 1963. Approximately ninety days after the stock purchase, this U.S. company sold its insulation assets and was later merged into Crown Cork. Prior to 1998, amounts paid to asbestos claimants were covered by a fund made available to Crown Cork under a 1985 settlement with carriers insuring Crown Cork through 1976, when Crown Cork became self-insured. The fund was depleted in 1998 and the Company has no remaining coverage for asbestos-related costs. The states of Alabama, Arizona, Arkansas, Florida, Georgia, Idaho, Indiana, Iowa, Kansas, Michigan, Mississippi, Nebraska, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Utah, West Virginia, Wisconsin and Wyoming have enacted legislation that limits asbestos-related liabilities under state law of companies such as Crown Cork that allegedly incurred these liabilities because they are successors by corporate merger to companies that had been involved with asbestos. The legislation, which applies to future and, with the exception of Arkansas, Georgia, South Carolina, South Dakota, West Virginia and Wyoming, pending claims at the time of enactment, caps asbestos-related liabilities at the fair market value of the predecessor's total gross assets adjusted for inflation. Crown Cork has paid significantly more for asbestos-related claims than the total value of its predecessor's assets adjusted for inflation. Crown Cork has integrated the legislation into its claims defense strategy. The Company cautions, however, that the legislation may be challenged and there can be no assurance regarding the ultimate effect of the legislation on Crown Cork. In June 2003, the State of Texas enacted legislation that limits the asbestos-related liabilities in Texas courts of companies such as Crown Cork that allegedly incurred these liabilities because they are successors by corporate merger to companies that had been involved with asbestos. The Texas legislation, which applies to future and pending claims, caps asbestos-related liabilities at the total gross value of the predecessor’s assets adjusted for inflation. Crown Cork has paid significantly more for asbestos-related claims than the total adjusted value of its predecessor’s assets. In October 2010, the Texas Supreme Court reversed a lower court decision, Barbara Robinson v. Crown Cork & Seal Company, Inc., No. 14-04-00658-CV, Fourteenth Court of Appeals, Texas, which had upheld the dismissal of an asbestos-related case against Crown Cork. The Texas Supreme Court held that the Texas legislation was unconstitutional under the Texas Constitution when applied to asbestos-related claims pending against Crown Cork when the legislation was enacted in June of 2003. The Company believes that the decision of the Texas Supreme Court is limited to retroactive application of the Texas legislation to asbestos-related cases that were pending against Crown Cork in Texas on June 11, 2003 and therefore, in its accrual, continues to assign no value to claims filed after June 11, 2003. In December 2001, the Commonwealth of Pennsylvania enacted legislation that limits the asbestos-related liabilities of Pennsylvania corporations that are successors by corporate merger to companies involved with asbestos. The legislation limits the successor’s liability for asbestos to the acquired company’s asset value adjusted for inflation. Crown Cork has paid significantly more for asbestos-related claims than the acquired company’s adjusted asset value. In November 2004, the legislation was amended to address a Pennsylvania Supreme Court decision (Ieropoli v. AC&S Corporation, et. al., No. 117 EM 2002) which held that the statute violated the Pennsylvania Constitution due to retroactive application. The Company cautions that the limitations of the statute, as amended, are subject to litigation and may not be upheld. The Company further cautions that an adverse ruling in any litigation relating to the constitutionality or applicability to Crown Cork of one or more statutes that limits the asbestos-related liability of alleged defendants like Crown Cork could have a material impact on the Company. The Company's approximate claims activity for the years ended 2021, 2020 and 2019 was as follows: 2021 2020 2019 Beginning claims 56,000 56,000 56,000 New claims 2,000 1,500 2,000 Settlements or dismissals (1,000) (1,500) (2,000) Ending claims 57,000 56,000 56,000 For the years ended December 31, 2021, 2020, and 2019, the Company made cash payments of $19, $21, and $22 to settle asbestos claims and pay related legal and defense costs. In the fourth quarter of each year, the Company performs an analysis of outstanding claims and categorizes by year of exposure and state filed. As of December 31, 2021 and December 31, 2020, the Company's outstanding claims were: 2021 2020 Claimants alleging first exposure after 1964 17,000 16,500 Claimants alleging first exposure before or during 1964 filed in: Texas 13,000 13,000 Pennsylvania 1,500 1,500 Other states that have enacted asbestos legislation 6,000 6,000 Other states 19,500 19,000 Total claims outstanding 57,000 56,000 The outstanding claims in each period exclude approximately 19,000 inactive claims. Due to the passage of time, the Company considers it unlikely that the plaintiffs in these cases will pursue further action against the Company. The exclusion of these inactive claims had no effect on the calculation of the Company’s accrual as the claims were filed in states, as described above, where the Company’s liability is limited by statute. With respect to claimants alleging first exposure to asbestos before or during 1964, the Company does not include in its accrual any amounts for settlements in states where the Company’s liability is limited by statute except for certain pending claims in Texas as described earlier. With respect to post-1964 claims, regardless of the existence of asbestos legislation, the Company does not include in its accrual any amounts for settlement of these claims because of increased difficulty of establishing identification of relevant insulation products as the cause of injury. Given its settlement experience with post-1964 claims, the Company does not believe that an adverse ruling in the Texas or Pennsylvania asbestos litigation cases, or in any other state that has enacted asbestos legislation, would have a material impact on the Company with respect to such claims. As of December 31, the percentage of outstanding claims related to claimants alleging serious diseases (primarily mesothelioma and other malignancies) were as follows: 2021 2020 2019 Total claims 24 % 23 % 22 % Pre-1965 claims in states without asbestos legislation 42 % 41 % 41 % Crown Cork has entered into arrangements with plaintiffs’ counsel in certain jurisdictions with respect to claims which are not yet filed, or asserted, against it. However, Crown Cork expects claims under these arrangements to be filed or asserted against Crown Cork in the future. The projected value of these claims is included in the Company’s estimated liability as of December 31, 2021. Approximately 82% of the claims outstanding at the end of 2021 were filed by plaintiffs who do not claim a specific amount of damages or claim a minimum amount as established by court rules relating to jurisdiction; approximately 15% were filed by plaintiffs who claim damages of less than $5; approximately 3% were filed by plaintiffs who claim damages from $5 to less than $100 (36% of whom claim damages less than $25) and 14 claims were filed by plaintiffs who claim damages in excess of $100. As of December 31, 2021, the Company’s accrual for pending and future asbestos-related claims and related legal costs was $237, including $198 for unasserted claims. The Company determines its accrual without limitation to a specified time period. It is reasonably possible that the actual loss could be in excess of the Company’s accrual. However, the Company is unable to estimate the reasonably possible loss in excess of its accrual due to uncertainty in the following assumptions that underlie the Company’s accrual and the possibility of losses in excess of such accrual: the amount of damages sought by the claimant, the Company and claimant’s willingness to negotiate a settlement, the terms of settlements of other defendants with asbestos-related liabilities, the bankruptcy filings of other defendants (which may result in additional claims and higher settlements for non-bankrupt defendants), the nature of pending and future claims (including the seriousness of alleged disease, whether claimants allege first exposure to asbestos before or during 1964 and the claimant’s ability to demonstrate the alleged link to Crown Cork), the volatility of the litigation environment, the defense strategies available to the Company, the level of future claims, the rate of receipt of claims, the jurisdiction in which claims are filed, and the effect of state asbestos legislation (including the validity and applicability of the Pennsylvania legislation to non-Pennsylvania jurisdictions, where the substantial majority of the Company’s asbestos cases are filed).

Commitments and Contingent Liab

Commitments and Contingent Liabilities	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingent Liabilities	Commitments and Contingent Liabilities The Company, along with others in most cases, has been identified by the EPA or a comparable state environmental agency as a Potentially Responsible Party (“PRP”) at a number of sites and has recorded aggregate accruals of $12 for its share of estimated future remediation costs at these sites. The Company has been identified as having either directly or indirectly disposed of commercial or industrial waste at the sites subject to the accrual, and where appropriate and supported by available information, generally has agreed to be responsible for a percentage of future remediation costs based on an estimated volume of materials disposed in proportion to the total materials disposed at each site. The Company has not had monetary sanctions imposed nor has the Company been notified of any potential monetary sanctions at any of the sites. The Company has also recorded aggregate accruals of $6 for remediation activities at various worldwide locations that are owned by the Company and for which the Company is not a member of a PRP group. Although the Company believes its accruals are adequate to cover its portion of future remediation costs, there can be no assurance that the ultimate payments will not exceed the amount of the Company’s accruals and will not have a material effect on its results of operations, financial position and cash flow. Any possible loss or range of potential loss that may be incurred in excess of the recorded accruals cannot be estimated. In March 2015, the Bundeskartellamt, or German Federal Cartel Office (“FCO”), conducted unannounced inspections of the premises of several metal packaging manufacturers, including a German subsidiary of the Company. The local court order authorizing the inspection cited FCO suspicions of anti-competitive agreements in the German market for the supply of metal packaging products. The Company conducted an internal investigation into the matter and discovered instances of inappropriate conduct by certain employees of German subsidiaries of the Company. The Company cooperated with the FCO and submitted a leniency application with the FCO which disclosed the findings of its internal investigation to date. In April 2018, the FCO discontinued its national investigation and referred the matter to the European Commission (the “Commission”). Following the referral, Commission officials conducted unannounced inspections of the premises of several metal packaging manufacturers, including Company subsidiaries in Germany, France and the U.K. The Commission's investigation is ongoing and, to date, the Commission has not officially charged the Company or any of its subsidiaries with violations of competition law. The Company is cooperating with the Commission and submitted a leniency application with the Commission with respect to the findings of the investigation in Germany referenced above. This application may lead to the reduction of possible future penalties. At this stage of the investigation the Company believes that a loss is probable but is unable to predict the ultimate outcome of the Commission’s investigation and is unable to estimate the loss or possible range of losses that could be incurred, and has therefore not recorded a charge in connection with the actions by the Commission. If the Commission finds that the Company or any of its subsidiaries violated competition law, fines levied by the Commission could be material to the Company's operating results and cash flows for the periods in which they are resolved or become reasonably estimable. In March 2017, U.S. Customs and Border Protection (“CBP”) at the Port of Milwaukee issued a penalty notification alleging that certain of the Company’s subsidiaries intentionally misclassified the importation of certain goods into the U.S. during the period 2004 -2009. CBP initially assessed a penalty of $18. The Company has acknowledged to CBP that the goods were misclassified and has paid all related duties, which CBP does not dispute. The Company has asserted that the misclassification was unintentional and disputes the penalty assessment by CBP. CBP has brought suit in the U.S. Court of International Trade seeking enforcement of the initial penalty against the Company. At the present time, based on the information available, the Company does not believe that a loss for the alleged intentional misclassification is probable. However, there can be no assurance that the Company will be successful in contesting the assessed penalty. On October 7, 2021, the French Autorité de la concurrence (the French Competition Authority or “FCA”) issued a statement of objections to 14 trade associations, one public entity and 101 legal entities from 28 corporate groups, including the Company, certain of its subsidiaries, other leading metal can manufacturers, certain can fillers and certain retailers in France. The FCA alleged violations of Articles 101 of the Treaty on the Functioning of the European Union and L.420-1 of the French Commercial Code. The statement of objections alleges, among other things, anti-competitive behavior in connection with the removal of bisphenol-A from metal packaging in France. The removal of bisphenol-A was mandated by French legislation that went into effect in 2015. If the FCA finds that the Company or its subsidiaries violated competition law, the FCA may levy fines. Proceedings with respect to this matter are ongoing and the Company is unable to predict the ultimate outcome including the amount of fines, if any, that may be levied by the FCA. The Company intends to vigorously defend against the allegations in the statement of objectives. The Company and its subsidiaries are also subject to various other lawsuits and claims with respect to labor, environmental, securities, vendor and other matters arising out of the Company’s normal course of business. While the impact on future financial results is not subject to reasonable estimation because considerable uncertainty exists, management believes that the ultimate liabilities resulting from such lawsuits and claims will not materially affect the Company’s consolidated earnings, financial position or cash flow. The Company has various commitments to purchase materials, supplies and utilities as part of the ordinary conduct of business. The Company’s basic raw materials for its products are aluminum and steel, both of which are purchased from multiple sources. The Company is subject to fluctuations in the cost of these raw materials and has periodically adjusted its selling prices to reflect these movements. There can be no assurance, however, that the Company will be able to fully recover any increases or fluctuations in raw material costs from its customers. The Company also has commitments for standby letters of credit and for purchases of capital assets.

Other Non-Current Liabilities

Other Non-Current Liabilities	12 Months Ended
	Dec. 31, 2021
Other Liabilities Disclosure [Abstract]
Other Non-Current Liabilities	Other Non-Current Liabilities 2021 2020 Deferred taxes $ 336 $ 350 Asbestos liabilities 212 226 Income taxes payable 26 26 Fair value of derivatives 1 23 Postemployment benefits 21 19 Environmental 12 12 Finance lease liabilities 8 10 Other 80 100 $ 696 $ 766 Income taxes payable includes unrecognized tax benefits as discussed in Note S .

Pension and Other Postretiremen

Pension and Other Postretirement Benefits	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Pension and Other Postretirement Benefits	Pension and Other Postretirement Benefits Pensions. The Company sponsors various pension plans covering certain U.S. and non-U.S. employees, and participates in certain multi-employer pension plans. The benefits under the Company plans are based primarily on years of service and either the employees’ remuneration near retirement or a fixed dollar multiple. A measurement date of December 31 was used for all plans presented below. The components of pension expense were as follows: U.S. Plans 2021 2020 2019 Service cost $ 20 $ 18 $ 15 Interest cost 25 38 50 Expected return on plan assets (63) (73) (70) Settlements — 3 — Curtailments and special termination benefits 9 — — Amortization of actuarial loss 58 56 55 Amortization of prior service cost 1 1 1 Net periodic cost $ 50 $ 43 $ 51 Non-U.S. Plans 2021 2020 2019 Service cost $ 13 $ 10 $ 13 Interest cost 32 52 70 Expected return on plan assets (72) (107) (138) Settlements 1,511 63 44 Curtailments — — (14) Amortization of actuarial loss 33 27 37 Amortization of prior service credit — — (1) Net periodic cost $ 1,517 $ 45 $ 11 The settlement charge in 2021 arose from the irrevocable transfer of the Company's U.K. pension plan to an insurer. In October 2021, the trustees of the Company's U.K. defined benefit pension plan (the "Plan") entered into a transaction to fully insure all of its U.K. pension liabilities. The Company made a cash contribution of $271 to enable the Plan to purchase a bulk annuity insurance contract for the benefit of the Plan participants. Subsequent to the purchase of the bulk annuity contract, each of the Plan participants was issued an individual annuity contract. The issuer of the individual annuity contract is solely responsible for paying each participant's benefits in full. The Company recorded a settlement charge of $1,511 ($1,040, net of tax) in November 2021, upon irrevocable transfer of the Plan's obligations. Of the $271, the Company was reimbursed $55 in the fourth quarter of 2021 and expects to receive an additional $110 of reimbursement in 2022 and 2023 as the plan sells its remaining illiquid assets. The settlement charges in 2020 and 2019 arose from the payment of lump sum buy-outs to settle certain pension obligations using plan assets The curtailment gain in 2019 was to recognize prior service credits that were previously recorded in accumulated other comprehensive income in connection with the closure of a non-U.S. defined pension plan. Additional pension expense of $5 in each of 2021, 2020 and 2019 was recognized for multi-employer plans. The projected benefit obligations, accumulated benefit obligations, plan assets and funded status of the Company's U.S. and non-U.S. plans were as follows: U.S. Plans Non-U.S. Plans 2021 2020 2021 2020 Projected Benefit Obligations Benefit obligations at January 1 $ 1,505 $ 1,440 $ 3,172 $ 3,155 Service cost 20 18 13 10 Interest cost 25 38 32 52 Plan participants’ contributions — — 2 2 Amendments 2 1 (3) — Settlements — (7) (2,982) (271) Curtailments (10) — (7) — Special termination benefits 6 — — — Actuarial (gain) / loss (43) 109 444 276 Benefits paid (92) (94) (165) (148) Foreign currency translation — — 7 96 Benefit obligations at December 31 $ 1,413 $ 1,505 $ 513 $ 3,172 Plan Assets Fair value of plan assets at January 1 $ 1,152 $ 1,131 $ 3,518 $ 3,480 Actual return on plan assets 115 113 (94) 334 Employer contributions 2 9 234 18 Plan participants’ contributions — — 2 2 Settlements — (7) (2,982) (271) Benefits paid (92) (94) (165) (152) Foreign currency translation — — 16 107 Fair value of plan assets at December 31 $ 1,177 $ 1,152 $ 529 $ 3,518 Funded status $ (236) $ (353) $ 16 $ 346 Accumulated benefit obligations at December 31 $ 1,361 $ 1,445 $ 474 $ 3,111 For the year ended December 31, 2021, actuarial losses for the Company’s U.S. and non-U.S. pension plans totaled $638. Actuarial gains and losses arise each year primarily due to changes in discount rates, differences in actual plan asset returns compared to expected returns, and changes in actuarial assumptions such as mortality. The loss in 2021 is primarily due to the remeasurement of the U.K. pension plan in conjunction with the settlement, partially offset by a gain of $65 due to actual asset returns higher than expected returns and higher discount rates at the end of 2021. U.S. pension plans with accumulated benefit obligations and projected benefit obligations in excess of plan assets were as follows: 2021 2020 Projected benefit obligations $ 1,413 $ 1,505 Accumulated benefit obligations 1,361 1,445 Fair value of plan assets 1,177 1,152 Non-U.S. pension plans with accumulated benefit obligations in excess of plan assets were as follows: 2021 2020 Projected benefit obligations $ 284 $ 354 Accumulated benefit obligations 253 320 Fair value of plan assets 147 191 Non-U.S. pension plans with projected benefit obligations in excess of plan assets were as follows: 2021 2020 Projected benefit obligations $ 288 $ 432 Accumulated benefit obligations 257 389 Fair value of plan assets 151 194 The Company’s investment strategy in its U.S. plan is designed to generate returns that are consistent with providing benefits to plan participants within the risk tolerance of the plan. Asset allocation is the primary determinant of return levels and investment risk exposure. The strategic ranges for asset allocation in the U.S. plans are as follows: U.S. equities 45 % to 55 % International equities 7 % to 13 % Fixed income 18 % to 28 % Balanced funds 7 % to 13 % Real estate 4 % to 10 % Pension assets are classified into three levels. Level 1 asset values are derived from quoted prices which are available in active markets as of the report date. Level 2 asset values are derived from other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the report date. Level 3 asset values are derived from unobservable pricing inputs that are not corroborated by market data or other objective sources. Level 1 Investments Equity securities are valued at the latest quoted prices taken from the primary exchange on which the security trades. Mutual funds are valued at the net asset value (NAV) of shares held at year-end. Level 2 Investments Fixed income securities, including government issued debt, corporate debt, asset-backed and structured debt securities are valued using the latest bid prices or valuations based on a matrix system (which considers such factors as benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and other reference data including market research publications). Derivatives, which consist mainly of interest rate swaps, are valued using a discounted cash flow pricing model based on observable market data. Level 3 Investments Hedge funds and private equity funds are valued at the NAV at year-end. The values assigned to private equity funds are based upon assessments of each underlying investment, incorporating valuations that consider the evaluation of financing and sale transactions with third parties, expected cash flows and market-based information, including comparable transactions, and performance multiples among other factors. Real estate investments are based on third party appraisals. Investments Measured Using NAV per Share Practical Expedient Investments measured using NAV per share as a practical expedient include investment funds that invest in global equity, emerging markets and fixed income. The global equity funds invest in equity securities of various market sectors including industrial materials, consumer discretionary goods and services, financial infrastructure, technology, and health care. The emerging markets funds invest in equity markets within financial services, consumer goods and services, energy, and technology. The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair value. Furthermore, while the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in different fair value measurements at the reporting date. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and may affect the valuation of the fair value of assets and their placement within the fair value hierarchy. The levels assigned to the defined benefit plan assets as of December 31, 2021 and 2020 are summarized in the tables below: 2021 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 68 $ 21 $ 89 Global large cap equity — 8 8 U.S. large cap equity 238 6 244 U.S. mid/small cap equity 332 25 357 Mutual funds – global equity 93 — 93 Mutual funds – U.S. equity 85 — 85 Mutual funds – fixed income 71 — 71 887 60 947 Level 2 Government issued debt securities — 17 17 Corporate debt securities 61 3 64 Insurance contracts — 110 110 Investment funds – fixed income — 38 38 61 168 229 Level 3 Investment funds – real estate 79 92 171 Private equity 5 2 7 Real estate – direct 25 15 40 109 109 218 Total assets in fair value hierarchy 1,057 337 1,394 Investments measured at NAV Practical Expedient (a) Investment funds – fixed income 112 25 137 Investment funds – global equity — 167 167 Investment funds – emerging markets 7 — 7 119 192 311 Total investments at fair value $ 1,176 $ 529 $ 1,705 2020 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 157 $ 498 $ 655 Global large cap equity — 9 9 U.S. large cap equity 178 4 182 U.S. mid/small cap equity 301 22 323 Mutual funds – global equity 88 — 88 Mutual funds – U.S. equity 56 — 56 Mutual funds – fixed income 75 — 75 855 533 1,388 Level 2 Government issued debt securities — 298 298 Corporate debt securities 58 647 705 Asset backed securities — 2 2 Structured debt — 1,034 1,034 Insurance contracts — 115 115 Derivatives — 166 166 Investment funds – fixed income — 128 128 Investment funds – global equity — 69 69 58 2,459 2,517 Level 3 Investment funds – real estate 91 181 272 Hedge funds — 2 2 Private equity 5 46 51 Real estate – direct 23 12 35 119 241 360 Total assets in fair value hierarchy 1,032 3,233 4,265 Investments measured at NAV Practical Expedient (a) Investment funds – fixed income 112 25 137 Investment funds – global equity — 141 141 Investment funds – emerging markets 7 — 7 Hedge funds — 109 109 119 275 394 Total investments at fair value $ 1,151 $ 3,508 $ 4,659 (a) Certain investments that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. Accrued income excluded from the tables above was as follows: 2021 2020 U.S. plan assets $ 1 $ 1 Non-U.S. plan assets — 10 Plan assets include $357 and $323 of the Company’s common stock at December 31, 2021 and 2020. The following tables reconcile the beginning and ending balances of plan assets measured using significant unobservable inputs (Level 3). Hedge Private Real Total Balance at January 1, 2020 $ 43 $ 75 $ 346 $ 464 Foreign currency translation 1 2 7 10 Asset returns – assets held at reporting date 3 6 (15) (6) Asset returns – assets sold during the period (12) (9) 3 (18) Purchases, sales and settlements, net (33) (23) (34) (90) Balance at December 31, 2020 2 51 307 360 Foreign currency translation — — (1) (1) Asset returns – assets held at reporting date (1) (48) 30 (19) Asset returns – assets sold during the period 1 39 3 43 Purchases, sales and settlements, net (2) (35) (128) (165) Balance at December 31, 2021 $ — $ 7 $ 211 $ 218 The following table presents additional information about the pension plan assets valued using net asset value as a practical expedient: Fair Value Redemption Frequency Redemption Notice Period Balance at December 31, 2021 Investment funds – fixed income $ 137 Semi-monthly 1- 5 days Investment funds – global equity 167 Daily 10 days Investment funds – emerging markets 7 Daily 30 days Balance at December 31, 2020 Investment funds – fixed income $ 137 Semi-monthly 1- 5 days Investment funds – global equity 141 Monthly 1- 5 days Investment funds – emerging markets 7 Daily 30 days Hedge funds 109 Monthly 1 - 30 days The pension plan assets valued using net asset value as a practical expedient do not have any unfunded commitments. Pension assets and liabilities included in the Consolidated Balance Sheets were: 2021 2020 Non-current assets $ 158 $ 532 Current liabilities 11 8 Non-current liabilities 367 537 The Company’s current liability at December 31, 2021, represents the expected required payments to be made for unfunded plans over the next twelve months. Total estimated 2022 employer contributions are $27 for the Company’s pension plans. Changes in the net loss and prior service cost (credit) for the Company’s pension plans were: 2021 2020 2019 Net loss Prior Net loss Prior Net loss Prior Balance at January 1 $ 1,802 $ 8 $ 1,808 $ 8 $ 1,962 $ (6) Reclassification to net periodic benefit cost (1,629) (4) (150) (1) (137) 14 Current year loss / (gain) 640 (2) 118 — (53) — Amendments (1) — — 1 — — Foreign currency translation 2 — 26 — 36 — Balance at December 31 $ 814 $ 2 $ 1,802 $ 8 $ 1,808 $ 8 Expected future benefit payments as of December 31, 2021 are: U.S. Non-U.S. 2022 $ 104 $ 31 2023 99 30 2024 99 30 2025 100 32 2026 85 32 2027 - 2031 419 360 The weighted average actuarial assumptions used to calculate the benefit obligations at December 31 were: U.S. Plans 2021 2020 2019 Discount rate 2.9 % 2.5 % 3.2 % Compensation increase 4.7 % 4.7 % 4.7 % Non-U.S. Plans 2021 2020 2019 Discount rate 2.5 % 1.4 % 2.1 % Compensation increase 2.5 % 3.0 % 3.0 % The weighted average actuarial assumptions used to calculate pension expense for each year were: U.S. Plans 2021 2020 2019 Discount rate - service cost 3.1 % 3.6 % 4.7 % Discount rate - interest cost 1.7 % 2.8 % 3.9 % Compensation increase 4.7 % 4.7 % 4.5 % Long-term rate of return 5.7 % 6.8 % 7.3 % Non-U.S. Plans 2021 2020 2019 Discount rate - service cost 2.2 % 2.6 % 3.0 % Discount rate - interest cost 1.8 % 1.9 % 2.7 % Compensation increase 2.5 % 3.0 % 3.2 % Long-term rate of return 3.3 % 3.3 % 4.3 % The expected long-term rate of return on plan assets is determined by taking into consideration expected long-term returns associated with each major asset class based on long-term historical ranges, inflation assumptions and the expected net value from active management of the assets based on actual results. Other Postretirement Benefit Plans. The Company sponsors unfunded plans to provide health care and life insurance benefits to certain retirees and survivors. Generally, the medical plans pay a stated percentage of medical expenses reduced by deductibles and other coverages. Life insurance benefits are generally provided by insurance contracts. The Company reserves the right, subject to existing agreements, to change, modify or discontinue the plans. A measurement date of December 31 was used for the plans presented below. The components of net postretirement benefits cost were as follows: Other Postretirement Benefits 2021 2020 2019 Service cost $ 1 $ 1 $ 1 Interest cost 4 5 6 Amortization of prior service credit (26) (26) (34) Amortization of actuarial loss 4 4 3 Net periodic benefit credit $ (17) $ (16) $ (24) Changes in the benefit obligations were: 2021 2020 Benefit obligations at January 1 $ 163 $ 161 Service cost 1 1 Interest cost 4 5 Actuarial (gain) / loss (20) 7 Benefits paid (10) (11) Foreign currency translation (1) — Benefit obligations at December 31 $ 137 $ 163 Changes in the net loss and prior service credit for the Company’s postretirement benefit plans were: 2021 2020 2019 Net Prior Net Prior Net Prior Balance at January 1 $ 45 $ (46) $ 42 $ (72) $ 31 $ (105) Reclassification to net periodic benefit cost (4) 26 (4) 26 (3) 34 Current year (gain) / loss (20) — 7 — 14 — Amendments — — — — — (1) Balance at December 31 $ 21 $ (20) $ 45 $ (46) $ 42 $ (72) Expected future benefit payments are as follows: Benefit Payments 2022 $ 14 2023 12 2024 11 2025 10 2026 10 2027 - 2031 43 The assumed health care cost trend rates at December 31, 2021 were as follows: Health care cost trend rate assumed for 2021 4.5 % Rate that the cost trend rate gradually declines to 3.8 % Year that the rate reaches the rate it is assumed to remain 2040 Weighted average discount rates used to calculate the benefit obligations at the end of each year and the cost for each year are presented below: 2021 2020 2019 Benefit obligations 3.4 % 2.8 % 3.5 % Service cost 5.9 % 4.1 % 4.8 % Interest cost 3.6 % 3.3 % 4.2 %

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The components of income before income taxes were as follows: 2021 2020 2019 U.S. $ 143 $ 97 $ 1 Foreign (562) 628 630 $ (419) $ 725 $ 631 The provision for income taxes consisted of the following: 2021 2020 2019 Current tax: U.S. federal $ 2 $ — $ (1) State and foreign 239 161 165 $ 241 $ 161 $ 164 Deferred tax: U.S. federal $ 46 $ 38 $ 17 State and foreign (344) — (45) (298) 38 (28) Total $ (57) $ 199 $ 136 The provision for income taxes differs from the amount of income tax determined by applying the U.S. statutory federal income tax rate to pre-tax income as a result of the following items: 2021 2020 2019 U.S. statutory rate at 21% $ (88) $ 152 $ 133 Tax on foreign income (29) 27 10 Valuation allowance changes 26 (11) (33) State taxes 9 5 7 U.S. taxes on foreign income, net of credits 13 14 15 Tax contingencies 8 1 19 Tax law changes (8) 4 (11) Other items, net 12 7 (4) Income tax provision / (benefit) $ (57) $ 199 $ 136 The Company benefits from certain incentives in Brazil which allow it to pay reduced income taxes. The incentives expire at various dates beginning in December 2025. These incentives increased net income attributable to the Company by $21 in 2021 and $17 in both 2020 and 2019. The Company paid taxes of $253, $189 and $173 in 2021, 2020 and 2019. In 2021, tax on foreign income includes income tax charges of $42 in continuing operations for reorganizations and other transactions required to prepare the European Tinplate business for sale. Additionally, the Company recorded an income tax charge of $44 to establish a valuation allowance for deferred tax assets related to tax loss carryforwards in France. The Company believes that it is more likely than not that these tax loss carryforwards will not be utilized after the sale of the European Tinplate business. See Note B for more information regarding the sale of the European Tinplate business. In 2021, the Company also recorded a tax benefit of $18 related to a deferred tax valuation allowance release resulting from improved profitability in a Transit Packaging corporate entity. Additionally, the Company also recorded income tax benefits related to tax law changes in India, Turkey and the U.K. In 2019, the Company recorded an income tax benefit of $36 related to a deferred tax valuation allowance release resulting from an internal reorganization in Transit Packaging. Additionally, the Company recorded a charge of $15 related to the settlement of a pre-acquisition tax contingency that arose from a transaction that occurred prior to its acquisition of Signode in 2018. The Company also recorded a benefit of $9 arising from tax law changes in India. As of December 31, 2021, the Company had not provided deferred taxes on approximately $1,500 of earnings in certain non-U.S. subsidiaries because such earnings are indefinitely reinvested in its international operations. Upon distribution of such earnings in the form of dividends or otherwise, the Company may be subject to incremental foreign tax. It is not practicable to estimate the amount of foreign tax that might be payable. The components of deferred taxes at December 31 were: 2021 2020 Assets Liabilities Assets Liabilities Tax carryforwards $ 346 $ — $ 424 $ — Intangible assets — 317 — 354 Property, plant and equipment 21 176 24 130 Pensions 105 $ 13 124 $ 101 Accruals and other 96 109 89 84 Asbestos 56 — 61 — Postretirement and postemployment benefits 31 — 35 — Lease liabilities 29 — 34 — Right of use assets — 28 — 33 Valuation allowances (227) — (204) — Total $ 457 $ 643 $ 587 $ 702 Tax carryforwards expire as follows: Year Amount 2022 $ 10 2023 12 2024 13 2025 28 2026 24 Thereafter 142 Unlimited 117 Tax carryforwards expiring after 2026 include $110 of U.S. state tax loss carryforwards. The unlimited category includes $33 of Luxembourg tax loss carryforwards and $62 of French tax loss carryforwards. Realization of any portion of the Company’s deferred tax assets is dependent upon the availability of taxable income in the relevant jurisdictions. The Company considers all sources of taxable income, including (i) taxable income in any available carryback period, (ii) the reversal of taxable temporary differences, (iii) tax-planning strategies, and (iv) taxable income expected to be generated in the future other than from reversing temporary differences. The Company also considers whether there have been cumulative losses in recent years. The Company records a valuation allowance when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company’s valuation allowances at December 31, 2021 include $167 primarily related to the portion of U.S. state tax loss carryforwards that the Company does not believe are more likely than not to be utilized prior to their expiration. The Company’s ability to utilize state tax loss carryforwards is impacted by several factors including taxable income, expiration dates, limitations imposed by certain states on the amount of loss carryforwards that can be used in a given year to offset taxable income and whether the state permits the Company to file a combined return. Management’s estimate of the appropriate valuation allowance in any jurisdiction involves a number of assumptions and judgments, including the amount and timing of future taxable income. Should future results differ from management’s estimates, it is possible there could be future adjustments to the valuation allowances that would result in an increase or decrease in tax expense in the period such changes in estimates are made. A reconciliation of unrecognized tax benefits follows: 2021 2020 2019 Balance at January 1 $ 42 $ 39 $ 35 Additions for prior year tax positions 9 1 20 Lapse of statute of limitations (1) — (1) Settlements — — (15) Foreign currency translation (2) 2 — Balance at December 31 $ 48 $ 42 $ 39 The Company’s unrecognized tax benefits include potential liabilities related to transfer pricing, foreign withholding taxes, and non-deductibility of expenses and exclude $2 of interest and penalties as of December 31, 2021. The total interest and penalties recorded in income tax expense was less than $1 in 2021, 2020 and 2019. As of December 31, 2021, unrecognized tax benefits of $48, if recognized, would affect the Company's effective tax rate. The Company’s unrecognized tax benefits are not expected to increase over the next twelve months and are expected to decrease as open tax years lapse or claims are settled. The Company is unable to estimate a range of reasonably possible changes in its unrecognized tax benefits in the next twelve months as it is unable to predict when, or if, the tax authorities will commence their audits, the time needed for the audits, and the audit findings that will require settlement with the applicable tax authorities, if any.

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Capital Stock	Capital Stock A summary of common share activity for the years ended December 31 follows (in shares): 2021 2020 2019 Common shares outstanding at January 1 134,801,030 135,577,878 135,173,948 Shares repurchased (9,121,328) (1,240,328) (106,388) Shares issued upon exercise of employee stock options — — 70,000 Restricted stock issued to employees, net of forfeitures 435,129 439,700 416,695 Shares issued to non-employee directors 16,968 23,780 23,623 Common shares outstanding at December 31 126,131,799 134,801,030 135,577,878 The Company declared and paid dividends of $0.80 per share in 2021. Additionally, on February 24, 2022, the Company's Board of Directors declared a dividend of $0.22 per share payable on March 24, 2022 to shareholders of record as of March 10, 2022. On December 9, 2021, the Company's Board of Directors authorized the repurchase of an aggregate amount of $3,000 of Company common stock through the end of 2024. The new authorization supersedes the previous authorization announced in February 2021, which authorized the repurchase of an aggregate amount of $1,500 of Company common stock through the end of 2023. Share repurchases under the Company's program may be made in the open market or through privately negotiated transactions, and at times and in such amounts as management deems appropriate. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions. The Company repurchased $950 of its shares during 2021. The Company is not obligated to acquire any shares of its common stock and the share repurchase program may be suspended or terminated at any time at the Company's discretion. Share repurchases are subject to the terms of the Company's debt agreements, market conditions and other factors. The Board of Directors has the authority to issue, at any time or from time to time, up to 30 million shares of preferred stock and has authority to fix the designations, number and voting rights, preferences, privileges, limitations, restrictions, conversion rights and other special or relative rights, if any, of any class or series of any class of preferred stock that may be desired, provided the shares of any such class or series of preferred stock shall not be entitled to more than one vote per share when voting as a class with holders of the Company's common stock. Dividends are payable when declared by the Company's Board of Directors and in accordance with the restrictions set forth in the Company's debt agreements. While the Company's debt agreements impose restrictions on the Company's ability to pay dividends and repurchase common stock, the debt agreements generally permit dividends and common stock repurchases provided that the Company is in compliance with applicable financial and other covenants and meets certain liquidity requirements.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss Attributable to Crown Holdings	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Accumulated Other Comprehensive Loss Attributable to Crown Holdings	Accumulated Other Comprehensive Loss Attributable to Crown Holdings The following table provides information about the changes in each component of accumulated other comprehensive income/ (loss) for the years ended December 31, 2021 and 2020. Defined benefit plans Foreign currency translation Gains and losses on cash flow hedges Total Balance at January 1, 2020 $ (1,449) $ (1,668) $ (14) $ (3,131) Other comprehensive (loss) / income before reclassifications (117) (91) 9 (199) Amounts reclassified from accumulated other comprehensive income 102 — 35 137 Other comprehensive (loss) / income (15) (91) 44 (62) Balance at December 31, 2020 (1,464) (1,759) 30 (3,193) Other comprehensive (loss) / income before reclassifications (419) 48 71 (300) Amounts reclassified from accumulated other comprehensive income 1,115 553 (73) 1,595 Other comprehensive income / (loss) 696 601 (2) 1,295 Balance at December 31, 2021 $ (768) $ (1,158) $ 28 $ (1,898) See Note N and Note R for further details of amounts reclassified from accumulated other comprehensive income related to cash flow hedges and defined benefit plans. During the year-ended December 31, 2021, the Company reclassified foreign currency translation as a result of the sale of the European Tinplate business. See Note B for more information.

Revenue

Revenue	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenue	Revenue For the years ended December 31, 2021, 2020 and 2019, the Company recognized revenue as follows: 2021 2020 2019 Revenue recognized over time $ 6,097 $ 5,032 $ 4,778 Revenue recognized at a point in time 5,297 4,360 4,781 Total $ 11,394 $ 9,392 $ 9,559 See Note Y for further disaggregation of the Company's revenue. The Company has applied the practical expedient to exclude disclosure of remaining performance obligations as its binding orders typically have a term of one year or less. Contract assets are typically recognized for work in process related to the Company's three-piece printed products and equipment business. Contract assets and liabilities are reported in a net position on a contract-by-contract basis. The Company had net contract assets of $23 and $20 as of December 31, 2021 and 2020 included in prepaid and other current assets. For the year ended December 31, 2021, the Company satisfied performance obligations related to contract assets at December 31, 2020

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation The Company’s shareholder-approved stock-based incentive compensation plans provide for the granting of awards in the form of stock options, deferred stock, restricted stock or stock appreciation rights (“SARs”). The awards may be subject to the achievement of certain performance goals as determined by the Compensation Committee designated by the Company’s Board of Directors. There have been no awards of SARs. At December 31, 2021, there were 2.2 million authorized shares available for future awards. Restricted and Deferred Stock Annually, the Company awards shares of restricted stock to certain senior executives in the form of time-vesting restricted stock and performance-based shares. The time-vesting restricted stock vests ratably over three years. The performance-based share awards are subject to either a market condition or a performance condition. For awards subject to a market condition, the metric is the Company’s Total Shareholder Return (“TSR”), which includes share price appreciation and dividends paid, during the three-year term of the award measured against the TSR of a peer group of companies. For awards subject to a performance condition, the metric is the Company's average return on invested capital over the three-year term. The performance-based shares cliff vest at the end of three years. The number of performance-based shares that will ultimately vest is based on the level of performance achieved, ranging between 0% and 200% of the shares originally awarded, and is settled in shares of common stock. Participants who terminate employment because of disability, death or, subject to Company approval, retirement, receive accelerated vesting of their service condition to the date of termination and, if approved, performance restrictions laps on the original vesting date. The Company also issues shares of time-vesting restricted stock to U.S. employees and deferred stock to non-U.S. employees which vest ratably over three A summary of restricted and deferred stock activity follows: Number of shares Non-vested shares outstanding at January 1, 2021 1,820,159 Awarded: Time-vesting 221,042 Performance-based 170,036 Released: Time-vesting (418,426) Performance-based (224,358) Forfeitures: Time-vesting (284,247) Performance-based — Non-vested shares outstanding at December 31, 2021 1,284,206 The average grant-date fair value of restricted stock awarded in 2021, 2020 and 2019 follows: 2021 2020 2019 Time-vesting $ 100.08 $ 70.07 $ 56.06 Performance-based 100.99 72.08 46.08 The fair values of the performance-based awards that include a market condition were calculated using a Monte Carlo valuation model and the following weighted average assumptions: 2021 2020 2019 Risk-free interest rate 0.2 % 1.6 % 2.5 % Expected term (years) 3 3 3 Expected stock price volatility 35.5 % 22.0 % 21.4 % At December 31, 2021, unrecognized compensation cost related to outstanding restricted and deferred stock was $48. The weighted average period over which the expense is expected to be recognized is 1.9 years. The aggregate market value of the shares released on the vesting dates was $66 in 2021.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table summarizes basic and diluted earnings per share ("EPS"). Basic EBS excludes all potentially dilutive securities and is computed by dividing net income attributable to Crown Holdings by the weighted average number of common shares outstanding during the period. Diluted EPS includes the effect of stock options and restricted stock, when dilutive, as calculated under the treasury stock method. 2021 2020 2019 Net (loss) / income from continuing operations attributable to Crown Holdings (507) 424 387 Net (loss) / income from discontinued operations attributable to Crown Holdings (53) 155 123 Net (loss) / income attributable to Crown Holdings $ (560) $ 579 $ 510 Weighted average shares outstanding: Basic 130.38 133.53 133.89 Add: dilutive stock options and restricted stock — 1.03 0.99 Diluted 130.38 134.56 134.88 Earnings per common share attributable to Crown Holdings: Basic (loss) / earnings per common share from continuing operations (3.89) 3.18 2.89 Basic (loss) / earnings per common share from discontinued operations (0.41) 1.16 0.92 Basic (loss) / earnings per share $ (4.30) $ 4.34 $ 3.81 Diluted (loss) / earnings per common share from continuing operations (3.89) 3.15 2.87 Diluted (loss) / earnings per common share from discontinued operations (0.41) 1.15 0.91 Diluted (loss) / earnings per share $ (4.30) $ 4.30 $ 3.78 Contingently issuable shares excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive 1.0 0.7 0.8

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Segment Information	Segment Information The Company’s business is generally organized by product line and geography. The Company has determined that it has the following reportable segments: Americas Beverage, European Beverage, Asia Pacific and Transit Packaging. Other includes the Company's food can, aerosol can and closures businesses in North America, and beverage tooling and equipment operations in the U.S. and U.K. The Company evaluates performance and allocates resources based on segment income. Segment income, which is not a defined term under GAAP, is defined by the Company as income from operations adjusted to exclude intangibles amortization charges, Restructuring and Other and the impact of fair value adjustments related to inventory acquired in an acquisition. Segment income should not be considered in isolation or as a substitute for net income data prepared in accordance with GAAP and may not be comparable to calculations of similarly titled measures by other companies. The tables below present information about operating segments reported as continuing operations for the three years ended December 31, 2021, 2020 and 2019: 2021 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 4,441 $ — $ 4,453 $ 108 $ 508 $ 756 European Beverage 1,843 133 2,025 51 55 259 Asia Pacific 1,322 — 1,784 61 68 182 Transit Packaging 2,530 25 4,225 41 58 318 Total reportable segments 10,136 158 12,487 261 689 $ 1,515 Other 1,258 114 1,129 17 58 Corporate and unallocated items — — 242 4 40 Total $ 11,394 $ 272 $ 13,858 $ 282 $ 787 2020 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 3,565 $ 2 $ 3,886 $ 93 $ 333 $ 652 European Beverage 1,473 39 1,977 47 72 215 Asia Pacific 1,168 — 1,808 56 69 175 Transit Packaging 2,018 13 4,195 45 40 254 Total reportable segments 8,224 54 11,866 241 514 $ 1,296 Other 1,168 100 927 15 30 Corporate and unallocated items — — 999 4 10 Total $ 9,392 $ 154 $ 13,792 $ 260 $ 554 2019 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 3,369 $ 12 $ 3,577 $ 88 $ 167 $ 534 European Beverage 1,497 2 1,782 54 82 190 Asia Pacific 1,290 — 1,604 52 65 194 Transit Packaging 2,274 9 4,157 57 27 290 Total reportable segments 8,430 23 11,120 251 341 $ 1,208 Other 1,129 110 904 14 24 Corporate and unallocated items — — 694 2 26 Total $ 9,559 $ 133 $ 12,718 $ 267 $ 391 Intersegment sales primarily include sales of cans, ends and parts and equipment used in the manufacturing process. Corporate and unallocated items include corporate and administrative costs, technology costs, and unallocated items such as stock-based compensation. A reconciliation of segment income of reportable segments to income before income taxes for the three years ended December 31, 2021, 2020 and 2019 follows: 2021 2020 2019 Segment income of reportable segments $ 1,515 $ 1,296 $ 1,208 Other 144 114 120 Corporate and unallocated items (159) (170) (162) Restructuring and other 28 (30) 30 Amortization of intangibles (165) (162) (169) Loss from early extinguishments of debt (68) — (27) Other pension and postretirement (1,515) (43) (10) Interest expense (253) (290) (367) Interest income 9 8 15 Foreign exchange 45 2 (7) Income / (loss) from continuing operations before income taxes and equity in net earnings of affiliates $ (419) $ 725 $ 631 For the three years ended December 31, 2021, 2020 and 2019, intercompany profit of $8, $9 and $6 was eliminated within segment income of other. For the year ended December 31, 2021, two customers each accounted for 11% of the Company's consolidated net sales. These customers are global beverage companies served by the Company's beverage operations in the Americas, Europe and Asia. These same two customers accounted for 11% and 10%, respectively, of the Company's consolidated net sales in 2020. For the year ended December 31, 2019, one of these customers accounted for 12% of the Company's consolidated net sales. Sales by major product were: 2021 2020 2019 Metal beverage cans and ends $ 6,982 $ 5,716 $ 5,588 Transit packaging 2,530 2,018 2,274 Metal food cans and ends 789 733 730 Other products 580 451 457 Other metal packaging 513 474 510 Consolidated net sales $ 11,394 $ 9,392 $ 9,559 The following table provides sales and long-lived asset information for the major countries in which the Company operates. Long-lived assets comprises property, plant and equipment. Net Sales Long-Lived Assets 2021 2020 2019 2021 2020 United States $ 4,182 $ 3,586 $ 3,407 $ 1,259 $ 922 Brazil 933 706 714 510 396 Mexico 896 681 834 437 421 Canada 782 662 508 97 93 United Kingdom 412 234 253 96 81 Other 4,189 3,523 3,843 1,637 1,739 Consolidated total $ 11,394 $ 9,392 $ 9,559 $ 4,036 $ 3,652

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts and Reserves	12 Months Ended
	Dec. 31, 2021
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts and Reserves	SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS AND RESERVES (In millions) COLUMN A COLUMN B COLUMN C COLUMN D COLUMN E COLUMN F Additions Description Balance at Charged to costs and expense Charged to Acquisitions Deductions Balance at For the year ended December 31, 2021 Allowances deducted from assets to which they apply: Deferred tax assets 204 38 (3) — (12) 227 For the year ended December 31, 2020 Allowances deducted from assets to which they apply: Deferred tax assets 242 (11) 1 — (28) 204 For the year ended December 31, 2019 Allowances deducted from assets to which they apply: Deferred tax assets 281 (33) 5 — (11) 242

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Business and Principles of Consolidation	Business and Principles of Consolidation . The consolidated financial statements include the accounts of Crown Holdings, Inc. (the “Company”) and its consolidated subsidiary companies (where the context requires, the “Company” shall include reference to the Company and its consolidated subsidiary companies). The Company is a worldwide leader in the design, manufacture and sale of packaging products for consumer goods and industrial products. The Company's consumer packaging solutions primarily support the beverage and food industries through the sale of aluminum and steel cans. The Company's packaging for industrial products includes steel and plastic consumables and equipment, paper-based protective packaging, and plastic film consumables and equipment, which are sold into the metals, food and beverage, construction, agricultural, corrugated and general industries. The financial statements were prepared in conformity with accounting principles generally accepted in the United States of America and reflect management’s estimates and assumptions. Actual results could differ from those estimates, impacting reported results of operations and financial position. All intercompany accounts and transactions are eliminated in consolidation. In deciding which entities should be reported on a consolidated basis, the Company first determines whether the entity is a variable interest entity (“VIE”). If an entity is a VIE, the Company determines whether it is the primary beneficiary and therefore, should consolidate the VIE. If an entity is not a VIE, the Company consolidates those entities in which it has control, including certain subsidiaries that are not majority-owned. Certain of the Company’s agreements with noncontrolling interests contain provisions in which the Company would surrender certain decision-making rights upon a change in control of the Company. Accordingly, consolidation of these operations may no longer be appropriate subsequent to a change in control of the Company, as defined in the agreements. Investments in companies in which the Company does not have control, but has the ability to exercise significant influence over operating and financial policies, are accounted for by the equity method. The proportionate share of the net income / (loss) resulting from these investments is reported in Equity in net earnings of affiliates in the Consolidated Statement of Operations. The carrying value of the Company's equity method investments are reported in Other non-current assets in the Consolidated Balance Sheets. Equity method investments are reported at cost and adjusted each period for the Company's share of the investee's income or loss and dividends paid, if any. The Company assess investments for impairment whenever events or changes in circumstances indicate that the carrying value of an investment may not be recoverable. Other investments are carried at cost.
Foreign Currency Translation	Foreign Currency Translation . For non-U.S. subsidiaries which operate in a local currency environment, assets and liabilities are translated into U.S. dollars at year-end exchange rates. Income, expense and cash flow items are translated at average exchange rates prevailing during the year. Translation adjustments for these subsidiaries are accumulated as a separate component of accumulated other comprehensive income in equity. For non-U.S. subsidiaries that use a U.S. dollar functional currency, local currency inventories and property, plant and equipment are translated into U.S. dollars at rates prevailing when acquired; all other assets and liabilities are translated at year-end exchange rates. Inventories charged to cost of sales and depreciation are remeasured at historical rates; all other income and expense items are translated at average exchange rates prevailing during the year. Gains and losses which result from remeasurement are included in earnings.
Revenue Recognition	Revenue Recognition . The majority of the Company’s revenues from metal packaging products are derived from multi-year requirement contracts with leading manufacturers and marketers of packaged consumer products for can sets, comprising a can and an end. As requirement contracts do not typically include fixed volumes, customers often purchase products pursuant to purchase orders or other communications which are short-term in nature. The can and the end are considered separate performance obligations because they are distinct and separately identifiable. Revenues from Transit Packaging are generally derived from individual purchase orders which may include multiple goods and services which are separate performance obligations because they are distinct and separately identifiable. The Company manufactures certain products that have no alternative use to the Company once they are printed or manufactured to customer specifications. If the Company has an enforceable right to payment for custom products at all times in the manufacturing process, revenue is recognized over time. In each of the Company’s geographic markets, revenue from beverage cans is primarily recognized over time using the units produced output method as beverage cans are generally printed for a specific customer in a continuous production process. The timing of revenue recognition for the Company’s other products, including beverage ends and three-piece products, which includes food cans and ends and aerosol cans and ends, may vary as these products may be printed or customized depending upon customer preferences which can vary by geographic market. Revenue that is recognized over time for the Company’s three-piece products and equipment business is generally recognized using the cost-to-cost input method as these products involve an intermediary step that results in customized work-in-process inventory. For products that follow a point in time model, revenue is generally recognized when title and risk of loss transfer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods or providing services. Standalone selling prices for each performance obligation are generally stated in the contract. When the Company offers variable consideration in the form of volume rebates to customers, it estimates the most likely amount of revenue to which it is expected to be entitled and includes the estimate in the transaction price, limited to the amount which is probable will not result in reversal of cumulative revenue recognized when the variable consideration is resolved. When the Company offers customers options to purchase additional product at discounted prices, judgment is required to determine if the discounted prices represent material rights. If so, the transaction price allocated to the discount is based on its relative standalone price and is recognized upon purchase of the additional product. Customer payment terms are typically less than one year and as such, the Company has applied the practical expedient to exclude consideration of significant financing components from the determination of transaction price. Taxes collected from customers and remitted to governmental authorities are excluded from net sales. Shipping and handling fees and costs from product sales are reported as cost of products sold and are accrued when the Company recognizes revenue over time before the shipping and handling activities occur. Costs to obtain a contract are generally immaterial but the Company has elected the practical expedient to expense these costs as incurred if the duration of the contract is one year or less. Unbilled receivables are recorded for revenue recognized over time when the Company has determined that control has passed to the customer but the customer has not yet been invoiced because the Company does not have present right to payment. The Company generally has a present right to payment when title of product transfers. Unbilled receivables are included in receivables in the Consolidated Balance Sheet with a corresponding decrease to inventory. Contract assets are recorded for revenue recognized over time when the Company has determined that control for a performance obligation has passed to the customer, but the right to invoice the customer is contingent upon the completion of the performance obligations included in the contract. Contract assets are classified as current as they are expected to be invoiced within one year and may not exceed their net realizable value. Contract liabilities are established if the Company must defer the recognition of a portion of consideration received because it has to satisfy a future obligation. Contract liabilities are classified as current or noncurrent based on when the Company expects to recognize revenue.
Stock-Based Compensation	Stock-Based Compensation . For awards with a service or market condition, compensation expense is recognized over the vesting period on a straight-line basis using the grant date fair value of the award and the estimated number of awards that are expected to vest. For awards with a performance condition, the Company assesses the probability of vesting at each reporting period and adjusts compensation cost based on its probability assessment. The Company’s plans provide for stock awards which may include accelerated vesting upon retirement, disability, or death of eligible employees. The Company considers a stock-based award to be vested when the service period is no longer contingent on the employee providing future service. Accordingly, the related compensation cost is recognized immediately for awards granted to retirement-eligible individuals, or over the period from the grant date to the date that retirement eligibility is achieved if less than the stated vesting period.
Cash and Cash Equivalents	Cash, Cash Equivalents and Restricted Cash. Cash equivalents represent investments with maturities of three months or less from the time of purchase and are carried at cost, which approximates fair value because of the short maturity of those instruments. Outstanding checks in excess of funds on deposit are included in accounts payable.
Restricted Cash	The Company generally classifies any cash that is legally restricted as to withdrawal or usage as restricted cash.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses. Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The measurement of expected credit losses is based on past events, historical experience, current conditions and forecasts that affect the collectability of accounts receivable.
Inventory Valuation	Inventory Valuation . Inventories are stated at the lower of cost or net realizable value, with cost principally determined under the first-in, first-out (“FIFO”) or average cost method.
Property, Plant And Equipment	Property, Plant and Equipment . Property, plant and equipment (“PP&E”) is carried at cost less accumulated depreciation and includes expenditures for new facilities and equipment and those costs which substantially increase the useful lives or capacity of existing PP&E. Cost of constructed assets includes capitalized interest incurred during the construction and development period. Maintenance and repairs, including labor and material costs for planned major maintenance such as annual production line overhauls, are expensed as incurred. When PP&E is retired or otherwise disposed, the net carrying amount is eliminated with any gain or loss on disposition recognized in earnings at that time. Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). The Company periodically reviews the estimated useful lives of its PP&E and, where appropriate, changes are made prospectively. Land improvements 25 Buildings and building improvements 25 – 40 Machinery and equipment 3– 18
Goodwill and Intangible Assets	Goodwill and Intangible Assets . Assets and liabilities of acquired businesses are recorded under the acquisition method of accounting at their estimated fair values at the dates of acquisition. Goodwill represents costs in excess of fair values assigned to the underlying identifiable net assets of acquired businesses. Goodwill is carried at cost and reviewed for impairment annually in the fourth quarter of each year or when facts and circumstances indicate goodwill may be impaired. Goodwill is allocated to the reporting units at the time of each acquisition based on the relative fair values of the reporting units. In assessing goodwill for impairment, the Company may first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. Further quantitative assessment may then be required. The quantitative assessment involves a number of assumptions and judgments, including the calculation of fair value for the Company’s identified reporting units. The Company determines the estimated fair value of each reporting unit based on an average of the estimated fair values using an income and a market approach. The income approach utilizes significant assumptions, including revenue and Adjusted EBITDA (a non-GAAP item defined by the Company as net customer sales, less cost of products sold excluding depreciation and amortization, less selling and administrative expenses) margin growth rates, discount rates and terminal year exit multiples. If the carrying value of a reporting unit exceeds its fair value, any impairment loss is measured by comparing the carrying value of the reporting unit to its fair value, not to exceed the carrying amount of goodwill. Definite-lived intangible assets are carried at cost less accumulated amortization. Definite-lived intangibles are amortized on a straight-line basis over their estimated useful lives described below (in years). Definite-lived intangible assets are tested for impairment when facts and circumstances indicate the carrying value may not be recoverable from their undiscounted cash flows. If impaired, the assets are written down to fair value based on either discounted cash flows or appraised values. Customer relationships 11 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8
Impairment or Disposal of Long-Lived Assets	Impairment or Disposal of Long-Lived Assets . In the event that facts and circumstances indicate that the carrying value of long-lived assets, primarily PP&E, may be impaired, the Company performs a recoverability evaluation. If the evaluation indicates that the carrying value of an asset is not recoverable from its undiscounted cash flows, an impairment loss is measured by comparing the carrying value of the asset to its fair value, based on discounted cash flows. Long-lived assets classified as held for sale are presented in the balance sheet at the lower of their carrying value or fair value less cost to sell.
Leases	Leases. The Company has operating and finance leases for land and buildings related to certain manufacturing facilities, warehouses and corporate offices, vehicle fleets and certain office and manufacturing equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet. The Company's lease terms include options to extend the lease when it is reasonably certain that the Company will exercise the option. Variable lease payment amounts that cannot be determined at commencement of the lease, such as increases in index rates, are not included in the measurement of the lease liabilities and corresponding right-of-use assets and are recognized in the period those payments are incurred. The Company separates lease and non-lease components of lease arrangements and allocates contract consideration based on standalone selling prices. Variable consideration is allocated to the lease and non-lease components to which the variable payments specifically relate. The discount rate implicit within the Company's leases is often not determinable and therefore the Company generally uses its incremental borrowing rate based on the information available at the commencement date of the lease in determining the present value of the lease payments. The incremental borrowing rate is determined based on lease term and the currency in which lease payments are made. The Company's leases do not contain any material residual value guarantees or material restrictive covenants.
Taxes on Income	Taxes on Income . The provision for income taxes is determined using the asset and liability approach. Deferred taxes represent the future expected tax consequences of differences between the financial reporting and tax bases of assets and liabilities based upon enacted tax rates and laws. The Company has made an accounting policy election to treat taxes due on future U.S. inclusions of certain intangible income of foreign subsidiaries as a current period expense when incurred. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not that a tax benefit will not be realized. Investment tax credits are accounted for using the deferral method. Income tax-related interest and penalties are reported as income tax expense.
Derivatives and Hedging	Derivatives and Hedging . All outstanding derivative financial instruments are recognized in the balance sheet at their fair values. The impact on earnings from recognizing the fair values of these instruments depends on their intended use, their hedge designation and their effectiveness in offsetting changes in the fair values of the exposures they are hedging. Changes in the fair values of instruments designated to reduce or eliminate adverse fluctuations in the fair values of recognized assets and liabilities are reported currently in earnings along with changes in the fair values of the hedged items. Changes in the effective portions of the fair values of instruments used to reduce or eliminate adverse fluctuations in cash flows of anticipated or forecasted transactions are reported in equity as a component of accumulated other comprehensive income. Amounts in accumulated other comprehensive income are reclassified to earnings when the related hedged items impact earnings or the forecasted transactions become probable of not occurring. Changes in the fair values of derivative instruments that are not designated as hedges or do not qualify for hedge accounting treatment are reported currently in earnings. Amounts reported in earnings are classified consistent with the item being hedged. The effectiveness of derivative instruments in reducing risks associated with the hedged exposures is assessed at inception and on an ongoing basis. Time value, a component of an instrument’s fair value, is excluded in assessing effectiveness for fair value hedges, except hedges of firm commitments, and included for cash flow hedges. Hedge accounting is discontinued prospectively when (i) the instrument is no longer effective in offsetting changes in fair value or cash flows of the underlying hedged item, (ii) the instrument expires, is sold, terminated or exercised, or (iii) designating the instrument as a hedge is no longer appropriate. The Company formally documents all relationships between its hedging instruments and hedged items at inception, including its risk management objective and strategy for establishing various hedge relationships. Cash flows from hedging instruments are classified in the Consolidated Statements of Cash Flows consistent with the items being hedged.
Treasury Stock	Treasury Stock . Treasury stock is reported at par value. The excess of fair value over par value is first charged to paid-in capital, if any, and then to retained earnings.
Research and Development	Research and Development . Research, development and engineering costs of $47 in 2021, $48 in 2020, and $50 in 2019 were expensed as incurred and reported in selling and administrative expense in the Consolidated Statements of Operations. Substantially all engineering and development costs are related to developing new products or designing significant improvements to existing products or processes. Costs primarily include employee salaries and benefits and facility costs.
Reclassifications	Reclassifications. Certain reclassifications of prior years’ data have been made to conform to the current year presentation.
Recent Accounting and Reporting Pronouncements	Recent Accounting and Reporting Pronouncements. Recently Adopted Accounting Standards On January 1, 2021, the Company adopted new guidance to simplify the accounting for income taxes by, among other things, reducing complexity in the interim-period accounting for year-to-date loss limitations and changes in tax laws. The guidance did not have a material impact on the Company's consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Estimated Useful Lives of PP&E	Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). The Company periodically reviews the estimated useful lives of its PP&E and, where appropriate, changes are made prospectively. Land improvements 25 Buildings and building improvements 25 – 40 Machinery and equipment 3– 18 2021 2020 Buildings and improvements $ 1,226 $ 1,137 Machinery and equipment 5,372 4,965 Land and improvements 208 223 Construction in progress 612 483 7,418 6,808 Less: accumulated depreciation and amortization (3,382) (3,156) $ 4,036 $ 3,652
Schedule of Gross Carrying Amounts and Accumulated Amortization of Finite-Lived Intangible Assets	Customer relationships 11 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8 Gross carrying amounts and accumulated amortization of finite-lived intangible assets by major class were as follows: December 31, 2021 December 31, 2020 Gross Accumulated amortization Net Gross Accumulated amortization Net Customer relationships $ 1,363 $ (443) $ 920 $ 1,413 $ (346) $ 1,067 Trade names 544 (86) 458 565 (65) 500 Technology 158 (88) 70 165 (67) 98 Long term supply contracts 137 (63) 74 142 (55) 87 Patents 15 (12) 3 13 (10) 3 $ 2,217 $ (692) $ 1,525 $ 2,298 $ (543) $ 1,755

Divestitures (Tables)

Divestitures (Tables)	12 Months Ended
	Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations	Major components of net (loss) / income from discontinued operations were as follows: For the Years Ended December 31 2021 2020 2019 Net sales $ 1,585 $ 2,183 $ 2,106 Cost of products sold, excluding depreciation and amortization 1,301 1,823 1,774 Depreciation and amortization 16 59 59 Selling and administrative expense 60 81 75 Restructuring and other 2 4 4 Goodwill impairment — — 25 Other pension and postretirement 1 2 3 Interest expense 6 10 11 Interest income — — (2) Foreign exchange — 3 2 Loss on sale of discontinued businesses 101 — — Transaction costs 34 — — Income from discontinued operations before tax 64 201 155 Provision for income taxes 116 45 30 Net (loss) / income from discontinued operations (52) 156 125 Net income from discontinued operations attributable to noncontrolling interests 1 1 2 Net (loss) / income from discontinued operations attributable to Crown Holdings $ (53) $ 155 $ 123 Major classes of assets and liabilities of the Business classified as held for sale at December 31, 2020 were as follows: Receivables, net $ 281 Inventories 410 Prepaid expenses and other current assets 30 Total current assets held for sale $ 721 Goodwill $ 1,447 Intangible assets, net 125 Property, plant and equipment, net 546 Operating lease right-of-use assets, net 43 Other non-current assets 17 Total non-current assets held for sale $ 2,178 Short-term debt $ 17 Current portion of operating lease liabilities 12 Accounts payable 725 Accrued liabilities 227 Total current liabilities held for sale $ 981 Postretirement and pension liabilities $ 77 Non-current portion of operating lease liabilities 32 Other non-current liabilities 90 Total non-current liabilities held for sale $ 199 The table above excludes assets held for sale unrelated to the Business that are not material for disclosure. The capital expenditures of the Business were as follows: For the Years Ended December 31 2021 2020 2019 Capital expenditures $ 29 $ 33 $ 41

Cash, Cash Equivalents, and R_2

Cash, Cash Equivalents, and Restricted Cash (Tables)	12 Months Ended
	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Schedule of Cash, Cash Equivalents and Restricted Cash	Cash, cash equivalents, and restricted cash included in the Company's Consolidated Balance Sheets and Statements of Cash Flows were as follows: 2021 2020 Cash and cash equivalents $ 531 $ 1,173 Restricted cash included in prepaid expenses and other current assets 61 64 Restricted cash included in other non-current assets 1 1 Total restricted cash 62 65 Total cash, cash equivalents and restricted cash $ 593 $ 1,238
Restrictions on Cash and Cash Equivalents	Cash, cash equivalents, and restricted cash included in the Company's Consolidated Balance Sheets and Statements of Cash Flows were as follows: 2021 2020 Cash and cash equivalents $ 531 $ 1,173 Restricted cash included in prepaid expenses and other current assets 61 64 Restricted cash included in other non-current assets 1 1 Total restricted cash 62 65 Total cash, cash equivalents and restricted cash $ 593 $ 1,238

Receivables (Tables)

Receivables (Tables)	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Schedule of Receivables	2021 2020 Accounts receivable $ 1,289 $ 1,084 Less: allowance for credit losses (20) (20) Net trade receivables 1,269 1,064 Unbilled receivables 325 248 Miscellaneous receivables 295 210 $ 1,889 $ 1,522

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Components of Inventories	2021 2020 Raw materials and supplies $ 1,094 $ 800 Work in process 120 89 Finished goods 521 374 $ 1,735 $ 1,263

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Changes in the carrying amount of goodwill by reportable segment for the years ended December 31, 2021 and 2020 were as follows: Americas Beverage European Beverage Transit Packaging Other Total Balance at January 1, 2020 $ 865 $ 534 $ 1,509 $ 184 $ 3,092 Foreign currency translation (26) 26 52 2 54 Balance at December 31, 2020 839 560 1,561 186 3,146 Held for sale reclassification — — (58) — (58) Foreign currency translation (14) (25) (42) — (81) Balance at December 31, 2021 $ 825 $ 535 $ 1,461 $ 186 $ 3,007 The carrying amount of goodwill at December 31, 2021 and 2020 was net of the following accumulated impairments: Americas Beverage European Beverage Other Total Accumulated impairments $ 29 $ 73 $ 11 $ 113

intangible Assets (Tables)

intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Gross Carrying Amounts and Accumulated Amortization of Finite-Lived Intangible Assets	Customer relationships 11 - 18 Trade names 8 - 27 Technology 6 - 8 Long-term supply contracts 15 Patents 8 Gross carrying amounts and accumulated amortization of finite-lived intangible assets by major class were as follows: December 31, 2021 December 31, 2020 Gross Accumulated amortization Net Gross Accumulated amortization Net Customer relationships $ 1,363 $ (443) $ 920 $ 1,413 $ (346) $ 1,067 Trade names 544 (86) 458 565 (65) 500 Technology 158 (88) 70 165 (67) 98 Long term supply contracts 137 (63) 74 142 (55) 87 Patents 15 (12) 3 13 (10) 3 $ 2,217 $ (692) $ 1,525 $ 2,298 $ (543) $ 1,755

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Summary of Property, Plant and Equipment	Depreciation is provided on a straight-line basis over the estimated useful lives of the assets described below (in years). The Company periodically reviews the estimated useful lives of its PP&E and, where appropriate, changes are made prospectively. Land improvements 25 Buildings and building improvements 25 – 40 Machinery and equipment 3– 18 2021 2020 Buildings and improvements $ 1,226 $ 1,137 Machinery and equipment 5,372 4,965 Land and improvements 208 223 Construction in progress 612 483 7,418 6,808 Less: accumulated depreciation and amortization (3,382) (3,156) $ 4,036 $ 3,652

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2021
Leases [Abstract]
Components of Lease Cost	The components of lease expense for the years ended December 31, 2021, 2020 and 2019 were as follows: 2021 2020 2019 Operating lease costs: Operating lease cost $ 48 $ 39 $ 36 Short-term lease cost 3 5 4 Total operating lease costs $ 51 $ 44 $ 40 Finance lease cost: Amortization of right-of-use assets $ 1 $ 1 $ 1 Total finance lease costs $ 1 $ 1 $ 1
Supplemental Cash Flow Information Related to Leases	Supplemental cash flow information related to leases was as follows: 2021 2020 2019 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 51 $ 44 $ 38 Financing cash flows from finance leases 2 3 15 Right-of-use assets obtained in exchange for lease obligations: Operating leases $ 73 $ 42 $ 22
Supplemental Balance Sheet Information Related to Leases	Supplemental balance sheet information related to finance leases was as follows: 2021 2020 Finance leases: Property, plant and equipment $ 26 $ 28 Accumulated depreciation (2) (2) Property, plant and equipment, net $ 24 $ 26 Accrued liabilities $ 2 $ 2 Other non-current liabilities 8 10 Total finance lease liabilities $ 10 $ 12
Weighted Average Remaining Lease Term and Discount Schedule	The weighted average remaining lease term and weighted average discount rates for each year were as follows: 2021 2020 Weighted average remaining lease term (years): Operating leases 10.8 10.4 Finance leases 5.7 6.6 Weighted average discount rate: Operating leases 4.3 % 4.4 % Finance leases 3.2 % 3.4 %
Maturities of Operating Lease Liabilities	Maturities of lease liabilities as of December 31, 2021 were as follows: Operating Leases Finance Leases 2022 $ 42 $ 2 2023 33 2 2024 26 2 2025 22 2 2026 18 2 Thereafter 112 1 Total lease payments 253 11 Less imputed interest (61) (1) $ 192 $ 10
Maturities of Finance Lease Liabilities	Maturities of lease liabilities as of December 31, 2021 were as follows: Operating Leases Finance Leases 2022 $ 42 $ 2 2023 33 2 2024 26 2 2025 22 2 2026 18 2 Thereafter 112 1 Total lease payments 253 11 Less imputed interest (61) (1) $ 192 $ 10

Other Non-Current Assets (Table

Other Non-Current Assets (Tables)	12 Months Ended
	Dec. 31, 2021
Investments, All Other Investments [Abstract]
Components of Other Non-Current Assets	2021 2020 Pension assets $ 158 $ 532 Deferred taxes 150 235 Investments 161 24 Fair value of derivatives 51 11 Other 84 83 $ 604 $ 885

Accrued Liabilities (Tables)

Accrued Liabilities (Tables)	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Accrued Liabilities	2021 2020 Salaries and employee benefits $ 169 $ 182 Accrued taxes, other than on income 104 117 Income taxes 101 81 Accrued interest 47 85 Fair value of derivatives 32 26 Asbestos liabilities 25 25 Pension and postretirement liabilities 25 21 Restructuring 4 12 Other 459 397 $ 966 $ 946

Restructuring and Other (Tables

Restructuring and Other (Tables)	12 Months Ended
	Dec. 31, 2021
Restructuring and Related Activities [Abstract]
Restructuring Charges by Segment and Type	The Company recorded restructuring and other items as follows: 2021 2020 2019 Other (income) / costs $ (42) $ 9 $ (41) Asset sales and impairments (20) 2 (7) Restructuring 29 19 18 Asbestos 5 — — $ (28) $ 30 $ (30) Restructuring charges by segment were as follows: 2021 2020 2019 Americas Beverage $ — $ — $ 1 European Beverage 3 — — Asia Pacific 1 1 3 Transit Packaging 19 19 6 Other 3 (1) 5 Corporate 3 — 3 $ 29 $ 19 $ 18 Restructuring charges by type were as follows: 2021 2020 2019 Termination benefits $ 10 $ 8 $ 14 Other exit costs 19 11 4 $ 29 $ 19 $ 18

Debt (Tables)

Debt (Tables)	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
Summary of Outstanding Debt	2021 2020 Principal Carrying Principal Carrying outstanding amount outstanding amount Short-term debt $ 75 $ 75 $ 104 $ 104 Long-term debt Senior secured borrowings: Revolving credit facilities 50 50 — — Term loan facilities U.S. dollar due 2024 1,002 997 1,029 1,023 Euro due 2024 1 344 344 387 387 Senior notes and debentures: €650 at 4.0% due 2022 — — 794 791 U. S. dollar at 4.50% due 2023 — — 1,000 997 €335 at 2.25% due 2023 381 380 409 407 €550 at 0.75% due 2023 626 624 671 666 €600 at 2.625% due 2024 683 680 733 729 €600 at 3.375% due 2025 683 679 733 728 U.S. dollar at 4.25% due 2026 400 396 400 396 U.S. dollar at 4.75% due 2026 875 867 875 865 U.S. dollar at 7.375% due 2026 350 348 350 348 €500 at 2.875% due 2026 570 565 610 603 U.S. dollar at 7.50% due 2096 40 40 40 40 Other indebtedness in various currencies: Fixed rate with rates in 2021 from 2.7% to 7.8% due through 2026 189 189 97 97 Variable rate with average rates in 2021 from 1.9% to 3.6% due through 2026 28 28 13 13 Total long-term debt 6,221 6,187 8,141 8,090 Less: current maturities (136) (135) (67) (67) Total long-term debt, less current maturities $ 6,085 $ 6,052 $ 8,074 $ 8,023
Schedule of Weighted Average Interest Rates	The weighted average interest rates were as follows: 2021 2020 2019 Short-term debt 0.6 % 2.1 % 2.8 % Revolving credit facilities 1.2 % 1.8 % 3.0 %

Derivative and Other Financia_2

Derivative and Other Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Impact on Accumulated Other Comprehensive Income and Earnings from Changes in Fair Value	The following tables set forth financial information about the impact on other comprehensive income ("OCI"), accumulated other comprehensive income ("AOCI") and earnings from changes in the fair value related to derivative instruments designated as cash flow hedges. Amount of gain / (loss) recognized in AOCI Derivatives in cash flow hedges 2021 2020 Foreign exchange $ (5) $ — Interest rate 2 (1) Commodities 74 10 $ 71 $ 9 Amount of gain / (loss) reclassified from AOCI into income Derivatives in cash flow hedges 2021 2020 Affected line item in the Foreign exchange $ (4) $ (3) Net sales Commodities (54) 18 Net sales Foreign exchange 2 (2) Cost of products sold Commodities 147 (59) Cost of products sold 91 (46) (Loss) / income from continuing operations before taxes and equity in net earnings of affiliates (23) 13 (Benefit from) / provision for income taxes 68 (33) Net (loss) / income from continuing operations Foreign exchange — (1) Net (loss) / income from discontinued operations Commodities 5 (1) Net (loss) / income from discontinued operations Total reclassified $ 73 $ (35) Net (loss) / income
Impact on Earnings from Derivatives Not Designated as Hedges	The following table sets forth the impact on earnings from derivatives not designated as hedges. Pre-tax amount of gain / (loss) recognized in earnings Derivatives not designated as hedges 2021 2020 Affected line item in the Foreign exchange $ (3) $ — Net sales Foreign exchange (1) (1) Cost of products sold Foreign exchange (29) 30 Foreign exchange Foreign exchange — 1 Net (loss) / income from discontinued operations $ (33) $ 30
Schedule of Impact on Other Comprehensive Income from Changes in Fair Value	The following tables set forth financial information about the impact on accumulated other comprehensive income from changes in the fair value of derivative instruments designated as net investment hedges. Amount of (loss) / gain recognized in AOCI Derivatives designated as net investment hedges 2021 2020 Foreign exchange $ 47 $ (48)
Fair Value of Financial Assets and Liabilities on Recurring Basis	The following table sets forth the Company's financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2021 and December 31, 2020, respectively. The fair value of these financial instruments were reported under Level 2 of the fair value hierarchy. Balance Sheet classification December 31, December 31, Balance Sheet classification December 31, December 31, Derivatives designated as hedging instruments Foreign exchange contracts cash flow Prepaid expenses and other current assets $ 3 $ 5 Accrued liabilities $ 10 $ 5 Current assets held for sale — 4 Current liabilities held for sale — 3 Other non-current assets — — Other non-current liabilities — 1 Foreign exchange contracts fair value Prepaid expenses and other current assets 1 2 Accrued liabilities 2 6 Commodities contracts cash flow Prepaid expenses and other current assets 53 43 Accrued liabilities 17 11 Current assets held for sale — 2 Current liabilities held for sale — — Other non-current assets 2 4 Other non-current liabilities 1 — Interest rate contracts cash flow Other non-current assets — — Other non-current liabilities — 2 Net investment hedge Other non-current assets 49 7 Other non-current liabilities — 20 $ 108 $ 67 $ 30 $ 48 Derivatives not designated as hedging instruments Foreign exchange contracts Prepaid expenses and other current assets $ 3 $ 9 Accrued liabilities $ 3 $ 4 $ 3 $ 9 $ 3 $ 4 Total derivatives $ 111 $ 76 $ 33 $ 52 Fair Value Hedge Carrying Amounts Carrying amount of the hedged assets and liabilities Line item in the Balance Sheet in which the hedged item is included December 31, 2021 December 31, 2020 Cash and cash equivalents 38 22 Receivables, net 21 11 Accrued liabilities 116 100
Offsetting Assets	In the table below, the aggregate fair values of the Company's derivative assets and liabilities are presented on both a gross and net basis, where appropriate. Gross amounts recognized in the Balance Sheet Gross amounts not offset in the Balance Sheet Net amount Balance at December 31, 2021 Derivative assets $ 111 $ 19 $ 92 Derivative liabilities 33 19 14 Balance at December 31, 2020 Derivative assets $ 76 $ 11 $ 65 Derivative liabilities 52 11 41
Offsetting Liabilities	In the table below, the aggregate fair values of the Company's derivative assets and liabilities are presented on both a gross and net basis, where appropriate. Gross amounts recognized in the Balance Sheet Gross amounts not offset in the Balance Sheet Net amount Balance at December 31, 2021 Derivative assets $ 111 $ 19 $ 92 Derivative liabilities 33 19 14 Balance at December 31, 2020 Derivative assets $ 76 $ 11 $ 65 Derivative liabilities 52 11 41
Notional Values of Outstanding Derivative Instruments in the Consolidated Balance Sheets	The aggregate U.S. dollar-equivalent notional values of outstanding derivative instruments in the Consolidated Balance Sheets at December 31, 2021 and December 31, 2020 were: December 31, 2021 December 31, 2020 Derivatives designated as cash flow hedges: Foreign exchange $ 241 $ 639 Commodities 261 231 Interest rate — 200 Derivatives designated as fair value hedges: Foreign exchange 229 183 Derivatives designated as net investment hedges: Foreign exchange 875 1,075 Derivatives not designated as hedges: Foreign exchange 617 722

Asbestos-Related Liabilities (T

Asbestos-Related Liabilities (Tables)	12 Months Ended
	Dec. 31, 2021
Liability for Asbestos and Environmental Claims [Abstract]
Summary of Claims Activity	The Company's approximate claims activity for the years ended 2021, 2020 and 2019 was as follows: 2021 2020 2019 Beginning claims 56,000 56,000 56,000 New claims 2,000 1,500 2,000 Settlements or dismissals (1,000) (1,500) (2,000) Ending claims 57,000 56,000 56,000
Summary of Outstanding Asbestos Claims by Year of Exposure and State Filed	In the fourth quarter of each year, the Company performs an analysis of outstanding claims and categorizes by year of exposure and state filed. As of December 31, 2021 and December 31, 2020, the Company's outstanding claims were: 2021 2020 Claimants alleging first exposure after 1964 17,000 16,500 Claimants alleging first exposure before or during 1964 filed in: Texas 13,000 13,000 Pennsylvania 1,500 1,500 Other states that have enacted asbestos legislation 6,000 6,000 Other states 19,500 19,000 Total claims outstanding 57,000 56,000
Summary of Percentage of Outstanding Claims Related to Claimants Alleging Serious Diseases	As of December 31, the percentage of outstanding claims related to claimants alleging serious diseases (primarily mesothelioma and other malignancies) were as follows: 2021 2020 2019 Total claims 24 % 23 % 22 % Pre-1965 claims in states without asbestos legislation 42 % 41 % 41 %

Other Non-Current Liabilities (

Other Non-Current Liabilities (Tables)	12 Months Ended
	Dec. 31, 2021
Other Liabilities Disclosure [Abstract]
Schedule of Other Non-Current Liabilities	2021 2020 Deferred taxes $ 336 $ 350 Asbestos liabilities 212 226 Income taxes payable 26 26 Fair value of derivatives 1 23 Postemployment benefits 21 19 Environmental 12 12 Finance lease liabilities 8 10 Other 80 100 $ 696 $ 766

Pension and Other Postretirem_2

Pension and Other Postretirement Benefits (Tables)	12 Months Ended
	Dec. 31, 2021
Retirement Benefits [Abstract]
Components of Pension Expense and Benefits Cost	The components of pension expense were as follows: U.S. Plans 2021 2020 2019 Service cost $ 20 $ 18 $ 15 Interest cost 25 38 50 Expected return on plan assets (63) (73) (70) Settlements — 3 — Curtailments and special termination benefits 9 — — Amortization of actuarial loss 58 56 55 Amortization of prior service cost 1 1 1 Net periodic cost $ 50 $ 43 $ 51 Non-U.S. Plans 2021 2020 2019 Service cost $ 13 $ 10 $ 13 Interest cost 32 52 70 Expected return on plan assets (72) (107) (138) Settlements 1,511 63 44 Curtailments — — (14) Amortization of actuarial loss 33 27 37 Amortization of prior service credit — — (1) Net periodic cost $ 1,517 $ 45 $ 11 The components of net postretirement benefits cost were as follows: Other Postretirement Benefits 2021 2020 2019 Service cost $ 1 $ 1 $ 1 Interest cost 4 5 6 Amortization of prior service credit (26) (26) (34) Amortization of actuarial loss 4 4 3 Net periodic benefit credit $ (17) $ (16) $ (24)
Schedule of Projected Benefit Obligations, Accumulated Benefit Obligations, Plan Assets and Funded Status	The projected benefit obligations, accumulated benefit obligations, plan assets and funded status of the Company's U.S. and non-U.S. plans were as follows: U.S. Plans Non-U.S. Plans 2021 2020 2021 2020 Projected Benefit Obligations Benefit obligations at January 1 $ 1,505 $ 1,440 $ 3,172 $ 3,155 Service cost 20 18 13 10 Interest cost 25 38 32 52 Plan participants’ contributions — — 2 2 Amendments 2 1 (3) — Settlements — (7) (2,982) (271) Curtailments (10) — (7) — Special termination benefits 6 — — — Actuarial (gain) / loss (43) 109 444 276 Benefits paid (92) (94) (165) (148) Foreign currency translation — — 7 96 Benefit obligations at December 31 $ 1,413 $ 1,505 $ 513 $ 3,172 Plan Assets Fair value of plan assets at January 1 $ 1,152 $ 1,131 $ 3,518 $ 3,480 Actual return on plan assets 115 113 (94) 334 Employer contributions 2 9 234 18 Plan participants’ contributions — — 2 2 Settlements — (7) (2,982) (271) Benefits paid (92) (94) (165) (152) Foreign currency translation — — 16 107 Fair value of plan assets at December 31 $ 1,177 $ 1,152 $ 529 $ 3,518 Funded status $ (236) $ (353) $ 16 $ 346 Accumulated benefit obligations at December 31 $ 1,361 $ 1,445 $ 474 $ 3,111
Information for Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets	U.S. pension plans with accumulated benefit obligations and projected benefit obligations in excess of plan assets were as follows: 2021 2020 Projected benefit obligations $ 1,413 $ 1,505 Accumulated benefit obligations 1,361 1,445 Fair value of plan assets 1,177 1,152 Non-U.S. pension plans with accumulated benefit obligations in excess of plan assets were as follows: 2021 2020 Projected benefit obligations $ 284 $ 354 Accumulated benefit obligations 253 320 Fair value of plan assets 147 191
Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets	Non-U.S. pension plans with projected benefit obligations in excess of plan assets were as follows: 2021 2020 Projected benefit obligations $ 288 $ 432 Accumulated benefit obligations 257 389 Fair value of plan assets 151 194
Schedule of Ranges for Asset Allocation and Summary of Defined Benefit Plan Assets and Accrued Income	The strategic ranges for asset allocation in the U.S. plans are as follows: U.S. equities 45 % to 55 % International equities 7 % to 13 % Fixed income 18 % to 28 % Balanced funds 7 % to 13 % Real estate 4 % to 10 % 2021 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 68 $ 21 $ 89 Global large cap equity — 8 8 U.S. large cap equity 238 6 244 U.S. mid/small cap equity 332 25 357 Mutual funds – global equity 93 — 93 Mutual funds – U.S. equity 85 — 85 Mutual funds – fixed income 71 — 71 887 60 947 Level 2 Government issued debt securities — 17 17 Corporate debt securities 61 3 64 Insurance contracts — 110 110 Investment funds – fixed income — 38 38 61 168 229 Level 3 Investment funds – real estate 79 92 171 Private equity 5 2 7 Real estate – direct 25 15 40 109 109 218 Total assets in fair value hierarchy 1,057 337 1,394 Investments measured at NAV Practical Expedient (a) Investment funds – fixed income 112 25 137 Investment funds – global equity — 167 167 Investment funds – emerging markets 7 — 7 119 192 311 Total investments at fair value $ 1,176 $ 529 $ 1,705 2020 U.S. plan Non-U.S. plan Total Level 1 Cash and cash equivalents $ 157 $ 498 $ 655 Global large cap equity — 9 9 U.S. large cap equity 178 4 182 U.S. mid/small cap equity 301 22 323 Mutual funds – global equity 88 — 88 Mutual funds – U.S. equity 56 — 56 Mutual funds – fixed income 75 — 75 855 533 1,388 Level 2 Government issued debt securities — 298 298 Corporate debt securities 58 647 705 Asset backed securities — 2 2 Structured debt — 1,034 1,034 Insurance contracts — 115 115 Derivatives — 166 166 Investment funds – fixed income — 128 128 Investment funds – global equity — 69 69 58 2,459 2,517 Level 3 Investment funds – real estate 91 181 272 Hedge funds — 2 2 Private equity 5 46 51 Real estate – direct 23 12 35 119 241 360 Total assets in fair value hierarchy 1,032 3,233 4,265 Investments measured at NAV Practical Expedient (a) Investment funds – fixed income 112 25 137 Investment funds – global equity — 141 141 Investment funds – emerging markets 7 — 7 Hedge funds — 109 109 119 275 394 Total investments at fair value $ 1,151 $ 3,508 $ 4,659 (a) Certain investments that are measured at fair value using the NAV per share practical expedient have not been classified in the fair value hierarchy. Accrued income excluded from the tables above was as follows: 2021 2020 U.S. plan assets $ 1 $ 1 Non-U.S. plan assets — 10
Reconciliation of Plan Assets Using Level 3	The following tables reconcile the beginning and ending balances of plan assets measured using significant unobservable inputs (Level 3). Hedge Private Real Total Balance at January 1, 2020 $ 43 $ 75 $ 346 $ 464 Foreign currency translation 1 2 7 10 Asset returns – assets held at reporting date 3 6 (15) (6) Asset returns – assets sold during the period (12) (9) 3 (18) Purchases, sales and settlements, net (33) (23) (34) (90) Balance at December 31, 2020 2 51 307 360 Foreign currency translation — — (1) (1) Asset returns – assets held at reporting date (1) (48) 30 (19) Asset returns – assets sold during the period 1 39 3 43 Purchases, sales and settlements, net (2) (35) (128) (165) Balance at December 31, 2021 $ — $ 7 $ 211 $ 218
Additional Information About Pension Plan Assets Valued Using Net Asset Value	The following table presents additional information about the pension plan assets valued using net asset value as a practical expedient: Fair Value Redemption Frequency Redemption Notice Period Balance at December 31, 2021 Investment funds – fixed income $ 137 Semi-monthly 1- 5 days Investment funds – global equity 167 Daily 10 days Investment funds – emerging markets 7 Daily 30 days Balance at December 31, 2020 Investment funds – fixed income $ 137 Semi-monthly 1- 5 days Investment funds – global equity 141 Monthly 1- 5 days Investment funds – emerging markets 7 Daily 30 days Hedge funds 109 Monthly 1 - 30 days
Schedule of Pension Assets and Liabilities	Pension assets and liabilities included in the Consolidated Balance Sheets were: 2021 2020 Non-current assets $ 158 $ 532 Current liabilities 11 8 Non-current liabilities 367 537
Schedule of Changes in Net Loss and Prior Service Cost/(Credit)	Changes in the net loss and prior service cost (credit) for the Company’s pension plans were: 2021 2020 2019 Net loss Prior Net loss Prior Net loss Prior Balance at January 1 $ 1,802 $ 8 $ 1,808 $ 8 $ 1,962 $ (6) Reclassification to net periodic benefit cost (1,629) (4) (150) (1) (137) 14 Current year loss / (gain) 640 (2) 118 — (53) — Amendments (1) — — 1 — — Foreign currency translation 2 — 26 — 36 — Balance at December 31 $ 814 $ 2 $ 1,802 $ 8 $ 1,808 $ 8 Changes in the net loss and prior service credit for the Company’s postretirement benefit plans were: 2021 2020 2019 Net Prior Net Prior Net Prior Balance at January 1 $ 45 $ (46) $ 42 $ (72) $ 31 $ (105) Reclassification to net periodic benefit cost (4) 26 (4) 26 (3) 34 Current year (gain) / loss (20) — 7 — 14 — Amendments — — — — — (1) Balance at December 31 $ 21 $ (20) $ 45 $ (46) $ 42 $ (72)
Schedule of Expected Future Benefit Payments	Expected future benefit payments as of December 31, 2021 are: U.S. Non-U.S. 2022 $ 104 $ 31 2023 99 30 2024 99 30 2025 100 32 2026 85 32 2027 - 2031 419 360 Expected future benefit payments are as follows: Benefit Payments 2022 $ 14 2023 12 2024 11 2025 10 2026 10 2027 - 2031 43
Schedule of Benefit Obligations Weighted Average Actuarial Assumptions	The weighted average actuarial assumptions used to calculate the benefit obligations at December 31 were: U.S. Plans 2021 2020 2019 Discount rate 2.9 % 2.5 % 3.2 % Compensation increase 4.7 % 4.7 % 4.7 % Non-U.S. Plans 2021 2020 2019 Discount rate 2.5 % 1.4 % 2.1 % Compensation increase 2.5 % 3.0 % 3.0 % The weighted average actuarial assumptions used to calculate pension expense for each year were: U.S. Plans 2021 2020 2019 Discount rate - service cost 3.1 % 3.6 % 4.7 % Discount rate - interest cost 1.7 % 2.8 % 3.9 % Compensation increase 4.7 % 4.7 % 4.5 % Long-term rate of return 5.7 % 6.8 % 7.3 % Non-U.S. Plans 2021 2020 2019 Discount rate - service cost 2.2 % 2.6 % 3.0 % Discount rate - interest cost 1.8 % 1.9 % 2.7 % Compensation increase 2.5 % 3.0 % 3.2 % Long-term rate of return 3.3 % 3.3 % 4.3 % Weighted average discount rates used to calculate the benefit obligations at the end of each year and the cost for each year are presented below: 2021 2020 2019 Benefit obligations 3.4 % 2.8 % 3.5 % Service cost 5.9 % 4.1 % 4.8 % Interest cost 3.6 % 3.3 % 4.2 %
Schedule of Changes in Benefit Obligations	Changes in the benefit obligations were: 2021 2020 Benefit obligations at January 1 $ 163 $ 161 Service cost 1 1 Interest cost 4 5 Actuarial (gain) / loss (20) 7 Benefits paid (10) (11) Foreign currency translation (1) — Benefit obligations at December 31 $ 137 $ 163
Schedule of Assumed Health Care Cost Trend Rates	The assumed health care cost trend rates at December 31, 2021 were as follows: Health care cost trend rate assumed for 2021 4.5 % Rate that the cost trend rate gradually declines to 3.8 % Year that the rate reaches the rate it is assumed to remain 2040

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Components of Income Before Income Taxes	The components of income before income taxes were as follows: 2021 2020 2019 U.S. $ 143 $ 97 $ 1 Foreign (562) 628 630 $ (419) $ 725 $ 631
Provision for Income Taxes	The provision for income taxes consisted of the following: 2021 2020 2019 Current tax: U.S. federal $ 2 $ — $ (1) State and foreign 239 161 165 $ 241 $ 161 $ 164 Deferred tax: U.S. federal $ 46 $ 38 $ 17 State and foreign (344) — (45) (298) 38 (28) Total $ (57) $ 199 $ 136
Schedule of U.S. Statutory Federal Income Tax Rate to Pre-tax Income	The provision for income taxes differs from the amount of income tax determined by applying the U.S. statutory federal income tax rate to pre-tax income as a result of the following items: 2021 2020 2019 U.S. statutory rate at 21% $ (88) $ 152 $ 133 Tax on foreign income (29) 27 10 Valuation allowance changes 26 (11) (33) State taxes 9 5 7 U.S. taxes on foreign income, net of credits 13 14 15 Tax contingencies 8 1 19 Tax law changes (8) 4 (11) Other items, net 12 7 (4) Income tax provision / (benefit) $ (57) $ 199 $ 136
Components of Deferred Taxes	The components of deferred taxes at December 31 were: 2021 2020 Assets Liabilities Assets Liabilities Tax carryforwards $ 346 $ — $ 424 $ — Intangible assets — 317 — 354 Property, plant and equipment 21 176 24 130 Pensions 105 $ 13 124 $ 101 Accruals and other 96 109 89 84 Asbestos 56 — 61 — Postretirement and postemployment benefits 31 — 35 — Lease liabilities 29 — 34 — Right of use assets — 28 — 33 Valuation allowances (227) — (204) — Total $ 457 $ 643 $ 587 $ 702
Schedule of Tax Loss and Credit Carryforwards Expiration	Tax carryforwards expire as follows: Year Amount 2022 $ 10 2023 12 2024 13 2025 28 2026 24 Thereafter 142 Unlimited 117
Reconciliation of Unrecognized Tax Benefits	A reconciliation of unrecognized tax benefits follows: 2021 2020 2019 Balance at January 1 $ 42 $ 39 $ 35 Additions for prior year tax positions 9 1 20 Lapse of statute of limitations (1) — (1) Settlements — — (15) Foreign currency translation (2) 2 — Balance at December 31 $ 48 $ 42 $ 39

Capital Stock (Tables)

Capital Stock (Tables)	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Summary of Common Share Activity	A summary of common share activity for the years ended December 31 follows (in shares): 2021 2020 2019 Common shares outstanding at January 1 134,801,030 135,577,878 135,173,948 Shares repurchased (9,121,328) (1,240,328) (106,388) Shares issued upon exercise of employee stock options — — 70,000 Restricted stock issued to employees, net of forfeitures 435,129 439,700 416,695 Shares issued to non-employee directors 16,968 23,780 23,623 Common shares outstanding at December 31 126,131,799 134,801,030 135,577,878

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss Attributable to Crown Holdings (Tables)	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	The following table provides information about the changes in each component of accumulated other comprehensive income/ (loss) for the years ended December 31, 2021 and 2020. Defined benefit plans Foreign currency translation Gains and losses on cash flow hedges Total Balance at January 1, 2020 $ (1,449) $ (1,668) $ (14) $ (3,131) Other comprehensive (loss) / income before reclassifications (117) (91) 9 (199) Amounts reclassified from accumulated other comprehensive income 102 — 35 137 Other comprehensive (loss) / income (15) (91) 44 (62) Balance at December 31, 2020 (1,464) (1,759) 30 (3,193) Other comprehensive (loss) / income before reclassifications (419) 48 71 (300) Amounts reclassified from accumulated other comprehensive income 1,115 553 (73) 1,595 Other comprehensive income / (loss) 696 601 (2) 1,295 Balance at December 31, 2021 $ (768) $ (1,158) $ 28 $ (1,898)

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	For the years ended December 31, 2021, 2020 and 2019, the Company recognized revenue as follows: 2021 2020 2019 Revenue recognized over time $ 6,097 $ 5,032 $ 4,778 Revenue recognized at a point in time 5,297 4,360 4,781 Total $ 11,394 $ 9,392 $ 9,559

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
Summary of Restricted and Deferred Stock Activity	A summary of restricted and deferred stock activity follows: Number of shares Non-vested shares outstanding at January 1, 2021 1,820,159 Awarded: Time-vesting 221,042 Performance-based 170,036 Released: Time-vesting (418,426) Performance-based (224,358) Forfeitures: Time-vesting (284,247) Performance-based — Non-vested shares outstanding at December 31, 2021 1,284,206
Summary of Average Grant-Date Fair Value of Restricted Stock	The average grant-date fair value of restricted stock awarded in 2021, 2020 and 2019 follows: 2021 2020 2019 Time-vesting $ 100.08 $ 70.07 $ 56.06 Performance-based 100.99 72.08 46.08
Schedule of Weighted Average Assumptions on Performance-Based Shares	The fair values of the performance-based awards that include a market condition were calculated using a Monte Carlo valuation model and the following weighted average assumptions: 2021 2020 2019 Risk-free interest rate 0.2 % 1.6 % 2.5 % Expected term (years) 3 3 3 Expected stock price volatility 35.5 % 22.0 % 21.4 %

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Summary of Basic and Diluted Earnings Per Share	The following table summarizes basic and diluted earnings per share ("EPS"). Basic EBS excludes all potentially dilutive securities and is computed by dividing net income attributable to Crown Holdings by the weighted average number of common shares outstanding during the period. Diluted EPS includes the effect of stock options and restricted stock, when dilutive, as calculated under the treasury stock method. 2021 2020 2019 Net (loss) / income from continuing operations attributable to Crown Holdings (507) 424 387 Net (loss) / income from discontinued operations attributable to Crown Holdings (53) 155 123 Net (loss) / income attributable to Crown Holdings $ (560) $ 579 $ 510 Weighted average shares outstanding: Basic 130.38 133.53 133.89 Add: dilutive stock options and restricted stock — 1.03 0.99 Diluted 130.38 134.56 134.88 Earnings per common share attributable to Crown Holdings: Basic (loss) / earnings per common share from continuing operations (3.89) 3.18 2.89 Basic (loss) / earnings per common share from discontinued operations (0.41) 1.16 0.92 Basic (loss) / earnings per share $ (4.30) $ 4.34 $ 3.81 Diluted (loss) / earnings per common share from continuing operations (3.89) 3.15 2.87 Diluted (loss) / earnings per common share from discontinued operations (0.41) 1.15 0.91 Diluted (loss) / earnings per share $ (4.30) $ 4.30 $ 3.78 Contingently issuable shares excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive 1.0 0.7 0.8

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2021
Segment Reporting [Abstract]
Information on Operating Segments	The tables below present information about operating segments reported as continuing operations for the three years ended December 31, 2021, 2020 and 2019: 2021 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 4,441 $ — $ 4,453 $ 108 $ 508 $ 756 European Beverage 1,843 133 2,025 51 55 259 Asia Pacific 1,322 — 1,784 61 68 182 Transit Packaging 2,530 25 4,225 41 58 318 Total reportable segments 10,136 158 12,487 261 689 $ 1,515 Other 1,258 114 1,129 17 58 Corporate and unallocated items — — 242 4 40 Total $ 11,394 $ 272 $ 13,858 $ 282 $ 787 2020 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 3,565 $ 2 $ 3,886 $ 93 $ 333 $ 652 European Beverage 1,473 39 1,977 47 72 215 Asia Pacific 1,168 — 1,808 56 69 175 Transit Packaging 2,018 13 4,195 45 40 254 Total reportable segments 8,224 54 11,866 241 514 $ 1,296 Other 1,168 100 927 15 30 Corporate and unallocated items — — 999 4 10 Total $ 9,392 $ 154 $ 13,792 $ 260 $ 554 2019 Inter- External segment Segment Capital Segment sales sales assets Depreciation expenditures income Americas Beverage $ 3,369 $ 12 $ 3,577 $ 88 $ 167 $ 534 European Beverage 1,497 2 1,782 54 82 190 Asia Pacific 1,290 — 1,604 52 65 194 Transit Packaging 2,274 9 4,157 57 27 290 Total reportable segments 8,430 23 11,120 251 341 $ 1,208 Other 1,129 110 904 14 24 Corporate and unallocated items — — 694 2 26 Total $ 9,559 $ 133 $ 12,718 $ 267 $ 391
Reconciliation of Segment Income	A reconciliation of segment income of reportable segments to income before income taxes for the three years ended December 31, 2021, 2020 and 2019 follows: 2021 2020 2019 Segment income of reportable segments $ 1,515 $ 1,296 $ 1,208 Other 144 114 120 Corporate and unallocated items (159) (170) (162) Restructuring and other 28 (30) 30 Amortization of intangibles (165) (162) (169) Loss from early extinguishments of debt (68) — (27) Other pension and postretirement (1,515) (43) (10) Interest expense (253) (290) (367) Interest income 9 8 15 Foreign exchange 45 2 (7) Income / (loss) from continuing operations before income taxes and equity in net earnings of affiliates $ (419) $ 725 $ 631
Summary of Sales by Major Product	Sales by major product were: 2021 2020 2019 Metal beverage cans and ends $ 6,982 $ 5,716 $ 5,588 Transit packaging 2,530 2,018 2,274 Metal food cans and ends 789 733 730 Other products 580 451 457 Other metal packaging 513 474 510 Consolidated net sales $ 11,394 $ 9,392 $ 9,559
Summary of Sales and Long-Lived Assets for the Major Countries	The following table provides sales and long-lived asset information for the major countries in which the Company operates. Long-lived assets comprises property, plant and equipment. Net Sales Long-Lived Assets 2021 2020 2019 2021 2020 United States $ 4,182 $ 3,586 $ 3,407 $ 1,259 $ 922 Brazil 933 706 714 510 396 Mexico 896 681 834 437 421 Canada 782 662 508 97 93 United Kingdom 412 234 253 96 81 Other 4,189 3,523 3,843 1,637 1,739 Consolidated total $ 11,394 $ 9,392 $ 9,559 $ 4,036 $ 3,652

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Property, Plant and Equipment (Details)	12 Months Ended
	Dec. 31, 2021
Land improvements
Property, Plant and Equipment [Line Items]
Estimated useful lives (in years)	25 years
Buildings and building improvements | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives (in years)	25 years
Buildings and building improvements | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives (in years)	40 years
Machinery and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives (in years)	3 years
Machinery and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives (in years)	18 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies Goodwill and Intangible Assets (Details)	12 Months Ended
	Dec. 31, 2021
Long term supply contracts
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	15 years
Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	8 years
Minimum | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	11 years
Minimum | Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	8 years
Minimum | Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	6 years
Maximum | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	18 years
Maximum | Trade names
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	27 years
Maximum | Technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life (in years)	8 years

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Research and Development (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Research, development and engineering costs	$ 47	$ 48	$ 50

Divestitures - Narrative (Detai

Divestitures - Narrative (Details) $ in Millions, € in Billions	Aug. 31, 2021USD ($)	Aug. 31, 2021EUR (€)	Jun. 30, 2022USD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of discontinued operations, net of cash disposed				$ 2,255	$ 0	$ 0
Accumulated other comprehensive loss				(1,898)	(3,193)
Loss from continuing operations before income				419	$ (725)	$ (631)
European Tinplate
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Impairment charge on assets held for sale	$ 101
Income tax expense related to sale of business	81
Loss from continuing operations before income				$ 8
European Tinplate | Foreign currency translation
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Accumulated other comprehensive loss	553
European Tinplate | Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of discontinued operations, net of cash disposed	$ 2,300	€ 1.9
Ownership interest after disposal	20.00%	20.00%
Transit Packaging | Discontinued Operations, Disposed of by Sale | Forecast
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from sale of discontinued operations, net of cash disposed			$ 180
Gain on disposition of business			$ 100

Divestitures (Details)

Divestitures (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net (loss) / income from discontinued operations	$ (52)	$ 156	$ 125
Net income from discontinued operations attributable to noncontrolling interests	1	1	2
Net (loss) / income from discontinued operations attributable to Crown Holdings	(53)	155	123
Total current assets held for sale	97	743
Total non-current assets held for sale	0	2,179
Total current liabilities held for sale	14	981
Total non-current liabilities held for sale	0	199
Capital expenditures	787	554	391
European Tinplate | Discontinued Operations, Disposed of by Sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net sales	1,585	2,183	2,106
Cost of products sold, excluding depreciation and amortization	1,301	1,823	1,774
Depreciation and amortization	16	59	59
Selling and administrative expense	60	81	75
Restructuring and other	2	4	4
Goodwill impairment	0	0	25
Other pension and postretirement	1	2	3
Interest expense	6	10	11
Interest income	0	0	(2)
Foreign exchange	0	3	2
Loss on sale of discontinued businesses	101	0	0
Transaction costs	34	0	0
Income from discontinued operations before tax	64	201	155
Provision for income taxes	116	45	30
Net (loss) / income from discontinued operations	(52)	156	125
Net income from discontinued operations attributable to noncontrolling interests	1	1	2
Net (loss) / income from discontinued operations attributable to Crown Holdings	(53)	155	123
Receivables, net	281
Inventories	410
Prepaid expenses and other current assets	30
Total current assets held for sale	721
Goodwill	1,447
Intangible assets, net	125
Property, plant and equipment, net	546
Operating lease right-of-use assets, net	43
Other non-current assets	17
Total non-current assets held for sale	2,178
Short-term debt	17
Current portion of operating lease liabilities	12
Accounts payable	725
Accrued liabilities	227
Total current liabilities held for sale	981
Postretirement and pension liabilities	77
Non-current portion of operating lease liabilities	32
Other non-current liabilities	90
Total non-current liabilities held for sale	199
Capital expenditures	$ 29	$ 33	$ 41

Cash, Cash Equivalents, and R_3

Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents	$ 531	$ 1,173
Restricted cash included in prepaid expenses and other current assets	61	64
Restricted cash included in other non-current assets	1	1
Total restricted cash	62	65
Total cash, cash equivalents and restricted cash	$ 593	$ 1,238	$ 663	$ 659

Receivables (Schedule of Receiv

Receivables (Schedule of Receivables) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Receivables [Abstract]
Accounts receivable	$ 1,289	$ 1,084
Less: allowance for credit losses	(20)	(20)
Net trade receivables	1,269	1,064
Unbilled receivables	325	248
Miscellaneous receivables	295	210
Receivables, net	$ 1,889	$ 1,522

Receivables - Schedule of Amoun

Receivables - Schedule of Amounts Securitized or Factored (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Receivables [Abstract]
Transfer of financial assets accounted for as sales, amount derecognized	$ 1,011	$ 852

Receivables (Narrative) (Detail

Receivables (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Receivables [Abstract]
Expenses related to securitization and factoring facilities	$ 13	$ 13	$ 13

Inventories (Schedule of Invent

Inventories (Schedule of Inventories) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 1,094	$ 800
Work in process	120	89
Finished goods	521	374
Total inventories	$ 1,735	$ 1,263

Goodwill (Schedule of Goodwill)

Goodwill (Schedule of Goodwill) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Goodwill [Roll Forward]
Balance at beginning of period	$ 3,146	$ 3,092
Held for sale reclassification	(58)
Foreign currency translation	(81)	54
Balance at end of period	3,007	3,146
Accumulated impairments balance	113
Americas Beverage
Goodwill [Roll Forward]
Balance at beginning of period	839	865
Held for sale reclassification	0
Foreign currency translation	(14)	(26)
Balance at end of period	825	839
Accumulated impairments balance	29
European Beverage
Goodwill [Roll Forward]
Balance at beginning of period	560	534
Held for sale reclassification	0
Foreign currency translation	(25)	26
Balance at end of period	535	560
Accumulated impairments balance	73
Transit Packaging
Goodwill [Roll Forward]
Balance at beginning of period	1,561	1,509
Held for sale reclassification	(58)
Foreign currency translation	(42)	52
Balance at end of period	1,461	1,561
Other
Goodwill [Roll Forward]
Balance at beginning of period	186	184
Held for sale reclassification	0
Foreign currency translation	0	2
Balance at end of period	186	$ 186
Accumulated impairments balance	$ 11

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Finite-Lived Intangible Assets [Line Items]
Gross	$ 2,217	$ 2,298
Accumulated amortization	(692)	(543)
Net	1,525	1,755
Amortization expense	165	162	$ 169
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2022	165
2023	165
2024	154
2025	147
2026	138
Discontinued Operations, Held-for-sale or Disposed of by Sale
Finite-Lived Intangible Assets [Line Items]
Net	13
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross	1,363	1,413
Accumulated amortization	(443)	(346)
Net	920	1,067
Trade names
Finite-Lived Intangible Assets [Line Items]
Gross	544	565
Accumulated amortization	(86)	(65)
Net	458	500
Technology
Finite-Lived Intangible Assets [Line Items]
Gross	158	165
Accumulated amortization	(88)	(67)
Net	70	98
Long term supply contracts
Finite-Lived Intangible Assets [Line Items]
Gross	137	142
Accumulated amortization	(63)	(55)
Net	74	87
Patents
Finite-Lived Intangible Assets [Line Items]
Gross	15	13
Accumulated amortization	(12)	(10)
Net	$ 3	$ 3

Property, Plant and Equipment_2

Property, Plant and Equipment (Schedule of Property, Plant and Equipment) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Property, Plant and Equipment [Abstract]
Buildings and improvements	$ 1,226	$ 1,137
Machinery and equipment	5,372	4,965
Land and improvements	208	223
Construction in progress	612	483
Property, plant and equipment, gross	7,418	6,808
Less: accumulated depreciation and amortization	(3,382)	(3,156)
Property, plant and equipment, net	$ 4,036	$ 3,652

Leases (Components of Lease Exp

Leases (Components of Lease Expense) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Operating lease costs:
Operating lease cost	$ 48	$ 39	$ 36
Short-term lease cost	3	5	4
Total operating lease costs	51	44	40
Finance lease cost:
Amortization of right-of-use assets	1	1	1
Total finance lease costs	$ 1	$ 1	$ 1

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Variable operating lease costs	$ 3	$ 3	$ 3
Interest on finance lease liabilities	$ 1	$ 1	$ 1

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information Related to Leases (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 51	$ 44	$ 38
Financing cash flows from finance leases	2	3	15
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 73	$ 42	$ 22

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet Information Related to Leases (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Finance leases:
Property, plant and equipment	$ 26	$ 28
Accumulated depreciation	(2)	(2)
Property, plant and equipment, net	24	26
Accrued liabilities	2	2
Other non-current liabilities	8	10
Total finance lease liabilities	$ 10	$ 12
Weighted average remaining lease term (years):
Operating leases	10 years 9 months 18 days	10 years 4 months 24 days
Finance leases	5 years 8 months 12 days	6 years 7 months 6 days
Weighted average discount rate:
Operating leases	4.30%	4.40%
Finance leases	3.20%	3.40%
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment, net	Property, plant and equipment, net
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other non-current liabilities	Other non-current liabilities

Leases (Operating and Finance L

Leases (Operating and Finance Lease Liability Maturity Schedule) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Operating Leases
2022	$ 42
2023	33
2024	26
2025	22
2026	18
Thereafter	112
Total lease payments	253
Less imputed interest	(61)
Total operating lease liabilities	192
Finance Leases
2022	2
2023	2
2024	2
2025	2
2026	2
Thereafter	1
Total lease payments	11
Less imputed interest	(1)
Total finance lease liabilities	$ 10	$ 12

Other Non-Current Assets (Sched

Other Non-Current Assets (Schedule of Other Non-Current Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Investments, All Other Investments [Abstract]
Pension assets	$ 158	$ 532
Deferred taxes	150	235
Investments	161	24
Fair value of derivatives	51	11
Other	84	83
Other non-current assets	$ 604	$ 885

Accrued Liabilities (Details)

Accrued Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
Salaries and employee benefits	$ 169	$ 182
Accrued taxes, other than on income	104	117
Income taxes	101	81
Accrued interest	47	85
Fair value of derivatives	32	26
Asbestos liabilities	25	25
Pension and postretirement liabilities	25	21
Restructuring	4	12
Other	459	397
Accrued liabilities	$ 966	$ 946

Restructuring and Other (Schedu

Restructuring and Other (Schedule of Restructuring and Other Charges) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Restructuring and Related Activities [Abstract]
Other (income) / costs	$ (42)	$ 9	$ (41)
Asset sales and impairments	(20)	2	(7)
Restructuring	29	19	18
Asbestos	5	0	0
Restructuring and other	$ (28)	$ 30	$ (30)

Restructuring and Other - Narra

Restructuring and Other - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]
Other (income) / costs	$ (42)	$ 9	$ (41)
Gain (loss) on restructuring	20	(2)	7
Americas Beverage
Restructuring Cost and Reserve [Line Items]
Other (income) / costs	$ 30
Impaired assets sales | Asia Pacific
Restructuring Cost and Reserve [Line Items]
Gain (loss) on restructuring			13
Termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring charges (benefit)			14
Headcount Reductions
Restructuring Cost and Reserve [Line Items]
Restructuring charges (benefit)			10
Indirect Taxes Paid
Restructuring Cost and Reserve [Line Items]
Other (income) / costs			50
Pre-Acquisition Related Litigation Settlement
Restructuring Cost and Reserve [Line Items]
Other (income) / costs			7
Transit Packaging
Restructuring Cost and Reserve [Line Items]
Restructuring charges (benefit)		$ 19
Fire at production facility | Asia Pacific
Restructuring Cost and Reserve [Line Items]
Gain (loss) on restructuring			$ (6)

Restructuring and Other (Charge

Restructuring and Other (Charges by Segment and Type) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Restructuring Cost and Reserve [Line Items]
Restructuring	$ 29	$ 19	$ 18
Termination benefits
Restructuring Cost and Reserve [Line Items]
Restructuring	10	8	14
Other exit costs
Restructuring Cost and Reserve [Line Items]
Restructuring	19	11	4
Other
Restructuring Cost and Reserve [Line Items]
Restructuring	3	(1)	5
Operating segments | Americas Beverage
Restructuring Cost and Reserve [Line Items]
Restructuring	0	0	1
Operating segments | European Beverage
Restructuring Cost and Reserve [Line Items]
Restructuring	3	0	0
Operating segments | Asia Pacific
Restructuring Cost and Reserve [Line Items]
Restructuring	1	1	3
Operating segments | Transit Packaging
Restructuring Cost and Reserve [Line Items]
Restructuring	19	19	6
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring	$ 3	$ 0	$ 3

Debt - Summary of Outstanding D

Debt - Summary of Outstanding Debt (Details) € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2021EUR (€)	Oct. 31, 2021USD ($)	Oct. 31, 2021EUR (€)	Dec. 31, 2020USD ($)	Dec. 31, 2020EUR (€)
Principal outstanding
Short-term debt	$ 75				$ 104
Total long-term debt	6,221				8,141
Less: current maturities	(136)				(67)
Total long-term debt, less current maturities	6,085				8,074
Carrying amount
Short-term debt	75				104
Total long-term debt	6,187				8,090
Less: current maturities	(135)				(67)
Total long-term debt, less current maturities	$ 6,052				8,023
Minimum | Revolving Credit Facility
Carrying amount
Basis spread on variable rate (as a percent)	0.00%
Maximum | Revolving Credit Facility
Carrying amount
Basis spread on variable rate (as a percent)	1.55%
Term loan facilities | U.S. dollar due 2024
Principal outstanding
Total long-term debt	$ 1,002				1,029
Carrying amount
Total long-term debt	997				1,023
Term loan facilities | Euro at EURIBOR plus 1.5% due 2024
Principal outstanding
Total long-term debt	344				387
Carrying amount
Total long-term debt	344				387
Debt instrument, face amount | €		€ 303				€ 317
Senior notes and debentures: | €650 at 4.0% due 2022
Principal outstanding
Total long-term debt	0				794
Carrying amount
Total long-term debt	$ 0				791
Debt instrument, face amount		€ 650	$ 754	€ 650
Debt instrument stated percentage	4.00%	4.00%	4.00%	4.00%
Senior notes and debentures: | U. S. dollar at 4.50% due 2023
Principal outstanding
Total long-term debt	$ 0				1,000
Carrying amount
Total long-term debt	$ 0				997
Debt instrument, face amount			$ 1,000
Debt instrument stated percentage	4.50%	4.50%	4.50%	4.50%
Senior notes and debentures: | €335 at 2.25% due 2023
Principal outstanding
Total long-term debt	$ 381				409
Carrying amount
Total long-term debt	$ 380				407
Debt instrument, face amount | €		€ 335
Debt instrument stated percentage	2.25%	2.25%
Senior notes and debentures: | €550 at 0.75% due 2023
Principal outstanding
Total long-term debt	$ 626				671
Carrying amount
Total long-term debt	$ 624				666
Debt instrument, face amount | €		€ 550
Debt instrument stated percentage	0.75%	0.75%
Senior notes and debentures: | €600 at 2.625% due 2024
Principal outstanding
Total long-term debt	$ 683				733
Carrying amount
Total long-term debt	$ 680				729
Debt instrument, face amount | €		€ 600
Debt instrument stated percentage	2.625%	2.625%
Senior notes and debentures: | €600 at 3.375% due 2025
Principal outstanding
Total long-term debt	$ 683				733
Carrying amount
Total long-term debt	$ 679				728
Debt instrument, face amount | €		€ 600
Debt instrument stated percentage	3.375%	3.375%
Senior notes and debentures: | U.S. dollar at 4.25% due 2026
Principal outstanding
Total long-term debt	$ 400				400
Carrying amount
Total long-term debt	$ 396				396
Debt instrument stated percentage	4.25%	4.25%
Senior notes and debentures: | U.S. dollar at 4.75% due 2026
Principal outstanding
Total long-term debt	$ 875				875
Carrying amount
Total long-term debt	$ 867				865
Debt instrument stated percentage	4.75%	4.75%
Senior notes and debentures: | U.S. dollar at 7.375% due 2026
Principal outstanding
Total long-term debt	$ 350				350
Carrying amount
Total long-term debt	$ 348				348
Debt instrument stated percentage	7.375%	7.375%
Senior notes and debentures: | €500 at 2.875% due 2026
Principal outstanding
Total long-term debt	$ 570				610
Carrying amount
Total long-term debt	$ 565				603
Debt instrument, face amount | €		€ 500
Debt instrument stated percentage	2.875%	2.875%
Senior notes and debentures: | U.S. dollar at 7.50% due 2096
Principal outstanding
Total long-term debt	$ 40				40
Carrying amount
Total long-term debt	$ 40				40
Debt instrument stated percentage	7.50%	7.50%
Other indebtedness, fixed rate
Principal outstanding
Total long-term debt	$ 189				97
Carrying amount
Total long-term debt	$ 189				97
Other indebtedness, fixed rate | Minimum
Carrying amount
Debt instrument stated percentage	2.70%	2.70%
Other indebtedness, fixed rate | Maximum
Carrying amount
Debt instrument stated percentage	7.80%	7.80%
Other indebtedness, variable rate
Principal outstanding
Total long-term debt	$ 28				13
Carrying amount
Total long-term debt	$ 28				13
Average variable rates	1.90%	1.90%
Debt instrument interest rate variable percentage rate range maximum	3.60%
Line of Credit | Revolving Credit Facility
Principal outstanding
Total long-term debt	$ 50				0
Carrying amount
Total long-term debt	$ 50				$ 0

Debt - Narrative (Details)

Debt - Narrative (Details) € in Millions, $ in Millions	1 Months Ended	12 Months Ended
	Oct. 31, 2021USD ($)	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Dec. 31, 2021EUR (€)	Oct. 31, 2021EUR (€)	Dec. 31, 2020EUR (€)
Debt Instrument [Line Items]
Long-term debt, fair value		$ 6,548	$ 8,617
Aggregate maturities of long term debt excluding unamortized discounts, year one		136
Aggregate maturities of long term debt excluding unamortized discounts, year two		1,144
Aggregate maturities of long term debt excluding unamortized discounts, year three		1,969
Aggregate maturities of long term debt excluding unamortized discounts, year four		715
Aggregate maturities of long term debt excluding unamortized discounts, year five		2,217
Cash payments for interest		294	302	$ 362
Loss from early extinguishments of debt		$ 68	$ 0	$ 27
€650 at 4.0% due 2022
Debt Instrument [Line Items]
Loss from early extinguishments of debt	$ 68
Senior notes and debentures: | U.S. dollar at 4.75% due 2026
Debt Instrument [Line Items]
Debt instrument stated percentage		4.75%			4.75%
Senior notes and debentures: | €500 at 2.875% due 2026
Debt Instrument [Line Items]
Debt instrument, face amount | €					€ 500
Debt instrument stated percentage		2.875%			2.875%
Senior notes and debentures: | €335 at 2.25% due 2023
Debt Instrument [Line Items]
Debt instrument, face amount | €					€ 335
Debt instrument stated percentage		2.25%			2.25%
Senior notes and debentures: | €550 at 0.75% due 2023
Debt Instrument [Line Items]
Debt instrument, face amount | €					€ 550
Debt instrument stated percentage		0.75%			0.75%
Senior notes and debentures: | €650 at 4.0% due 2022
Debt Instrument [Line Items]
Debt instrument, face amount	$ 754				€ 650	€ 650
Debt instrument stated percentage	4.00%	4.00%			4.00%	4.00%
Senior notes and debentures: | U. S. dollar at 4.50% due 2023
Debt Instrument [Line Items]
Debt instrument, face amount	$ 1,000
Debt instrument stated percentage	4.50%	4.50%			4.50%	4.50%
Term loan facilities | Euro at EURIBOR plus 1.5% due 2024
Debt Instrument [Line Items]
Debt instrument, face amount | €					€ 303		€ 317
Revolving Credit Facility
Debt Instrument [Line Items]
Credit facility, available borrowing capacity		$ 1,535
Line of credit facility, maximum borrowing capacity		1,650
Outstanding letters of credit		65
Proceeds from lines of credit		$ 50
Debt covenant, leverage ratio		5			5
Revolving Credit Facility | Minimum
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)		0.00%
Revolving Credit Facility | Maximum
Debt Instrument [Line Items]
Provisions for letters of credit		$ 310
Basis spread on variable rate (as a percent)		1.55%

Debt (Schedule of Weighted Aver

Debt (Schedule of Weighted Average Interest Rates) (Details)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Short-term debt	0.60%	2.10%	2.80%
Revolving credit facilities	1.20%	1.80%	3.00%

Derivative and Other Financia_3

Derivative and Other Financial Instruments (Narrative) (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Derivative Instruments, Gain (Loss) [Line Items]
Objectives for using derivative instruments	The Company’s objective in managing exposure to market and interest rate risk is to limit the impact on earnings and cash flow.
Net gain to be reclassified to earnings	$ 34,000,000
Gain, net of tax, expected to be reclassified to earnings	28,000,000
Reclassification of anticipated transactions that were no longer considered probable	0	$ 0
Foreign exchange
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on foreign exchange contracts designated as fair value hedges	$ 3,000,000	$ 27,000,000
Minimum
Derivative Instruments, Gain (Loss) [Line Items]
Contracts outstanding, maturity	1 month
Maximum
Derivative Instruments, Gain (Loss) [Line Items]
Contracts outstanding, maturity	34 months

Derivative and Other Financia_4

Derivative and Other Financial Instruments (Accumulated Other Comprehensive Income ("AOCI") and Earnings from Changes in Fair Value Related to Derivative Instruments) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) recognized in AOCI	$ 71	$ 9
Net (loss) / income from discontinued operations	(52)	156	$ 125
Net (loss) / income	(411)	688	$ 625
Derivatives in cash flow hedges | Derivatives designated as hedges: | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Provision for income taxes	(23)	13
Derivatives qualifying as hedges	68	(33)
Net (loss) / income	73	(35)
Foreign exchange
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) recognized in AOCI	(5)	0
Foreign exchange | Derivatives in cash flow hedges | Derivatives designated as hedges: | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Net (loss) / income from discontinued operations	0	(1)
Foreign exchange | Net sales | Derivatives in cash flow hedges | Derivatives designated as hedges: | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Amounts of gain/(loss) reclassified from AOCI into income	(4)	(3)
Foreign exchange | Cost of products sold | Derivatives in cash flow hedges | Derivatives designated as hedges: | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Amounts of gain/(loss) reclassified from AOCI into income	2	(2)
Interest rate
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) recognized in AOCI	2	(1)
Commodities
Derivative Instruments, Gain (Loss) [Line Items]
Amount of gain/(loss) recognized in AOCI	74	10
Commodities | Derivatives in cash flow hedges | Derivatives designated as hedges: | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Amounts of gain/(loss) reclassified from AOCI into income	91	(46)
Net (loss) / income from discontinued operations	5	(1)
Commodities | Net sales | Derivatives in cash flow hedges | Derivatives designated as hedges: | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Amounts of gain/(loss) reclassified from AOCI into income	(54)	18
Commodities | Cost of products sold | Derivatives in cash flow hedges | Derivatives designated as hedges: | Reclassification out of Accumulated Other Comprehensive Income
Derivative Instruments, Gain (Loss) [Line Items]
Amounts of gain/(loss) reclassified from AOCI into income	$ 147	$ (59)

Derivative and Other Financia_5

Derivative and Other Financial Instruments (Derivatives Not Designated as Hedges Income Statement) (Details) - Derivatives not designated as hedges - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Net Investment Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	$ (33)	$ 30
Foreign exchange | Net sales | Net Investment Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	(3)	0
Foreign exchange | Cost of products sold | Net Investment Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	(1)	(1)
Foreign exchange | Foreign exchange | Net Investment Hedging
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	(29)	30
Foreign exchange | Net (loss) / income from discontinued operations
Derivative Instruments, Gain (Loss) [Line Items]
Pre-tax amount of gain / (loss) recognized in earnings	$ 0	$ 1

Derivative and Other Financia_6

Derivative and Other Financial Instruments (Net Investment Hedge Narrative) (Details) € in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)	Dec. 31, 2021EUR (€)
Derivative [Line Items]
Gain (loss), recognized in OCI	$ 103	$ (1)
Gain (loss) on net investment hedge, net of tax	(103)	1
Carrying amount of hedged net investment	1,493		€ 1,312
Foreign exchange
Derivative [Line Items]
Gain (loss), recognized in OCI	47	(48)
Accumulated Other Comprehensive Loss
Derivative [Line Items]
Gain (loss), recognized in OCI	69	(33)
Gain (loss) on net investment hedge, net of tax	$ (92)	$ 10

Derivative and Other Financia_7

Derivative and Other Financial Instruments (Impact on OCI from Changes in Derivative Fair Value) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Derivative [Line Items]
Amount of gain/(loss) recognized in OCI	$ 103	$ (1)
Foreign exchange
Derivative [Line Items]
Amount of gain/(loss) recognized in OCI	$ 47	$ (48)

Derivative and Other Financia_8

Derivative and Other Financial Instruments (Fair Values of Financial Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Derivative assets
Total	$ 111	$ 76
Derivative liabilities
Total	33	52
Level 2
Derivative assets
Total	111	76
Derivative liabilities
Total	33	52
Derivatives designated as hedges: | Other assets | Level 2
Derivative assets
Derivatives designated as hedging instruments	108	67
Derivatives designated as hedges: | Other non-current liabilities | Net investment hedge | Level 2
Derivative liabilities
Derivatives designated as hedging instruments	0	20
Derivatives designated as hedges: | Other liabilities | Level 2
Derivative liabilities
Derivatives designated as hedging instruments	30	48
Derivatives not designated as hedges: | Prepaid Expenses and Other Current Assets | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives not designated as hedging instruments	3	9
Derivatives not designated as hedges: | Other assets | Level 2
Derivative assets
Derivatives not designated as hedging instruments	3	9
Derivatives not designated as hedges: | Accrued liabilities | Foreign exchange contracts cash flow | Level 2
Derivative liabilities
Derivatives not designated as hedging instruments	3	4
Derivatives not designated as hedges: | Other liabilities | Level 2
Derivative assets
Derivatives not designated as hedging instruments	3	4
Derivatives in cash flow hedges | Derivatives designated as hedges: | Prepaid Expenses and Other Current Assets | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	3	5
Derivatives in cash flow hedges | Derivatives designated as hedges: | Prepaid Expenses and Other Current Assets | Commodities contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	53	43
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current assets | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	0	0
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current assets | Commodities contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	2	4
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current assets | Interest rate contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	0	0
Derivatives in cash flow hedges | Derivatives designated as hedges: | Accrued liabilities | Foreign exchange contracts cash flow | Level 2
Derivative liabilities
Derivatives designated as hedging instruments	10	5
Derivatives in cash flow hedges | Derivatives designated as hedges: | Accrued liabilities | Commodities contracts cash flow | Level 2
Derivative liabilities
Derivatives designated as hedging instruments	17	11
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current liabilities | Foreign exchange contracts cash flow | Level 2
Derivative liabilities
Derivatives designated as hedging instruments	0	1
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current liabilities | Commodities contracts cash flow | Level 2
Derivative liabilities
Derivatives designated as hedging instruments	1	0
Derivatives in cash flow hedges | Derivatives designated as hedges: | Other non-current liabilities | Interest rate contracts cash flow | Level 2
Derivative liabilities
Derivatives designated as hedging instruments	0	2
Derivatives in cash flow hedges | Derivatives designated as hedges: | Current assets held for sale | Foreign exchange contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	0	4
Derivatives in cash flow hedges | Derivatives designated as hedges: | Current assets held for sale | Commodities contracts cash flow | Level 2
Derivative assets
Derivatives designated as hedging instruments	0	2
Derivatives in cash flow hedges | Derivatives designated as hedges: | Current liabilities held for sale | Foreign exchange contracts cash flow | Level 2
Derivative liabilities
Derivatives designated as hedging instruments	0	3
Derivatives in cash flow hedges | Derivatives designated as hedges: | Current liabilities held for sale | Commodities contracts cash flow | Level 2
Derivative liabilities
Derivatives designated as hedging instruments	0	0
Derivatives in fair value hedges | Derivatives designated as hedges: | Prepaid Expenses and Other Current Assets | Foreign exchange contracts fair value | Level 2
Derivative assets
Derivatives designated as hedging instruments	1	2
Derivatives in fair value hedges | Derivatives designated as hedges: | Accrued liabilities | Foreign exchange contracts fair value | Level 2
Derivative liabilities
Derivatives designated as hedging instruments	2	6
Net investment hedge | Derivatives designated as hedges: | Other non-current assets | Level 2
Derivative assets
Derivatives designated as hedging instruments	$ 49	$ 7

Derivative and Other Financia_9

Derivative and Other Financial Instruments (Carrying Amount of Hedged Assets and Liabilities) (Details) - Derivatives designated as hedges - Derivatives in fair value hedges - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Derivative [Line Items]
Cumulative amount of fair value hedge adjustments included in carrying amounts	$ 1	$ 4
Cash and cash equivalents
Derivative [Line Items]
Derivative instruments in hedges, assets	38	22
Receivables, net
Derivative [Line Items]
Derivative instruments in hedges, assets	21	11
Accrued liabilities
Derivative [Line Items]
Accrued liabilities	$ 116	$ 100

Derivative and Other Financi_10

Derivative and Other Financial Instruments (Schedule of Offsetting Derivative Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Derivative assets
Gross amounts recognized in the Balance Sheet	$ 111	$ 76
Gross amounts not offset in the Balance Sheet	19	11
Net amount	92	65
Derivative liabilities
Gross amounts recognized in the Balance Sheet	33	52
Gross amounts not offset in the Balance Sheet	19	11
Net amount	$ 14	$ 41

Derivative and Other Financi_11

Derivative and Other Financial Instruments (Notional Values of Outstanding Derivative Instruments in the Consolidated Balance Sheet) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Derivatives designated as hedges | Derivatives in cash flow hedges | Foreign exchange
Derivatives, Fair Value [Line Items]
Derivative, notional values	$ 241	$ 639
Derivatives designated as hedges | Derivatives in cash flow hedges | Commodities
Derivatives, Fair Value [Line Items]
Derivative, notional values	261	231
Derivatives designated as hedges | Derivatives in cash flow hedges | Interest rate
Derivatives, Fair Value [Line Items]
Derivative, notional values	0	200
Derivatives designated as hedges | Derivatives in fair value hedges | Foreign exchange
Derivatives, Fair Value [Line Items]
Derivative, notional values	229	183
Derivatives designated as hedges | Net Investment Hedging | Foreign exchange
Derivatives, Fair Value [Line Items]
Derivative, notional values	875	1,075
Derivatives not designated as hedges | Foreign exchange
Derivatives, Fair Value [Line Items]
Derivative, notional values	$ 617	$ 722

Asbestos-Related Liabilities (N

Asbestos-Related Liabilities (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)claimpendingClaim	Dec. 31, 2020USD ($)claim	Dec. 31, 2019USD ($)claim	Dec. 31, 2018claim
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Holding period for insulation operations (in days)	90 days
Liability for asbestos and environmental claims, net, payment for claims	$ 19	$ 21	$ 22
Number of inactive claims | claim	19,000
Percentage of claims that do not specify damages	82.00%
Claims outstanding | claim	57,000	56,000	56,000	56,000
Accrued asbestos claims and related legal costs	$ 237
Unasserted claims	$ 198
Damage claims less than $5
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Percentage of claims damages specified	15.00%
Damage claims less than $5 | Maximum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 5
Damage claims from $5 to less than $100
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Percentage of claims damages specified	3.00%
Damage claims from $5 to less than $100 | Maximum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 100
Damage claims from $5 to less than $100 | Minimum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 5
Damage claims less than $25
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Percentage of claims damages specified	36.00%
Damage claims less than $25 | Maximum
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 25
Damages claims in excess of $100
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Damages claims amount	$ 100
Claims outstanding | pendingClaim	14

Asbestos-Related Liabilities (S

Asbestos-Related Liabilities (Summary of Claims Activity) (Details) - claim	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Loss Contingency, Pending Claims [Roll Forward]
Beginning claims	56,000	56,000	56,000
New claims	2,000	1,500	2,000
Settlements or dismissals	(1,000)	(1,500)	(2,000)
Ending claims	57,000	56,000	56,000

Asbestos-Related Liabilities _2

Asbestos-Related Liabilities (Summary of Outstanding Claims by Year Of Exposure and State Filed) (Details) - claim	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	57,000	56,000	56,000	56,000
Claimants alleging first exposure after 1964
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	17,000	16,500
Claimants alleging first exposure before or during 1964 | Texas
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	13,000	13,000
Claimants alleging first exposure before or during 1964 | Pennsylvania
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	1,500	1,500
Claimants alleging first exposure before or during 1964 | Other states that have enacted asbestos legislation
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	6,000	6,000
Claimants alleging first exposure before or during 1964 | Other states
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims outstanding	19,500	19,000

Asbestos-Related Liabilities _3

Asbestos-Related Liabilities (Summary of Percentage of Outstanding Claims Related to Claimants Alleging Serious Diseases) (Details)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Total claims
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims alleging serious diseases, percentage	24.00%	23.00%	22.00%
Pre-1965 claims in states without asbestos legislation
Causes of Increase (Decrease) in Liability for Unpaid Claims and Claims Adjustment Expense [Line Items]
Claims alleging serious diseases, percentage	42.00%	41.00%	41.00%

Commitments and Contingent Li_2

Commitments and Contingent Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2021	Mar. 31, 2017
PRP Site
Commitments And Contingent Liabilities [Line Items]
Estimated future remediation costs	$ 12
Non- PRP Sites
Commitments And Contingent Liabilities [Line Items]
Estimated future remediation costs	$ 6
Penalty Notification Alleging Misclassification of Importation of Certain Goods into U.S. During 2004-2009 | U.S. Customs and Border Protection
Commitments And Contingent Liabilities [Line Items]
Initial and subsequent penalty assessed		$ 18

Other Non-Current Liabilities_2

Other Non-Current Liabilities (Schedule of Other Non-Current Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Other Liabilities Disclosure [Abstract]
Deferred taxes	$ 336	$ 350
Asbestos liabilities	212	226
Income taxes payable	26	26
Fair value of derivatives	1	23
Postemployment benefits	21	19
Environmental	12	12
Finance lease liabilities	8	10
Other	80	100
Other non-current liabilities	$ 696	$ 766

Pension and Other Postretirem_3

Pension and Other Postretirement Benefits (Components of Pension Expense) (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Nov. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Settlements	$ 1,511
Other Postretirement Benefits
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost		$ 1	$ 1	$ 1
Interest cost		4	5	6
Amortization of actuarial loss		4	4	3
Amortization of prior service cost		(26)	(26)	(34)
Net periodic cost		(17)	(16)	(24)
U.S. Plans | Pension Plan
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost		20	18	15
Interest cost		25	38	50
Expected return on plan assets		(63)	(73)	(70)
Settlements		0	3	0
Curtailments		9	0	0
Amortization of actuarial loss		58	56	55
Amortization of prior service cost		1	1	1
Net periodic cost		50	43	51
Non-U.S. Plans | Pension Plan
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]
Service cost		13	10	13
Interest cost		32	52	70
Expected return on plan assets		(72)	(107)	(138)
Settlements		1,511	63	44
Curtailments		0	0	(14)
Amortization of actuarial loss		33	27	37
Amortization of prior service cost		0	0	(1)
Net periodic cost		$ 1,517	$ 45	$ 11

Pension and Other Postretirem_4

Pension and Other Postretirement Benefits (Narrative) (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Nov. 30, 2021	Dec. 31, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer contributions		$ 55			$ 271
Settlements	$ 1,511
Settlement charge, net of tax	$ 1,040
Multiemployer plans, additional expense					5	$ 5	$ 5
Actuarial loss					638
Defined benefit plan, benefit obligation, asset returns					65
Amounts of common stock included in plan assets		357			357	323
Defined benefit plan, estimated employer contributions		$ 27			27
Total contributions					12	13	11
Forecast
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer contributions			$ 110	$ 110
Pension Plan | Non-U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer contributions					234	18
Settlements					1,511	63	44
Actuarial loss					444	276
Pension Plan | U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Employer contributions					2	9
Settlements					0	3	$ 0
Actuarial loss					(43)	109
Other Postretirement Benefits
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Actuarial loss					$ (20)	$ 7

Pension and Other Postretirem_5

Pension and Other Postretirement Benefits (Schedule of Projected and Changes in Benefit Obligations) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Projected Benefit Obligations
Actuarial (gain) / loss		$ 638
Plan Assets
Employer contributions	$ 55	271
Other Postretirement Benefits
Projected Benefit Obligations
Benefit obligations at beginning of period		163	$ 161
Service cost		1	1	$ 1
Interest cost		4	5	6
Actuarial (gain) / loss		(20)	7
Benefits paid		(10)	(11)
Foreign currency translation		(1)	0
Benefit obligations at end of period	137	137	163	161
U.S. Plans | Pension Plan
Projected Benefit Obligations
Benefit obligations at beginning of period		1,505	1,440
Service cost		20	18	15
Interest cost		25	38	50
Plan participants’ contributions		0	0
Amendments		2	1
Settlements		0	(7)
Curtailments		(10)	0
Special termination benefits		6	0
Actuarial (gain) / loss		(43)	109
Benefits paid		(92)	(94)
Foreign currency translation		0	0
Benefit obligations at end of period	1,413	1,413	1,505	1,440
Plan Assets
Balance at beginning of period		1,152	1,131
Actual return on plan assets		115	113
Employer contributions		2	9
Plan participants’ contributions		0	0
Settlements		0	(7)
Benefits paid		(92)	(94)
Foreign currency translation		0	0
Balance at end of period	1,177	1,177	1,152	1,131
Funded status	(236)	(236)	(353)
Accumulated benefit obligations at end of period	1,361	1,361	1,445
Non-U.S. Plans | Pension Plan
Projected Benefit Obligations
Benefit obligations at beginning of period		3,172	3,155
Service cost		13	10	13
Interest cost		32	52	70
Plan participants’ contributions		2	2
Amendments		(3)	0
Settlements		(2,982)	(271)
Curtailments		(7)	0
Special termination benefits		0	0
Actuarial (gain) / loss		444	276
Benefits paid		(165)	(148)
Foreign currency translation		7	96
Benefit obligations at end of period	513	513	3,172	3,155
Plan Assets
Balance at beginning of period		3,518	3,480
Actual return on plan assets		(94)	334
Employer contributions		234	18
Plan participants’ contributions		2	2
Settlements		(2,982)	(271)
Benefits paid		(165)	(152)
Foreign currency translation		16	107
Balance at end of period	529	529	3,518	$ 3,480
Funded status	16	16	346
Accumulated benefit obligations at end of period	$ 474	$ 474	$ 3,111

Pension and Other Postretirem_6

Pension and Other Postretirement Benefits (Schedule of Accumulated Benefit Obligations in Excess of Plan Assets) (Details) - Pension Plan - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	$ 1,413	$ 1,505
Accumulated benefit obligations	1,361	1,445
Fair value of plan assets	1,177	1,152
Non-U.S. Plans
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	284	354
Accumulated benefit obligations	253	320
Fair value of plan assets	$ 147	$ 191

Pension and Other Postretirem_7

Pension and Other Postretirement Benefits (Schedule of Projected Benefit Obligations in Excess of Plan Assets) (Details) - Foreign Plan - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligations	$ 288	$ 432
Accumulated benefit obligations	257	389
Fair value of plan assets	$ 151	$ 194

Pension and Other Postretirem_8

Pension and Other Postretirement Benefits (Summary of Strategic Ranges for Assets Allocation Plan) (Details) - Pension Plan - U.S. Plans	Dec. 31, 2021
Minimum | U.S. equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	45.00%
Minimum | International equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	7.00%
Minimum | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	18.00%
Minimum | Balanced funds
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	7.00%
Minimum | Real estate
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	4.00%
Maximum | U.S. equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	55.00%
Maximum | International equities
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	13.00%
Maximum | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	28.00%
Maximum | Balanced funds
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	13.00%
Maximum | Real estate
Defined Benefit Plan Disclosure [Line Items]
Target plan asset allocations	10.00%

Pension and Other Postretirem_9

Pension and Other Postretirement Benefits (Schedule of Defined Benefit Plan Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	$ 218	$ 360	$ 464
Level 3 | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	2	43
Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	7	51	75
Level 3 | Real estate – direct
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	211	307	346
Fair Value Measured at Net Asset Value Per Share | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	137	137
Fair Value Measured at Net Asset Value Per Share | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	167	141
Fair Value Measured at Net Asset Value Per Share | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		109
Fair Value Measured at Net Asset Value Per Share | Investment funds – emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	7	7
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan fair value of plan assets excluding accrued income	1,705	4,659
Pension Plan | Total assets in fair value hierarchy
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	1,394	4,265
Pension Plan | Level 1
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	947	1,388
Pension Plan | Level 1 | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	89	655
Pension Plan | Level 1 | Global large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	8	9
Pension Plan | Level 1 | U.S. large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	244	182
Pension Plan | Level 1 | U.S. mid/small cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	357	323
Pension Plan | Level 1 | Mutual funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	93	88
Pension Plan | Level 1 | Mutual funds – U.S. equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	85	56
Pension Plan | Level 1 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	71	75
Pension Plan | Level 2
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	229	2,517
Pension Plan | Level 2 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	38	128
Pension Plan | Level 2 | Government issued debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	17	298
Pension Plan | Level 2 | Corporate debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	64	705
Pension Plan | Level 2 | Asset backed securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		2
Pension Plan | Level 2 | Structured debt
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		1,034
Pension Plan | Level 2 | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	110	115
Pension Plan | Level 2 | Derivatives
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		166
Pension Plan | Level 2 | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		69
Pension Plan | Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	218	360
Pension Plan | Level 3 | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		272
Pension Plan | Level 3 | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	171	2
Pension Plan | Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	7	51
Pension Plan | Level 3 | Real estate – direct
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	40	35
Pension Plan | Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	311	394
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	137	137
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	167	141
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		109
Pension Plan | Fair Value Measured at Net Asset Value Per Share | Investment funds – emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	7	7
Pension Plan | U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	1,177	1,152	1,131
Defined benefit plan fair value of plan assets excluding accrued income	1,176	1,151
Accrued income	1	1
Pension Plan | U.S. Plans | Total assets in fair value hierarchy
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	1,057	1,032
Pension Plan | U.S. Plans | Level 1
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	887	855
Pension Plan | U.S. Plans | Level 1 | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	68	157
Pension Plan | U.S. Plans | Level 1 | Global large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 1 | U.S. large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	238	178
Pension Plan | U.S. Plans | Level 1 | U.S. mid/small cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	332	301
Pension Plan | U.S. Plans | Level 1 | Mutual funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	93	88
Pension Plan | U.S. Plans | Level 1 | Mutual funds – U.S. equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	85	56
Pension Plan | U.S. Plans | Level 1 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	71	75
Pension Plan | U.S. Plans | Level 2
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	61	58
Pension Plan | U.S. Plans | Level 2 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 2 | Government issued debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 2 | Corporate debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	61	58
Pension Plan | U.S. Plans | Level 2 | Asset backed securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		0
Pension Plan | U.S. Plans | Level 2 | Structured debt
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		0
Pension Plan | U.S. Plans | Level 2 | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Level 2 | Derivatives
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		0
Pension Plan | U.S. Plans | Level 2 | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		0
Pension Plan | U.S. Plans | Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	109	119
Pension Plan | U.S. Plans | Level 3 | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		91
Pension Plan | U.S. Plans | Level 3 | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	79	0
Pension Plan | U.S. Plans | Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	5	5
Pension Plan | U.S. Plans | Level 3 | Real estate – direct
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	25	23
Pension Plan | U.S. Plans | Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	119	119
Pension Plan | U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	112	112
Pension Plan | U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		0
Pension Plan | U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds – emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	7	7
Pension Plan | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	529	3,518	$ 3,480
Defined benefit plan fair value of plan assets excluding accrued income	529	3,508
Accrued income	0	10
Pension Plan | Non-U.S. Plans | Total assets in fair value hierarchy
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	337	3,233
Pension Plan | Non-U.S. Plans | Level 1
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	60	533
Pension Plan | Non-U.S. Plans | Level 1 | Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	21	498
Pension Plan | Non-U.S. Plans | Level 1 | Global large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	8	9
Pension Plan | Non-U.S. Plans | Level 1 | U.S. large cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	6	4
Pension Plan | Non-U.S. Plans | Level 1 | U.S. mid/small cap equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	25	22
Pension Plan | Non-U.S. Plans | Level 1 | Mutual funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | Non-U.S. Plans | Level 1 | Mutual funds – U.S. equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | Non-U.S. Plans | Level 1 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	0	0
Pension Plan | Non-U.S. Plans | Level 2
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	168	2,459
Pension Plan | Non-U.S. Plans | Level 2 | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	38	128
Pension Plan | Non-U.S. Plans | Level 2 | Government issued debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	17	298
Pension Plan | Non-U.S. Plans | Level 2 | Corporate debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	3	647
Pension Plan | Non-U.S. Plans | Level 2 | Asset backed securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		2
Pension Plan | Non-U.S. Plans | Level 2 | Structured debt
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		1,034
Pension Plan | Non-U.S. Plans | Level 2 | Insurance contracts
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	110	115
Pension Plan | Non-U.S. Plans | Level 2 | Derivatives
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		166
Pension Plan | Non-U.S. Plans | Level 2 | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		69
Pension Plan | Non-U.S. Plans | Level 3
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	109	241
Pension Plan | Non-U.S. Plans | Level 3 | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		181
Pension Plan | Non-U.S. Plans | Level 3 | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	92	2
Pension Plan | Non-U.S. Plans | Level 3 | Private equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	2	46
Pension Plan | Non-U.S. Plans | Level 3 | Real estate – direct
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	15	12
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	192	275
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Fixed income
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	25	25
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds – global equity
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	167	141
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds – real estate
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value		109
Pension Plan | Non-U.S. Plans | Fair Value Measured at Net Asset Value Per Share | Investment funds – emerging markets
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan assets at fair value	$ 0	$ 0

Pension and Other Postretire_10

Pension and Other Postretirement Benefits (Schedule of Reconciliation of Plan Assets Measured by Significant Unobservable Inputs) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Level 3
Plan Assets
Balance at beginning of period	$ 360	$ 464
Foreign currency translation	(1)	10
Asset returns – assets held at reporting date	(19)	(6)
Asset returns – assets sold during the period	43	(18)
Purchases, sales and settlements, net	(165)	(90)
Balance at end of period	218	360
Level 3 | Hedge funds
Plan Assets
Balance at beginning of period	2	43
Foreign currency translation	0	1
Asset returns – assets held at reporting date	(1)	3
Asset returns – assets sold during the period	1	(12)
Purchases, sales and settlements, net	(2)	(33)
Balance at end of period	0	2
Level 3 | Private equity
Plan Assets
Balance at beginning of period	51	75
Foreign currency translation	0	2
Asset returns – assets held at reporting date	(48)	6
Asset returns – assets sold during the period	39	(9)
Purchases, sales and settlements, net	(35)	(23)
Balance at end of period	7	51
Level 3 | Real estate – direct
Plan Assets
Balance at beginning of period	307	346
Foreign currency translation	(1)	7
Asset returns – assets held at reporting date	30	(15)
Asset returns – assets sold during the period	3	3
Purchases, sales and settlements, net	(128)	(34)
Balance at end of period	211	307
Fair Value Measured at Net Asset Value Per Share | Investment funds – global equity
Plan Assets
Balance at beginning of period	141
Balance at end of period	167	141
Fair Value Measured at Net Asset Value Per Share | Investment funds – emerging markets
Plan Assets
Balance at beginning of period	7
Balance at end of period	7	7
Fair Value Measured at Net Asset Value Per Share | Hedge funds
Plan Assets
Balance at beginning of period	109
Balance at end of period		109
Fair Value Measured at Net Asset Value Per Share | Investment funds – fixed income
Plan Assets
Balance at beginning of period	137
Balance at end of period	$ 137	$ 137

Pension and Other Postretire_11

Pension and Other Postretirement Benefits (Additional Information About Pension Plan Assets Valued Using Net Asset Value) (Details) - Fair Value Measured at Net Asset Value Per Share - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Investment funds – fixed income
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets at fair value	$ 137	$ 137
Redemption Notice Period	10 days
Investment funds – global equity
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets at fair value	$ 167	141
Investment funds – emerging markets
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets at fair value	$ 7	$ 7
Redemption Notice Period	30 days	30 days
Hedge funds
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined benefit plan assets at fair value		$ 109
Minimum | Investment funds – fixed income
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period	1 day	1 day
Minimum | Hedge funds
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period		1 day
Maximum | Investment funds – fixed income
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period	5 days	5 days
Maximum | Hedge funds
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Redemption Notice Period		30 days

Pension and Other Postretire_12

Pension and Other Postretirement Benefits (Schedule of Pension Assets/(Liabilities)) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Retirement Benefits [Abstract]
Non-current assets	$ 158	$ 532
Current liabilities	11	8
Non-current liabilities	$ 367	$ 537

Pension and Other Postretire_13

Pension and Other Postretirement Benefits (Schedule of Changes in Net Loss and Prior Service Cost/(Credit)) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Pension Plan
Net loss
Balance at beginning of period	$ 1,802	$ 1,808	$ 1,962
Reclassification to net periodic benefit cost	(1,629)	(150)	(137)
Current year loss / (gain)	640	118	(53)
Amendments	(1)	0	0
Foreign currency translation	2	26	36
Balance at end of period	814	1,802	1,808
Prior service
Balance at beginning of period	8	8	(6)
Reclassification to net periodic benefit cost	(4)	(1)	14
Current year loss / (gain)	(2)	0	0
Amendments	0	1	0
Foreign currency translation	0	0	0
Balance at end of period	2	8	8
Other Postretirement Benefits
Net loss
Balance at beginning of period	45	42	31
Reclassification to net periodic benefit cost	(4)	(4)	(3)
Current year loss / (gain)	(20)	7	14
Amendments	0	0	0
Balance at end of period	21	45	42
Prior service
Balance at beginning of period	(46)	(72)	(105)
Reclassification to net periodic benefit cost	26	26	34
Current year loss / (gain)	0	0	0
Amendments	0	0	(1)
Balance at end of period	$ (20)	$ (46)	$ (72)

Pension and Other Postretire_14

Pension and Other Postretirement Benefits (Schedule of Expected Future Benefit Payments) (Details) $ in Millions	Dec. 31, 2021USD ($)
Other Postretirement Benefits
Defined Benefit Plan, Expected Future Benefit Payment 2020 Net Prior Service
2022	$ 14
2023	12
2024	11
2025	10
2026	10
2027 - 2031	43
Defined Benefit Plan, Expected Future Benefit Payment 2020
2022	14
2023	12
2024	11
2025	10
2026	10
2027 - 2031	43
U.S. Plans | Pension Plan
Defined Benefit Plan, Expected Future Benefit Payment 2020 Net Prior Service
2022	104
2023	99
2024	99
2025	100
2026	85
2027 - 2031	419
Defined Benefit Plan, Expected Future Benefit Payment 2020
2022	104
2023	99
2024	99
2025	100
2026	85
2027 - 2031	419
Non-U.S. Plans | Pension Plan
Defined Benefit Plan, Expected Future Benefit Payment 2020 Net Prior Service
2022	31
2023	30
2024	30
2025	32
2026	32
2027 - 2031	360
Defined Benefit Plan, Expected Future Benefit Payment 2020
2022	31
2023	30
2024	30
2025	32
2026	32
2027 - 2031	$ 360

Pension and Other Postretire_15

Pension and Other Postretirement Benefits (Assumptions Used) (Details) - Pension Plan	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	2.90%	2.50%	3.20%
Compensation increase	4.70%	4.70%	4.70%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - service cost	3.10%	3.60%	4.70%
Discount rate - interest cost	1.70%	2.80%	3.90%
Compensation increase	4.70%	4.70%	4.50%
Long-term rate of return	5.70%	6.80%	7.30%
Non-U.S. Plans
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate	2.50%	1.40%	2.10%
Compensation increase	2.50%	3.00%	3.00%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate - service cost	2.20%	2.60%	3.00%
Discount rate - interest cost	1.80%	1.90%	2.70%
Compensation increase	2.50%	3.00%	3.20%
Long-term rate of return	3.30%	3.30%	4.30%

Pension and Other Postretire_16

Pension and Other Postretirement Benefits (Schedule of Assumed Health Care Cost Trend Rates) (Details) - Other Postretirement Benefits	Dec. 31, 2021
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Health care cost trend rate assumed for 2021	4.50%
Rate that the cost trend rate gradually declines to	3.80%

Pension and Other Postretire_17

Pension and Other Postretirement Benefits (Weighted Average Discount Rates used to Calculate the Benefit Obligations (Details) - Other Postretirement Benefits	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Defined Benefit Plan Disclosure [Line Items]
Benefit obligations	3.40%	2.80%	3.50%
Service cost	5.90%	4.10%	4.80%
Interest cost	3.60%	3.30%	4.20%

Income Taxes (Components of Inc

Income Taxes (Components of Income Before Income Taxes and Equity Earnings) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract]
U.S.	$ 143	$ 97	$ 1
Foreign	(562)	628	630
(Loss) / income from continuing operations before income taxes and equity in net earnings of affiliates	$ (419)	$ 725	$ 631

Income Taxes (Provision for Inc

Income Taxes (Provision for Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current tax:
U.S. federal	$ 2	$ 0	$ (1)
State and foreign	239	161	165
Current tax, total	241	161	164
Deferred tax:
U.S. federal	46	38	17
State and foreign	(344)	0	(45)
Deferred tax, total	(298)	38	(28)
Total	$ (57)	$ 199	$ 136

Income Taxes (Effective Income

Income Taxes (Effective Income Tax Reconciliation) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Effective Income Tax Rate Reconciliation, Amount [Abstract]
U.S. statutory rate at 21%	$ (88)	$ 152	$ 133
Tax on foreign income	(29)	27	10
Valuation allowance changes	26	(11)	(33)
State taxes	9	5	7
U.S. taxes on foreign income, net of credits	13	14	15
Tax contingencies	8	1	19
Tax law changes	(8)	4	(11)
Other items, net	12	7	(4)
Total	$ (57)	$ 199	$ 136

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Taxes [Line Items]
Taxes paid	$ 253	$ 189	$ 173
(Benefit from) / provision for income taxes	(57)	199	136
Tax contingencies	8	1	19
Deferred taxes on earnings of foreign subsidiaries		1,500
Valuation allowance	227	204
Unrecognized tax benefits, interest and penalties excluded from reserves		2
Interest and penalties expenses	1	1	1
Unrecognized tax benefits that if recognized would affect ETR	48
European Tinplate
Income Taxes [Line Items]
(Benefit from) / provision for income taxes	42
European Tinplate | Transit Packaging
Income Taxes [Line Items]
(Benefit from) / provision for income taxes	(18)
Signode
Income Taxes [Line Items]
Tax loss carryforwards	33
INDIA
Income Taxes [Line Items]
Tax contingencies			9
Brazil
Income Taxes [Line Items]
Increase in net income attributable to the Company resulting from incentives	21	$ 17	17
Signode
Income Taxes [Line Items]
Tax contingencies			15
State
Income Taxes [Line Items]
Tax loss carryforwards	110
Valuation allowance	167
France
Income Taxes [Line Items]
(Benefit from) / provision for income taxes	44
Tax loss carryforwards	$ 62
Internal Reorganization
Income Taxes [Line Items]
(Benefit from) / provision for income taxes			$ 36

Income Taxes (Components of Def

Income Taxes (Components of Deferred Taxes) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Assets
Tax carryforwards	$ 346	$ 424
Intangible assets	0	0
Property, plant and equipment	21	24
Accruals and other	105	124
Accruals and other	96	89
Asbestos	56	61
Postretirement and postemployment benefits	31	35
Lease liabilities	29	34
Valuation allowances	(227)	(204)
Total	457	587
Liabilities
Tax carryforwards	0	0
Intangible assets	317	354
Property, plant and equipment	176	130
Pensions	13	101
Accruals and other	109	84
Asbestos	0	0
Postretirement and postemployment benefits	0	0
Right of use assets	28	33
Total	$ 643	$ 702

Income Taxes (Tax Loss and Cred

Income Taxes (Tax Loss and Credit Carryforwards Expirations) (Details) $ in Millions	Dec. 31, 2021USD ($)
Income Tax Disclosure [Abstract]
2022	$ 10
2023	12
2024	13
2025	28
2026	24
Thereafter	142
Unlimited	$ 117

Income Taxes (Reconciliation of

Income Taxes (Reconciliation of Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of period	$ 42	$ 39	$ 35
Additions for prior year tax positions	9	1	20
Lapse of statute of limitations	(1)	0	(1)
Settlements	0	0	(15)
Foreign currency translation	(2)		0
Foreign currency translation		2
Balance at end of period	$ 48	$ 42	$ 39

Capital Stock (Summary of Commo

Capital Stock (Summary of Common Stock Activity) (Details) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common shares outstanding at beginning of period (in shares)	134,801,030	135,577,878	135,173,948
Shares repurchased (in shares)	(9,121,328)	(1,240,328)	(106,388)
Shares issued upon exercise of employee stock options (in shares)	0	0	70,000
Common shares outstanding at end of period (in shares)	126,131,799	134,801,030	135,577,878
Restricted stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued to employees, net of forfeitures (in shares)	435,129	439,700	416,695
Share-based Payment Arrangement | Share-based Payment Arrangement, Nonemployee
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued to employees, net of forfeitures (in shares)	16,968	23,780	23,623

Capital Stock (Narrative) (Deta

Capital Stock (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	Feb. 24, 2022	Feb. 25, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 09, 2021	Feb. 28, 2021
Class of Stock [Line Items]
Common stock, dividends, per share, declared (in dollars per share)		$ 0.80
Stock repurchase program, authorized amount						$ 3,000	$ 1,500
Common stock repurchased			$ 950	$ 66	$ 7
Preferred stock, shares authorized (in shares)			30,000,000	30,000,000
Subsequent Event
Class of Stock [Line Items]
Common stock, dividends, per share, declared (in dollars per share)	$ 0.22

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss Attributable to Crown Holdings (Schedule of AOCI) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Increase (Decrease) in AOCI [Roll Forward]
Balance at beginning of period	$ 2,604	$ 2,092
Other comprehensive (loss) / income before reclassifications	(300)	(199)
Amounts reclassified from accumulated other comprehensive income	1,595	137
Other comprehensive income / (loss)	1,295	(62)
Balance at end of period	2,330	2,604
Defined benefit plans
Increase (Decrease) in AOCI [Roll Forward]
Balance at beginning of period	(1,464)	(1,449)
Other comprehensive (loss) / income before reclassifications	(419)	(117)
Amounts reclassified from accumulated other comprehensive income	1,115	102
Other comprehensive income / (loss)	696	(15)
Balance at end of period	(768)	(1,464)
Foreign currency translation
Increase (Decrease) in AOCI [Roll Forward]
Balance at beginning of period	(1,759)	(1,668)
Other comprehensive (loss) / income before reclassifications	48	(91)
Amounts reclassified from accumulated other comprehensive income	553	0
Other comprehensive income / (loss)	601	(91)
Balance at end of period	(1,158)	(1,759)
Gains and losses on cash flow hedges
Increase (Decrease) in AOCI [Roll Forward]
Balance at beginning of period	30	(14)
Other comprehensive (loss) / income before reclassifications	71	9
Amounts reclassified from accumulated other comprehensive income	(73)	35
Other comprehensive income / (loss)	(2)	44
Balance at end of period	28	30
Accumulated Other Comprehensive Loss
Increase (Decrease) in AOCI [Roll Forward]
Balance at beginning of period	(3,193)	(3,131)
Balance at end of period	$ (1,898)	$ (3,193)

Revenue (Narrative) (Details)

Revenue (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized	$ 11,394	$ 9,392	$ 9,559
Transferred over Time
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized	6,097	5,032	4,778
Transferred at Point in Time
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue recognized	$ 5,297	$ 4,360	$ 4,781

Revenue (Contracts with Custome

Revenue (Contracts with Customer Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Net contract assets	$ 23	$ 20

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2021USD ($)shares
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for future issuance (in shares) | shares	2.2
Time-vested restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years) for shares awarded	3 years
Performance-based shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period (in years) for shares awarded	3 years
Award vesting period	3 years
Level of performance achieved based on shares awarded, minimum	0.00%
Level of performance achieved based on shares awarded, maximum	200.00%
Time-vested restricted stock and deferred stock | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	3 years
Time-vested restricted stock and deferred stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period	5 years
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 48
Weighted average recognition period, in years	1 year 10 months 24 days
Aggregate market value of the shares released and issued on the vesting dates	$ 66

Stock-Based Compensation (Summa

Stock-Based Compensation (Summary of Restricted Stock Transactions) (Details)	12 Months Ended
	Dec. 31, 2021shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested shares outstanding at beginning of period (in shares)	1,820,159
Non-vested shares outstanding at end of period (in shares)	1,284,206
Time-vesting
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Awarded (in shares)	221,042
Released (in shares)	(418,426)
Forfeitures (in shares)	(284,247)
Performance-based
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Awarded (in shares)	170,036
Released (in shares)	(224,358)
Forfeitures (in shares)	0

Stock-Based Compensation (Sched

Stock-Based Compensation (Schedule of Grant Date Fair Value of Restricted Stock) (Details) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Time-vesting
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average grant-date fair value of restricted stock awarded (in dollars per share)	$ 100.08	$ 70.07	$ 56.06
Performance-based
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Average grant-date fair value of restricted stock awarded (in dollars per share)	$ 100.99	$ 72.08	$ 46.08

Stock-Based Compensation (Fair

Stock-Based Compensation (Fair Value Assumptions) (Details) - Performance-based shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	0.20%	1.60%	2.50%
Expected term (years)	3 years	3 years	3 years
Expected stock price volatility	35.50%	22.00%	21.40%

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Earnings Per Share [Abstract]
Net (loss) / income from continuing operations attributable to Crown Holdings	$ (507)	$ 424	$ 387
Net (loss) / income from discontinued operations attributable to Crown Holdings	(53)	155	123
Net (loss) / income attributable to Crown Holdings	$ (560)	$ 579	$ 510
Weighted average shares outstanding:
Basic (in shares)	130,380	133,530	133,890
Add: dilutive stock options and restricted stock (in shares)	0	1,030	990
Diluted (in shares)	130,380	134,560	134,880
Basic (loss) / earnings per common share from continuing operations (in dollars per share)	$ (3.89)	$ 3.18	$ 2.89
Basic (loss) / earnings per common share from discontinued operations (in dollars per share)	(0.41)	1.16	0.92
Basic (in dollars per share)	(4.30)	4.34	3.81
Diluted (loss) / earnings per common share from continuing operations (in dollars per share)	(3.89)	3.15	2.87
Diluted (loss) / earnings per common share from discontinued operations (in dollars per share)	(0.41)	1.15	0.91
Diluted (in dollars per share)	$ (4.30)	$ 4.30	$ 3.78
Contingently issuable shares excluded from the computation of diluted earnings per share because the effect would have been anti-dilutive (in shares)	1,000	700	800

Segment Information (Informatio

Segment Information (Information About Operating Segments) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Net sales	$ 11,394	$ 9,392	$ 9,559
Segment assets	13,858	16,691	12,718
Segment assets		13,792
Depreciation	282	260	267
Capital expenditures	787	554	391
Segment income	1,363	1,048	1,027
Operating segments
Segment Reporting Information [Line Items]
Net sales	10,136	8,224	8,430
Segment assets	12,487		11,120
Segment assets		11,866
Depreciation	261	241	251
Capital expenditures	689	514	341
Segment income	1,515	1,296	1,208
Operating segments | Americas Beverage
Segment Reporting Information [Line Items]
Net sales	4,441	3,565	3,369
Segment assets	4,453		3,577
Segment assets		3,886
Depreciation	108	93	88
Capital expenditures	508	333	167
Segment income	756	652	534
Operating segments | European Beverage
Segment Reporting Information [Line Items]
Net sales	1,843	1,473	1,497
Segment assets	2,025		1,782
Segment assets		1,977
Depreciation	51	47	54
Capital expenditures	55	72	82
Segment income	259	215	190
Operating segments | Asia Pacific
Segment Reporting Information [Line Items]
Net sales	1,322	1,168	1,290
Segment assets	1,784		1,604
Segment assets		1,808
Depreciation	61	56	52
Capital expenditures	68	69	65
Segment income	182	175	194
Operating segments | Transit Packaging
Segment Reporting Information [Line Items]
Net sales	2,530	2,018	2,274
Segment assets	4,225		4,157
Segment assets		4,195
Depreciation	41	45	57
Capital expenditures	58	40	27
Segment income	318	254	290
Intersegment sales
Segment Reporting Information [Line Items]
Net sales	272	154	133
Intersegment sales | Reportable segments
Segment Reporting Information [Line Items]
Net sales	158	54	23
Intersegment sales | Americas Beverage
Segment Reporting Information [Line Items]
Net sales	0	2	12
Intersegment sales | European Beverage
Segment Reporting Information [Line Items]
Net sales	133	39	2
Intersegment sales | Asia Pacific
Segment Reporting Information [Line Items]
Net sales	0	0	0
Intersegment sales | Transit Packaging
Segment Reporting Information [Line Items]
Net sales	25	13	9
Intersegment sales | Other
Segment Reporting Information [Line Items]
Net sales	114	100	110
Other | Other
Segment Reporting Information [Line Items]
Net sales	1,258	1,168	1,129
Segment assets	1,129		904
Segment assets		927
Depreciation	17	15	14
Capital expenditures	58	30	24
Segment income	144	114	120
Corporate and unallocated items
Segment Reporting Information [Line Items]
Net sales	0	0	0
Segment assets	242		694
Segment assets		999
Depreciation	4	4	2
Capital expenditures	$ 40	$ 10	$ 26

Segment Information (Reconcilia

Segment Information (Reconciliation of Segment Income) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment income	$ 1,363	$ 1,048	$ 1,027
Restructuring and other	28	(30)	30
Amortization of intangibles	(165)	(162)	(169)
Loss from early extinguishments of debt	(68)	0	(27)
Other pension and postretirement	(1,515)	(43)	(10)
Interest expense	(253)	(290)	(367)
Interest income	9	8	15
Foreign exchange	45	2	(7)
(Loss) / income from continuing operations before income taxes and equity in net earnings of affiliates	(419)	725	631
Intercompany profit related to non-reportable segments	8	9	6
Operating segments
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment income	1,515	1,296	1,208
Other | Other
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Segment income	144	114	120
Corporate and unallocated items
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Corporate and unallocated items	$ (159)	$ (170)	$ (162)

Segment Information (Summary of

Segment Information (Summary of Sales by Major Product) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Revenue recognized	$ 11,394	$ 9,392	$ 9,559
Metal beverage cans and ends
Segment Reporting Information [Line Items]
Revenue recognized	6,982	5,716	5,588
Metal food cans and ends
Segment Reporting Information [Line Items]
Revenue recognized	789	733	730
Transit Packaging
Segment Reporting Information [Line Items]
Revenue recognized	2,530	2,018	2,274
Other metal packaging
Segment Reporting Information [Line Items]
Revenue recognized	513	474	510
Other products
Segment Reporting Information [Line Items]
Revenue recognized	$ 580	$ 451	$ 457

Segment Information (Concentrat

Segment Information (Concentration Risk) (Details) - Revenue Benchmark - Customer Concentration Risk	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Customer A
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%	11.00%	12.00%
Customer B
Concentration Risk [Line Items]
Concentration risk, percentage	11.00%	10.00%

Segment Information (Summary _2

Segment Information (Summary of Sales and Long-Lived Assets for The Major Countries) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Net sales	$ 11,394	$ 9,392	$ 9,559
Long-Lived Assets	4,036	3,652
United States
Segment Reporting Information [Line Items]
Net sales	4,182	3,586	3,407
Long-Lived Assets	1,259	922
Brazil
Segment Reporting Information [Line Items]
Net sales	933	706	714
Long-Lived Assets	510	396
Mexico
Segment Reporting Information [Line Items]
Net sales	896	681	834
Long-Lived Assets	437	421
Canada
Segment Reporting Information [Line Items]
Net sales	782	662	508
Long-Lived Assets	97	93
United Kingdom
Segment Reporting Information [Line Items]
Net sales	412	234	253
Long-Lived Assets	96	81
Other
Segment Reporting Information [Line Items]
Net sales	4,189	3,523	$ 3,843
Long-Lived Assets	$ 1,637	$ 1,739

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts and Reserves (Details) - Deferred tax assets - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at beginning of period	$ 204	$ 242	$ 281
Charged to costs and expense	38	(11)	(33)
Charged to other  accounts	(3)	1	5
Acquisitions	0	0	0
Deductions – write-offs	(12)	(28)	(11)
Balance at end of period	$ 227	$ 204	$ 242